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Pulmonary Arterial Hypertension (PAH) is a progressive, potentially fatal disease that 
results in the remodeling of the pulmonary vasculature.  Currently the gold standard for 
diagnosis of pulmonary hypertension is through right heart catheterization, an invasive and 
costly procedure where pressure measurements are made directly within the affected vessels. 
Since PAH is associated with the remodeling of the pulmonary arteries, others have proposed 
quantifying the vessel geometry depicted in computed tomography (CT) images as a non-
invasive technique for diagnosis of PAH. The work presented here proposes a similar method of 
diagnosis by defining and incorporating techniques that are both manual in nature in reference to 
the segmentation process and automated with the modeling and anatomic measurement 
quantification steps. Data comprised of both normal and disease cases were gathered and the 
vessel geometry (specifically the pulmonary trunk, right main pulmonary artery and the left main 
pulmonary artery) were measured both manually and automatically. A comparison of the 
automated measurements of the vessel geometry to the manual measurements showed no 
significant difference between the means of the two groups. A significant difference was found 
between the cases and the controls leading to the possibility of classifying images based on the 
vessel geometry. Logistic regression and naïve Bayes models were constructed from the data for 
discriminating the cases from the controls. Overall, the Naïve Bayes model performed better 
with a higher sensitivity of 42.9% compared to 19% and a small decrease in specificity of 90.9% 
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 v 
from 96.6%, and the model is able to classify correctly more of the patients with disease. Due to 
the permanent nature of the disease a type I error is acceptable; we prefer to classify patients that 
do not have the disease as positives than vice versa. We found that the segmenting of additional 
branches of the pulmonary vasculature could provide additional information for the improvement 
of the models presented here. In conclusion, we were able to quantify the vessel geometry 
depicted in CT images as a non-invasive technique for diagnosing PAH and we have shown that 
the two classes of measurements are not significantly different.   
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1.0  INTRODUCTION 
This chapter summarizes the motivation and the main goals for this study. 
1.1 DESCRIPTION AND SIGNIFICANCE OF THE PROBLEM 
Pulmonary hypertension (PH) is a common condition that is often overlooked until late in 
its progression [1].  PH affects thousands of people each year in the United States and a prompt 
and accurate diagnosis is vital to improving patient outcome. In 2002 in the United States, 
15,668 people died and 260,000 were hospitalized for PH [2, 3]. The focus of this research is on 
a subset of PH specifically, pulmonary arterial hypertension (PAH).  Although PAH is a rare 
disease it is becoming more and more prevalent. A study published in 2011 by Frost et al. stated 
that the prevalence of category 1 PAH as defined by the world health organization is 10.6 
cases/million of adult inhabitants and incidence of 2.0 cases/million of adult inhabitants/year in 
the United States [4].  In 2010 a study by Bandesch et al. reported using information gathered 
from registries in France and the United States that the mean age at diagnosis is 50 years with the 
ratio of female to male of 3.9 [5]. Currently, the median interval from symptom onset to 
diagnosis is 1.1 years [5]; this has not changed since the 1980’s [6]. In 2007 it was reported that 
3-year survival has improved from 48% reported in 1991 [7] to 67% in the U.S [8].  
Diagnosis of PAH is currently obtained with pressure measurements acquired with right 
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heart catheterization, an invasive and costly procedure. However, since PAH results in a 
remodeling of the pulmonary vasculature, it is possible that non-invasive visualization of the 
pulmonary arteries (via magnetic resonance imaging (MRI) or computed tomography (CT)) may 
provide sufficient information for diagnosing PAH. It may be possible to identify the presence of 
disease from the vasculature remodeling prior to symptom onset and improve the time it takes 
for detection and diagnosis. The work described in this dissertation will establish the technical 
basis for semi-automated pulmonary vasculature quantification and demonstrate the feasibility of 
using this semi-automated quantification to diagnose PAH. In this work we use Computed 
Tomography Pulmonary Angiography (CTPA) examinations, since these examinations are 
readily available from the UPMC PACS (University of Pittsburgh Medical Center Picture 
Archiving and Communication Systems). However, in principle, the techniques we have 
developed here could also be applied to Magnetic Resonance Pulmonary Angiography. 
1.2 TWO HYPOTHESES 
Hypothesis 1: Accurate models of the pulmonary arterial tree can be generated semi-
automatically from CTPA images. (Specific Aims 1 and 2 below) 
To address the problem of finding a method of diagnosing PAH in a non-invasive 
manner, the first step is to establish the technical basis for pulmonary vasculature quantification; 
this is described in the first hypothesis. 
Hypothesis 2: Morphological measurements made from the semi-automatically generated 
models can accurately differentiate pulmonary hypertension cases from healthy control cases. 
 3 
(Specific Aim 3 below) 
The second hypothesis will demonstrate the feasibility of using the methods derived in 
the first hypothesis for modeling the pulmonary vasculature for quantification of said vasculature 
in the diagnosis of PAH.  
To test and further define these hypotheses we performed the following specific aims: 
1.2.1 Specific Aims for Hypothesis 1 
Specific Aim 1: Create a repository of CTPA exams. The exams consisted of cases that are 
positive for PAH and controls that are negative for PAH. 
 To determine the ability of modeling the pulmonary vasculature data it is necessary to 
learn and improve the modeling process. Specific aim 1 is focused solely on gathering this data.  
 
Specific Aim 2: Create and validate PUMA, a PUlmonary Mapping and Analysis tool that semi-
automatically generates pulmonary vascular models.  
 In this aim we take the data identified in aim 1 and use it for generating vascular models 
for quantification. 
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1.2.2 Specific Aim for Hypothesis 2 
Specific Aim 3: Use PUMA to diagnose PAH. This was done by performing semi-automated 
measurements of vascular diameters and making comparisons to measurements from known 
normal cases. 
The final aim takes the output (models) generated in the first hypothesis, specifically aim 
2 and learns characteristic information of the vasculature along with quantifying the vasculature 
for the classification of disease. 
1.3 GLOSSARY OF TERMS 
This section summarizes and defines the key acronyms used throughout this dissertation. 
 
CT or CTPA (Computed Tomography or Computed Tomography Pulmonary 
Angiography) ~ an imaging modality that uses x-rays for gathering data on the pulmonary 
vasculature. 
LMPA ~ Left Main Pulmonary Artery 
MPAP or PAMP (Mean Pulmonary Artery Pressure) ~ Pressure measurement taken during 
the right heart catheterization procedure used in the diagnosis of disease. 
PH (Pulmonary Hypertension) ~ Disease associated with the atrophy of the pulmonary blood 
vessels. 
PAH (Pulmonary Arterial Hypertension) ~ Sub-category of etiologies that are known causes 
of pulmonary hypertension 
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PCWP (Pulmonary Capillary Wedge Pressure) ~ Pressure measurement taken during the 
right heart catheterization procedure used in the diagnosis of disease. 
PT ~ Pulmonary Trunk 
PVR (Pulmonary Vascular Resistance) ~ is the resulting measure of the TPG divided by the 
cardiac output. A value greater than 2.5-3 Woods units is indicative of disease. 
RMPA ~ Right Main Pulmonary Artery 
RV (Right Ventricle) ~ the anatomical location in the heart whose health is associated with 
determining stage of disease. 
TPG (Trans-pulmonary Gradient) ~ the difference between the MPAP and the PCWP, a value 
<15 mmHg indicates the presence of disease. 
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2.0  BACKGROUND 
This chapter is a review of background relevant to both the problem and the proposed 
solution. An overview is given of PAH, related diagnostic techniques including both imaging 
and non-imaging tests, and the basis of the algorithmic approaches for the vascular analysis. 
Figure 1. Diagram of the Heart and Lungs as a Reference Guide 
 
*This image is from http://www.bartleby.com/107/138.html and is in the public domain because 
its copyright has expired. 
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2.1 ANATOMY OF THE PULMONARY VASCULATURE 
A widely used nomenclature of the pulmonary arteries is as follows. The first order artery 
is the pulmonary trunk, which then bifurcates into the second order arteries, the left and right 
main pulmonary arteries (LMPA and RMPA respectively). The RMPA is longer than the left and 
travels down toward the right lung, passing beneath the aortic arch before bifurcating into the 
third order arteries or upper and lower trunks also known as lobar arteries. The LMPA is a 
continuation of the pulmonary trunk and travels over the left main bronchus before splitting into 
the lobar arteries. The fourth order arteries are the segmental arteries whose branching pattern 
follows that of the segmental bronchi, with a total of ten segmental arteries on the right and eight 
on the left. The fifth order arteries are the subsegmental arteries, which arise directly from the 
segmental arteries. The final order to be discussed is the sixth order which are the arteries that 
arise directly from the first divisions of the subsegmental arteries [9]. This research is focused on 
the first and second order arteries only due to the difficulties with the segmentation process that 
will be described in detail in following sections. Figure 2a is a screenshot of an examination used 
in this study with the pulmonary vasculature anatomy labeled as used in this research. Figure 2b 
is a drawing reproduced from “Gray’s Anatomy” showing the pulmonary anatomy. 
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*This image is from “Gray’s Anatomy” and is in the public domain because its copyright has 
expired. 
Figure 2a) Computed Tomography Exam with Labeled Pulmonary Vasculature, 2b) Drawing of 
the pulmonary arteries showing the branching of the arteries. 
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2.2 OVERVIEW OF PULMONARY ARTERIAL HYPERTENSION  
Pulmonary hypertension (PH) is a complex disorder with many etiologies which are 
divided into five main categories. Table 1 outlines these categories in the revised World Health 
Organization (WHO) classification of PH [10]. According to the current definitions the focus of 
the research presented here is on pulmonary arterial hypertension (PAH) (WHO Group 1 in 
Table 1.). 
In 1951 Dr. David Dresdale coined the phrases “primary” and “secondary” pulmonary 
hypertension.  These terms have since been replaced with pulmonary arterial hypertension (PAH, 
WHO Group 1) and PH resulting from other causes (WHO Groups 2-5), respectively 
(ACCF/AHA 2009).  
Pulmonary arterial hypertension (PAH) is defined as abnormal elevation of pressure in 
the mean pulmonary artery pressure (MPAP) > 25 mmHg at rest or > 30 mmHg during exercise 
[11] and pulmonary venous pressure (also defined as left atrial or left ventricular end-diastolic 
pressure) ≤ 15 mm Hg. It is, by definition, an abnormality of the pulmonary arterial vascular bed. 
In a healthy, normal patient, the pulmonary vascular bed can handle the volume of blood passed 
through the pulmonary arteries from the right ventricle at a normal resting flow of approximately 
5 L/min at rest and up to 30 L/min with exercise. There is low resistance to the blood flow, and 
when the volume of the blood increases, the vessels dilate in compensation. In patients with 
PAH, the vascular bed is deteriorated and the ability for the pulmonary vessels to compensate for 
increased flow or volume is impaired, resulting in an increase in the arterial pressure. In relation 
to the heart this means that when the pressure is elevated for a prolonged amount of time the 
right ventricle hypertrophies in order to compensate for the increased resistance. Over time the 
right ventricle will dilate and eventually fail [1]. 
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The prognosis of PAH is poor; there is a 15% mortality rate for the first year with modern 
therapies. Median survival without treatment is 2.8 years with 1-, 3-, and 5-year survival rates of 
68%, 48%, and 34%, respectively [7]. With continuous prostanoid treatment this has improved to 
be 87-88%, 63-71%, and 56%, respectively [12, 13].  Similar results have been seen with the oral 
endothelin receptor antagonist bosentan monotherapy (82-96%, 67-89% at 1 and 2 years) [14].  
Characteristics used in predicting a poor prognosis include advanced functional class, poor 
exercise capacity measured by the 6-minute walk test, high right atrial pressure, significant right 
ventricular dysfunction, evidence of RV failure, low cardiac index, elevated brain natriuretic 
peptide, and an underlying diagnosis of scleroderma spectrum of diseases (i.e. diseases that 
involve the fibrosis or hardening of the skin that can affect all areas of the body including the 
organs) [10, 15]. RV function in particular is a critical determinant of patient outcomes in PH, 
causing at least half of all PH deaths, and has recently been recognized as an important avenue 
for further research [7, 16]. However, current markers of RV failure that have been associated 
with poor outcomes only recognize end stage disease. Identifying which patients will progress to 
RV failure and at what time in the course of disease has been difficult.  
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Table 1. Revised WHO Classification of PH [10]. 
 
 
 
 
 
Main Categories Sub-Categories Specific Etiologies 
1. Pulmonary 
Arterial  
Hypertension 
(PAH) 
1.1.  Idiopathic (IPAH) 
 
1.2.  Familial (FPAH) 
 
1.3.  Associated with (APAH) 
 
1.4.  Associated with Significant 
venous or capillary involvement 
 
1.5.  Persistent pulmonary 
hypertension of the newborn 
1.3.1 APAH causes: 
Connective tissue disorder, Congenital 
systemic-pulmonary shunts, Portal 
hypertension, HIV infection, Drugs and 
toxins, Thyroid disorders, Glycogen 
storage disease, Gaucher’s disease 
Hereditary hemorrhagic telanglectasia, 
Hemoglobinopathies, Chronic 
myeloproliferative disorders, splenectomy 
1.4.1 Causes: 
Pulmonary veno-occlusive disease 
(PVOD), Pulmonary capillary 
hemangiomatosis (PCH) 
2. Pulmonary 
Hypertension 
with Left Heart 
Disease 
2.1 Left-sided atrial or ventricular 
heart disease 
 
2.2 Left-sided valvular heart disease 
 
3. Pulmonary 
Hypertension 
associated with 
lung diseases 
and/or 
hypoxemia 
3.1. Chronic Obstructive Pulmonary 
Disease  
 
3.2.  Interstitial Lung Disease 
3.3.  Sleep disordered breathing 
 
3.4.  Alveolar hypoventilation 
disorders 
 
3.5. Chronic Exposure to high 
altitude 
3.6.   Developmental Abnormalities 
 
4. Pulmonary 
Hypertension 
due to Chronic 
Thrombotic 
and/or embolic 
disease 
(CTEPH) 
4.1. Thromboembolic obstruction of 
proximal pulmonary arteries 
 
4.2. Thromboembolic obstruction of 
distal pulmonary arteries 
 
4.3.Nonthrombotic pulmonary 
embolism  
4.3.1 Causes: 
Tumor, parasites, foreign material 
5. Miscellaneous 
 Sarcoidosis, Histiocytosis X, 
Lymphangiomatosis, Compression of the 
pulmonary vessels (adenopathy, tumor, 
fibrosing meadiastinitis) 
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2.2.1 Diagnosing PAH 
Pressure values obtained from right-sided heart catheterization are the gold standard in 
PH diagnosis [1, 17-19]. Pressure measurements such as the mean pulmonary artery pressure 
(MPAP), pulmonary capillary wedge pressure (PCWP), trans-pulmonary gradient (TPG = MPAP 
- PCWP), and pulmonary vascular resistance (PVR = TPG / cardiac output) are how the disease 
is defined and diagnosed. A PCWP < 15 mmHg, a PVR value greater than 2.5-3 Woods units 
and a TPG > 10 mmHg are all indicative of PAH. Heart catheterization is an invasive procedure 
with known complications [17-19]. According to a study by Hoeper et. al., out of 7,218 right 
heart catheterization procedures there were 76 (1.1%) adverse events and four (0.055%) fatal 
events [20]. In regards to the study they report the more frequent complications were related to 
venous access and arrhythmias [20]. Other common complications include infection, bleeding 
and pain at the catheter insertion point [21]. Damage to the blood vessels can occur while the 
catheter is being threaded to the heart.  The catheter may cause a hole or scrape the vessel along 
the way. However, this is a rare event [21]. Other less common complications include 
arrhythmias, blood clots, low blood pressure, and a buildup of fluid in the pericardium from 
perforation of the heart, and pulmonary artery rupture [20, 21]. Incidence rates for these 
complications were not reported in the referenced studies; however, although they are “common” 
complications they are also rare events.  
In addition to the health related complications there is also the issue of expense. Heart 
catheterization is a costly procedure, reducing the need for this test would lower the expense 
involved in obtaining the diagnosis.  
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Studies have been done to identify less invasive procedures for the diagnosis of PH, in 
particular using computed tomography (CT) of the chest. One such study is by Grubstein et al. 
[22]. They wanted to "assesses the capability  of computed tomography angiography and high 
resolution CT to diagnose and estimate the severity of pulmonary hypertension as compared with 
standard means of right heart catheterization, echocardiography and pulmonary function tests" 
[22].  They measured the diameters of the ascending aorta, main pulmonary trunk and the right 
and left main arteries. They then compared their findings to their control group and concluded 
that the "size of the main pulmonary artery on CT angiography has a good predictive value 
regarding the severity of pulmonary hypertension."  It has also been reported by Grubstein et al. 
that there may be a "correlation between the ratio of the main pulmonary artery ascending aorta 
diameters and the pressure measurement by right heart catheterization [22]." A key component 
of this dissertation research is to understand the relationship of the sizes of these vessels and the 
physical changes they go through when affected by PH. Another group, Engelke et al., generated 
a review article "High-resolution CT and CT Angiography of Peripheral Pulmonary Vascular 
Disorders." In their review they reported that "the correlation between pulmonary artery dilation 
and the degree of pulmonary hypertension at CT angiography is nonlinear" [23]. It also mentions 
that for adult patients a diameter of 29 mm for the distal main pulmonary artery at its widest 
point has a positive predictive value of 95%, and if the width exceeds the diameter of the 
ascending aorta then it also has a positive predictive value of 95% [23]. Ng et al. performed a 
study to determine if the ratio of the main pulmonary artery diameter to the aortic diameter can 
be predictive of PH using CT exams [24]. They performed a series of analyses incorporating age 
as a variable in their analysis. They concluded that if the patient is younger than 50 years of age, 
there is a strong correlation between the pulmonary artery radius and the mean pulmonary artery 
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pressure in a heterogeneous study. They conclude that a ratio greater than 1 is indicative of PH 
[24].  Another group Edwards et al. report that patients with a main pulmonary artery diameter 
greater than 3.32 cm is indicative of PH [25].  
Up to this point all of the referenced studies have performed their analysis using manual 
measurements of the vasculature by experts. Our approach is a semi-automated method of 
measuring the necessary vasculature, using manual calculations as a way of checking the validity 
of our model. Devaraj et al. [26] performed a comparison of the CT measurements and the mean 
arterial pressure using linear regression, followed by a multivariate regression to establish a 
pressure index and lastly they ran a logistic regression and ROC analysis to test the diagnostic 
ability of the CT-echocardiography composite. They concluded that the combination of "CT and 
echocardiographic markers of PH is more closely related to the mean arterial pressure than either 
test" alone [26]. In this study we will be performing a similar regression-based analysis using 
CTPA images and pressure measurements gathered from right heart catheterization tests. The 
underlying goal of these studies is the same as ours: to find alternative, less invasive yet reliable 
methods for the diagnosis of PAH.  
Another related area of research focuses on the distensibility of the pulmonary artery. The 
difference in size of the pulmonary artery is measured between systole and diastole during the 
cardiac cycle. The group Abel et al. in a study titled “Pulmonary artery and right ventricle 
assessment in pulmonary hypertension: correlation between functional parameters of ECG-gated 
CT and right-side heart catheterization” reported that “Pulmonary artery distensibility was 
significantly correlated to mPAP” [27] or mean pulmonary artery pressure.  
While the studies listed here are not exhaustive, they provide a representative sample of 
the studies that have been reported.   
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For the detection of PH from visualization of the pulmonary arteries, most radiologists 
concentrate on the dilation of the main pulmonary artery both in absolute terms and in relation to 
the ascending aorta [23, 26]. Another sign of PH is the tapering of peripheral arteries [23]. It has 
been suggested that using computer aided detection (CAD) to assist radiologists may reduce the 
number of false negatives [28].  
 
2.3 IMAGING TECHNIQUES USED IN DIAGNOSING PH 
 This section provides a review of the imaging tools that are currently available. Although 
the focus of this dissertation is on the use of CT images all of the modalities discussed can be 
used in the detection of PH in some capacity and may have the potential for similar studies for 
the diagnosis of PH. The field of medical imaging is just over 100 years old, however, the 
concept has been around for centuries [29-33]. The purpose of the field is to allow the clinician 
to see inside in the patient to diagnose a condition by visualizing the data obtained directly from 
the patient. The main focus of medical imaging is to improve the quality of the images for 
radiologists to evaluate. A Czech mathematician, Johann Radon derived a transform for 
reconstructing cross sectional information from a series of planar projections from around an 
object, also known as a 3D image [30, 31]. Although these theories have been known for over 
fifty years, it was not until the 1970's when digital computing was finally powerful enough to 
create images from the data that cross sectional imaging became prevalent in medicine [31].  
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2.3.1 X-Ray 
Wilhelm Conrad Roentgen accidentally discovered x-rays in 1895 while experimenting 
with electron beams. While experimenting, he noticed a fluorescent screen in his lab began to 
glow when the beam was turned on. This was expected to occur when fluorescent materials were 
exposed to electromagnetic radiation. However, he attempted to block the radiation with 
cardboard and the glowing screen was not expected.  Roentgen experimented by placing a 
number of different objects between the tube and the screen in an attempt to prevent the screen 
from glowing. He then placed his hand between the two and the silhouette of the bones in his 
hand could be seen on the screen. Roentgen immediately recognized the value of using x-ray 
radiation for imaging and the positive effects it could have on the medical community [30, 31, 
33].  Six years after announcing his achievement he received the Nobel prize [30, 31]. X-rays 
were denoted as such by Roentgen because the type of radiation that was occurring was 
unknown [29, 32]. X-rays are a form of ionizing radiation and long term exposure can be 
detrimental to one's health. Health issues can arise if 1) the rays carry enough energy that when 
they collide with atoms within the patient's body they cause electrons to detach from those atoms 
resulting in free floating negatively charged electrons and or positively charged ions, and 2) the 
exposure to the rays is long enough [34]. The heart of an X-ray machine is an electrode pair 
made up of a cathode and an anode housed in a glass vacuum tube.  The cathode contains a 
filament that is heated by passing current through it.  The heat causes negatively charged 
electrons to be ejected from the filaments surface. The positively charged anode, composed of a 
flat tungsten disc, pulls the electrons through the tube. There is a large voltage difference 
between the cathode and anode causing the electrons to fly through the tube with a great deal of 
force. This process creates x-rays in two ways. The first is the photoelectric effect, which occurs 
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when the electrons collide with the tungsten atoms of the anode with such force that it kicks an 
electron off the lower orbital of the tungsten atom. To stabilize the tungsten an electron from the 
higher orbital must drop down to fill the place of the ejected electron. This drop from a high 
energy level to the low level causes a release in energy in the form of an x-ray photon. The 
second way is due to Compton's Scattering, which occurs when the tungsten atom's nucleus 
attracts the moving electron just enough to change its course. The electron slows down as it 
speeds past the nucleus to change direction. The action of slowing down causes the electron to 
emit energy in the form of an x-ray photon [34-36].  To combat the heat that these processes 
generate the machine contains a motor that rotates the anode to prevent it from melting and 
immerses the anode in an oil bath to diffuse the heat. The entire machine is surrounded by a thick 
lead shield to prevent the x-rays from escaping in all directions. A small window in the shield 
allows some of the x-ray photons to escape in a narrow beam. The beam then travels through a 
series of filters on its way to the patient. A detector placed on the opposite side of the patient 
records the pattern of x-ray light that passes all the way through the patient's body [34, 36].  
2.3.2 Computed Tomography (CT) 
Ronald Bracewell and William Oldendorf were the first two pioneers of CT imaging. 
They gathered their data and in 1955 Bracewell was able to reconstruct a two-dimensional map 
of a solar image using Fourier transforms. In 1960 Oldendorf lacked the computational tools to 
interpret the quantity of data he would need to generate the images but was able to demonstrate 
how to reconstruct a two-dimensional display of images and the beginnings of the CT machine 
[31]. The main goal of Oldendorf's work was to determine whether internal structures within 
dense structures could be identified by transmission measurements [37].  It was not until the 
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1970's when digital computing was finally powerful enough, to create images from the data [30].  
The CT scanner began as a crude instrument in 1971 in London by Godfrey Hounsfield [31, 38]. 
It was installed in Atkinson Morley Hospital[38]. However, three-dimensional imaging was not 
seen until 1972 when X-ray computed tomography (CT) was independently developed by 
Godfrey Hounsfield and Alan Cormack. For their discovery they shared the Nobel prize in 
medicine in 1979. Their primary contribution was the engineering aspect that proved what had 
previously been theorized on paper by the scientists that came before.  These systems where 
patented in 1975 and began being used shortly thereafter [30].  A CT scan is developed using x-
rays to generate tomographic images that “slice” through the body. (“Tomos” is Greek for slice 
or section.) In a typical CT, the technician first places the patient on the table and performs what 
is called a "scout view", a 2D image of the patient.  The goal is to learn anatomical landmarks 
and to determine the exact location and range of the CT scans. Once the scout scan is completed, 
the computer system sends instruction to the table, the x-ray tube and detector. The table travels 
horizontally at a constant speed while both the x-ray tube and detector remains stationary.  See 
Figure 3, the patient is lying on the table as it moves through the opening in the machine that 
houses the x-ray tube and detector. The high voltage generator achieves the desired voltage and 
keeps both the voltage and the current to the x-ray rotation tube at the predetermined level. The 
x-ray tube produces a fan shaped beam of x-rays directed at the patient and the resulting x-ray 
photons that exit the patient's body are picked up by the detectors. Occurring simultaneously, the 
data acquisition system is uniformly sampling the detectors outputs and converting the analog 
signals to digital signals. The data are then preprocessed and enhanced before viewing and 
storage [37, 39].   
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Figure 3. An Example of a patient undergoing a CT exam 
 
*This image is open source licensed under the Creative Commons Attribution 3.0 
Unported license 
CTA is when CT is used to specifically image the arteries. In conventional angiography, 
a catheter is threaded through the groin to the vascular structure to be imaged where a contrast 
media is directly injected. In CTA or CTPA (Computed Tomography Pulmonary Angiography) a 
catheter is inserted into a vein in the arm where the contrast media is injected. By using a venous 
injection, the cost and risks of the procedure are dramatically decreased. The contrast media, 
typically an iodinated material, has a high CT number, allowing the arteries to be well 
differentiated from any surrounding soft tissue [40].  
Interpreting or processing CT scans can become difficult due to the presence of artifacts 
in the image. A CT artifact is any discrepancy between the reconstructed values in the image and 
the true attenuation coefficients of the patient, the value quantifying how easily the x-ray beam 
passes through the tissue. There are four major categories of artifacts: 1) streaking, appears as 
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straight lines going across the image in some direction; 2) shading, appears as shadowing near 
objects of high contrast and can mimic pathology and lead to misdiagnosis; 3) rings and bands, 
appear as rings and bands that are superimposed on the original image structure; 4) 
miscellaneous, covers all of the other artifacts that are not as common. Artifacts can be a result 
of a failure in the system design, the x-ray tube, the detector or a problem related to the patient 
[37].   The artifacts of issue in relation to PH are when they appear as streaks through the image 
or vessel beading, or when there is beading in oblique vessels resulting from partial volume 
artifacts that appear more severe in peripheral vessels [23]. The presence of artifacts can disrupt 
the segmentation process. The segmentation algorithm may not be able to differentiate the 
artifact from the vasculature and mark it as a vessel or it may remove it all together resulting in 
an inaccurate segmentation and image that will be difficult to use in analysis.  
2.3.2.1 Artifacts Common to CT Images 
Artifacts Related to System Design 
Aliasing is a type of artifact that can occur due to sampling errors. Sampling is the first 
step when gathering the data to compile a CT image. The detectors sample the continuous wave 
of x-ray photons to gather signals that represent the current view for that slice. The sampling 
occurs in groups categorized by time to divide the views into slices. There are rules in place to 
prevent the production of artifacts, however, aliasing can occur when the data are not sampled at 
a rate that is twice as high as the highest spatial frequency within the dataset. Let us say Y is the 
spatial sampling distance that is equal to the detector channel spacing; the difference in 
frequency absorbed between adjacent detectors. The sampling is occurring at the rate of 1/Y. If 
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the fraction of the spatial sampling distance is too small, where sampling areas are overlapping 
then the signals will overlap as well causing the development of aliasing artifacts [37, 41]. 
Partial volume is another type of artifact that can occur; it happens when the object is 
partially protruded into the scanning plane. The thicker the slice the more likely partial volume 
will occur. Due to the way the x-ray beam diverges into the z-direction (the Cartesian coordinate 
in a three dimensional space). The effect of the partially protruded object is angular dependent. 
When the CT scanner rotates so that the patient is closer to the detector the x-ray beam profile is 
wide enough that the patient is within the field of view. However, when it rotates to the opposite 
side, part of the patient will be out of the beam path creating inconsistencies in the data resulting 
in shadowing and streak type artifacts [37]. 
Scatter is another cause of artifacts related to the effects of Compton’s scattering. Due to 
Compton scattering not all of the x-rays that reach the detector are primary photons. Depending 
on how the CT system is designed a portion of the detected signal can be generated from the 
scatter. The scattered photons cause the detected signals to deviate from the true measurements 
of the x-ray intensities and will result in shading, streaks or number shift type artifacts [37]. 
Noise induced streaks are artifacts that result from the amount of x-ray photons that are 
generated from the x-ray tube. Excessive photon noise will cause severe streaking in the 
resulting image [37]. The presence of high attenuation objects is often the culprit in this type of 
artifact.  Often the objects responsible are metal implants such as joint prosthesis, surgical clips 
and dental fillings [42]. This can also happen when the parameters are not properly selected. The 
main causes of these types of artifacts are due to the limitations of the CT system itself. For 
instance, if the patient is larger and not enough x-ray photons can be produced to generate a clear 
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image of the patient using thin slices. This is the limit of the scanner and can sometimes result in 
unusable images [37]. 
Artifacts Related to the X-ray Tube 
One cause is off-focal radiation, which is caused by secondary electrons and field 
emission electrons. When the high speed electron crashes into the target, electrons are emitted 
from the site of impact. Most of these electrons are high velocity and return to the target at a 
point outside of the focal point and produce x-ray photons at their point of impact. Therefore, the 
x-ray source will have a high intensity center spot surrounded by a low intensity halo. This halo 
area will cause degradation to areas that are of low contrast and shading artifacts will develop 
that can sometimes render the image useless or mimic pathology leading to a misdiagnosis [37]. 
Tube-arcing or tube split will occur if there are impurities in the tube resulting in a 
temporary short circuit. When this occurs there is a significant increase in current and decrease in 
voltage. The CT system has a mechanism built in to detect this type of phenomenon, when it is 
detected the power supply is turned off to prevent further arcing. After a period of time the x-ray 
tube returns to its normal functioning level. However, the time in between there is a noticeable 
decrease in the production of the x-ray photons. If this is an isolated event there are methods 
built into the data acquisition and reconstruction to handle this situation, but if this occurs again 
the scan will be stopped to prevent unnecessary exposure to the patient and generating a 
degraded, useless image [37]. 
Tube rotor wobble is another class of issues that can create artifacts related to the x-ray 
tube. This is a group of mechanical failures that can result from a lack of rigidity in the gantry, 
mechanical misalignment, or x-ray tube rotor wobble. All of these have the same effect resulting 
in streaking artifacts across the images. The cause for this event is when the x-ray beam position 
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deviates from the position assumed by the reconstruction algorithm. These effects result from the 
high rate of speed at which the rotor shaft spins. The rotor shaft spins to keep the amount of heat 
generated by the electron beam down, over time this system wears down and needs to be 
replaced or artifacts of this nature will be seen [37]. 
Detector-Induced Artifacts 
Offset, gain, nonlinearity and radiation damage all lead to ring artifacts. All of these 
issues are due to malfunctions with the detector.  Another issue deals with primary speed and 
afterglow. When we expose a patient to the x-ray beam once shut off there are still excited 
electrons that are passing through and the detector output will not reach zero right away. The 
amount of time taken for the detector to stop receiving a signal is the afterglow, while the 
amount of time it takes for the signal to decay with short time constants is the primary speed. 
The primary speed affects the spatial resolution of the images and the afterglow usually affects 
image artifacts. Finally there is the uniformity of the detectors response. We assume that the 
detectors response does not change with where the x-ray photon hits the detector. When this is 
not the case some of the detector responses are significantly different from that of their 
neighbors.  This can be caused by a change in the reflective material placed between the 
detectors, mechanical stress, radiation exposure, or age. 
Patient-Induced Artifacts 
When a patient moves either voluntarily or involuntarily during a scan artifacts can be 
created. The patient could move in and out of the scanning plane, or they could move within the 
scanning plane. Another occurrence that causes artifact generation is called beam hardening, 
which can be a result of the polychromatic x-ray beam spectrum and energy dependent 
attenuation coefficients. Low energy photons have high energy attenuation coefficients and high 
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energy photons have low energy attenuation coefficients. When the beam, which is a mix of 
these two classes of photons, is sent through soft tissue most of the low energy photons are 
absorbed leaving mostly high energy photons. Due to this phenomenon the issue has been coined 
“beam hardening”. These types of artifacts can be reduced through the use of adequate beam 
filtration. Another cause of artifacts is when the patient has metal object within their body. These 
types of artifacts will vary in size and shape significantly based on the type of object the patient 
has within their body. Finally the last cause for patient induced artifacts is incomplete projection 
which is simply when part of the image is not able to be reconstructed. This will occur when the 
patient is not entirely within the scan field of view. This happens more often than not because the 
opening of the gantry is much larger than the scan field of view. If the patient is not 
appropriately placed then the image will be truncated. The areas where truncation does occur 
near the edges there will be bright shading artifacts. 
The advantages of using CT scans are that they are fast and can scan bone and cartilage. 
They also improve contrast resolution and decrease structural noise. The disadvantages are that 
since CT scans also use x-rays they also have ionizing radiation, they have limited tissue 
definition and application and are expensive [31, 38].  
2.3.3 Lung Perfusion Ventilation Scan 
A lung perfusion ventilation scan or VQ scan, measures both the oxygen and blood flow 
in the lungs. This test involves two types of scans. The ventilation scan shows the air flow in the 
lungs and the perfusion scan shows the blood flow. Both the ventilation and the perfusion scans 
use radioactive isotopes, a type of nuclear medicine. The isotopes are either inhaled for the 
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ventilation scan, or injected into a vein in the arm for the perfusion scan. Changes in the flows 
may be a symptom of pulmonary hypertension[40]. 
2.3.4 Magnetic Resonance Imaging (MRI) 
Magnetic Resonance Imaging (MRI) uses magnetic fields and radio waves to create images. 
Tools such as x-rays expose patients to ionizing radiation that can create free radicals or break 
chemical bonds. MRI employs a method that does not affect the patient's body chemistry but 
instead records information collected from the movement of the atoms deep in the nuclei of the 
cells[43]. MRI uses magnetic fields and radio waves to create images.  The first human MRI 
took 5 hours to generate and was performed on July 3, 1977. It took seven years for Drs. 
Raymond Damadian, Larry Minkoff, and Michael Goldsmith to reach the point of generating 
practical images. The main obstacle for MRI scanners was having the ability to generate a strong 
enough magnetic field to create the image. For this reason the maturity of the MRI remained 
stagnant until engineers were able to build super conducting magnets capable of creating an 
appropriate magnetic field [30, 31]. Patients are placed on the bore of the scanner and inserted 
into the magnetic field. To prevent interference from outside, the magnet is housed in large 
masses of iron surrounded by a Faraday cage. When the patient is exposed to a high magnetic 
field the hydrogen atoms within the patient have a strong tendency to line up with the direction 
of the field [30, 43, 44]. The hydrogen atoms are targeted because its nucleus has a single proton 
and a large magnetic moment. When subjected to the field, the hydrogen protons in the patient 
will line up in the direction of either the feet or the head. The majority of these protons will 
cancel each other out, for each one lined up toward the feet, one toward the head will cancel it 
out. Only a couple of protons out of every million will remain.  Once aligned a pulse of low-level 
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radio waves is directed through the patient. The pulse causes the protons in that area of the body 
to absorb the energy required to make them spin at a particular frequency, in a particular 
direction [30, 44]. The specific frequency of resonance is called the Larmor frequency and is 
calculated based on the particular nuclei being imaged and the strength of the main magnetic 
field. The goal is to spin more atoms in the opposite direction, which is the higher energy state, 
than the amount that remain in the low energy state. For this to occur the pulse must be in 
resonance with the Larmor frequency [44]. 
 The pulses are usually directed through the use of a coil which can be specific to a part of 
the body. There are three gradient magnets arranged inside the main magnet so that when they 
are turned on and off very rapidly in a specific manner, they alter the main magnetic field on a 
very local level. This gives the medical professionals the ability to choose exactly which area of 
the body to image. An MRI is able to generate a slice from any part of the body in any direction 
without moving the patient or machine [30, 44].  
 When the pulse is turned off, the hydrogen protons begin to return to their original 
alignments within the magnetic field and release their excess stored energy to return to that lower 
energy level. When this happens, they give off a signal based on their spin densities that the coil 
now picks up and sends to the computer system. What the system receives is mathematical data 
that is converted, through the use of Fourier transforms into an image. Image reconstruction uses 
Fourier transforms to convert the information gathered into image information that represents the 
two dimensional distribution of the spin densities [44].  
 The resulting MRI images can be used in the same manner as the CT images for detecting 
PH. In fact, the methods outlined and described in this dissertation can be directly applied to MR 
data, CT data was only used because of its availability.  
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2.3.5  Ultrasound 
Ultrasound is unlike any of the other imaging techniques previously discussed. It 
produces real time images, does not use ionizing radiation, and is fairly inexpensive. It utilizes a 
piezoelectric quartz crystal to create high frequency acoustic energy in the range of 3 to 10 
Megahertz. This energy is then reflected off the surfaces of the organs within the body.  The 
transducer is the same device used to create the signal and is also used to measure the returning 
echo information. Ultrasound machines typically contain a linear array of transducers and 
produce an image that is a pie shaped slice of the patient's body [30]. The problem with 
ultrasound in regards to identifying pulmonary disease is that the images retrieved are not clear 
in part due to respiration [31].  Ultrasound imaging relies on transmission of sound waves and 
therefore the signal is degraded when the beam has to travel through air (lungs) as compared to 
through solid tissue. Conditions of increased lung volumes (such as COPD) exacerbate this. 
In 1949 Douglas Howry built the first rudimentary ultrasound machine using Navy 
surplus SONAR equipment and bomber parts. Employing self-experimentation he focused the 
machine on his thigh and obtained an image of the tissue. He built a second machine that was 
more sophisticated than the first that he called a "somascope." It later evolved into B-mode 
imaging which is a way of obtaining two-dimensional images by recording sound echoes from 
tissue. By hand he measured the distances from the surface of the body to each organ and using 
these measurements constructed a compound picture from the cross-sectional images. He 
continued to refine his work along with other groups working in parallel over the years. When 
their techniques were merged with digital computers in the 1970's the ultrasound devices of 
today were created [31]. 
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Some advantages of ultrasound, as mentioned earlier, are that it is inexpensive, functions 
in real time, and is non-invasive. The drawbacks are that the image is not clear, is very operator 
dependent, and has difficulty imaging the areas around the lungs [31]. 
2.3.6 Nuclear Medicine 
Nuclear medicine uses radioactive solutions injected into the patient and images how the 
solution is distributed through the body using a detector array to catch and quantify the amount 
of radiation being emitted from the body. The main difference between this system and the CT 
scan is that the source of radiation for the CT is external and the distribution of it is known 
whereas, for nuclear medicine the source, which is the solution, is internalized and the 
distribution is not known [30].   
In 1952 the first positron scanner was used to image brain tumors in patients. In 1954 the 
"photoscan" was invented by David Kuhl, he created the first transmission image of the lungs of 
a naval student. However the connection between transmission and emission was not yet 
validated. Emission images began with the first SPECT machine by Kuhl in 1968. At the time it 
was the most inexpensive and convenient imaging technology available.  In 1973 Ter-Pogossian 
and his group created the first positron imaging device and nicknamed it the "lead chicken." In 
1983 radioactive tracers pioneered by George Hevesy were first used in PET scans to record and 
map the functioning of sight. Finally in the mid 1980's PET scanners and the 
radiopharmaceutical manufacturing reached the point where exploration stopped and 
simplification and fine tuning has begun [31]. 
The images generated in nuclear medicine are often hard to distinguish and have poor 
spatial recognition; they usually have low resolution and a high amount of noise. A benefit of 
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nuclear medicine is that it allows the physician to capture the physiological activity of the patient 
and not just the locations of the patient’s anatomy. The choice of the radioactive solution will 
affect the quality of the resulting image. Radioactive iodine is very good for generating images 
of the thyroid and parathyroid glands. Radioactive tracers can be attached to numerous different 
substances. The image quality is due to our inability to use high radiation doses because of the 
detrimental effects it will have on the patients [30].  
2.4 MEDICAL IMAGE PROCESSING 
Medical imaging systems are tools used by medical professionals to aid in diagnosis and 
care for a patient.  The data gathered by these systems are often in the form of 2D images, 
composed of data arrays that can be organized using two Cartesian dimensions.  This 
information must be preprocessed prior to reaching the clinician in order to make informed 
decisions. The process of diagnosing and treating a patient in regards to imaging occurs in three 
main steps. The data must be first preprocessed, meaning filtered, remove the noise and the 
features enhanced. Next the information is either given to the clinician where the condition or 
event can be detected or it is first identified by the machine and then passed on to the clinician.  
The final step is the quantitative analysis of the detected condition. There are three problems that 
are inherent to medical image processing. They are filtering, segmentation and registration [30]. 
Only an overview will be given of the processing techniques; they will not be discussed in detail. 
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2.4.1 Filtering   
This includes the procedures for preprocessing the data gathered by the medical imaging 
techniques previously described. This happens prior to when detection and analysis are 
performed. Filtering removes noise, enhances features and reduces any effects that occurred 
during image acquisition. Generally, a filter defines some neighborhood function. Median 
filtering for instance, used in this research, takes the 3x3x3 neighborhood of a point and replaces 
the point with the median value of the neighborhood [45]. Two more examples of filtering are 1) 
convolution which is a one dimensional operation that applies a filter kernel to an image to 
smooth it out and 2) Fourier transform which decomposes the image into component sinusoidal 
spatial functions for computational viewing and manipulation [30].  
2.4.2 Segmentation 
Segmentation is the process of breaking up the image or 2D array into regions that have 
cohesive properties. One example of segmentation is thresholding. It is a binary process where 
for each pixel a decision is made based on its intensity level independent of its neighbors. If the 
intensity is greater than some value the pixel is classified differently than if its value is below a 
certain level. For a CT image the intensity is reported in Hounsfield units and are calibrated to 
correspond to the attenuation of the X-rays measured within the tissue [30].  
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2.4.3 Registration 
Registration is the process of transforming multiple data streams into one coordinate 
system to create a more powerful diagnostic tool [30, 46]. Multiple images taken from different 
perspectives, at different times and recorded by different sensors are overlaid on one another to 
create one master dataset. Registration contains four key steps: 1) feature detection, 2) feature 
matching, 3) transform model estimation and 4) image resampling and transformation [46].  
 
2.5 EXTRACTING VASCULAR FEATURES 
2.5.1 Vascular Segmentation 
Studies have been done to find a solution to segmenting the pulmonary vasculature. The 
closeness of the vessel voxel signals between vessels and the tissue surrounding the lungs make 
thresholding difficult, as almost inevitably the vascular segmentation “bleeds” into these 
surrounding structures. Consequently, more involved segmentation techniques are needed. 
Masutani et al. developed a method for vasculature segmentation using 3D image analysis 
methods combined with anatomic knowledge [47]. They sequentially segment several anatomic 
structures using the properties of each structure for the next step in the segmentation and to 
validate intermediate results [47]. Masutani et al. were able to successfully segment the 
pulmonary vasculature however, they were not able to separate the pulmonary vessels from the 
heart and corresponding arteries [47].  Another group Zhou et al. developed a method of 
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segmentation for the identification of pulmonary embolisms. Zhou's group developed a multi-
scale Hessian matrix-based filter that incorporates expectation-maximization (EM) analysis [48]. 
The EM analysis is used to separate the vasculature from the rest of the anatomy [48]. They then 
apply a series of filters for vessel enhancement similar to the method presented in this research. 
The method I used combines a series of mathematical morphological filters for isolating the 
vasculature and for enhancement of the vessels described in more detail in Section 3.2.1. Zhou 
et. al. only had 2 cases for development and only segmented the peripheral pulmonary vessels 
due to the difficulty in segmenting the larger pulmonary vessels from the heart. The research 
being presented segments the main pulmonary arteries with a few branching levels eliminating 
all other competing structures. The goals of all the segmentation methods are the same, to isolate 
the vasculature less any of the surrounding anatomy. 
2.5.2 Mathematical Morphology 
Mathematical morphology is used often to simplify the image for easier analysis by 
reducing the noise or generating skeletons (i.e. medial lines). For our purposes we apply these 
different methods throughout this research from segmenting the image, to cleaning up the image, 
followed by preprocessing and simplification of the segmented image into the skeleton that 
represents the vessel paths. Finally, we will use them to model the shape of the vasculature in 3D 
form. A skeleton in our case is a one voxel thick line that is medially located in all of the vessels 
of the vasculature.  
Mathematical morphology includes opening and closing methods, such as the 
preprocessing methods used in Section 3.2.3. Opening and closing is also used for extracting 
information from the segmentation in the generation of the skeleton using the hit-or-miss filter or 
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parallel thinning algorithms discussed in Section 3.2.4.  The two main methods of mathematical 
morphology are erosion and dilation, demonstrated in Figures 4a-d. Figure 4a is an example of 
erosion where it is shown that only when the origin of b is completely contained inside a are the 
pixel values retained, else they are deleted or eroded. We are assuming the origin of b is at the 
center[49]. Figure 4b is a demonstration of dilation the second key method in mathematical 
morphology. It is a dual operation to erosion (4c). Dilation (4d) expands the image to include the 
portions of the structural element that match the image (based on erosion) [49].  
  
Figure 4a-d: An example of erosion and dilation:(a) is the original image data, (b) is the 
structural element, (c) is the eroded image and (d) is the dilated image. 
Opening and closing are the two secondary classes of methods. Opening is when an 
image is first eroded and then that resulting image is dilated. Closing is the opposite: dilation 
followed by erosion; closing typically smooth’s out corners and areas that are protruding into the 
image [49]. 
2.5.3 Machine Learning 
Machine learning is the use of computational methods and algorithms to learn patterns 
and derive mathematical models from a dataset.  .Machine learning is a powerful set of tools 
because it enables the algorithm being used to predict classifications for outputs for instances 
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that were not used for learning [50]. Author Tom Mitchell defines Machine Learning as “the 
study of computer algorithms that improve automatically through experience. Applications range 
from data-mining programs that discover general rules in large data sets, to information filtering 
systems that automatically learn users' interests. [51]”  
There are two common classes of machine learning methods: supervised and 
unsupervised learning. Supervised learning is when the training set is labeled with designated 
classifications. An example is the prediction of whether or not a patient has a specific disease 
based on a number of variables (e.g., blood pressure, hematocrit level and gender). The training 
set will have all the patients labeled as either positive for the presence of disease or negative for 
presence of the disease. This is different from unsupervised learning where there would be no 
designation of positive or negative for disease [50]. An example is the clustering of patients into 
similar groups. I used supervised learning methods in this research for addressing hypothesis 2. 
2.5.4 Algorithms 
There are two main classes of algorithms that can be applied, namely, classification and 
regression. Classification models group different data points into groups based on their attributes 
[50]. The underlying goal of all model building techniques is to find the best fitting and 
biologically reasonable model to describe the relationship between the outcome variable and the 
predictor variables [52]. In this section I give a brief overview of the four different classifiers 
used in this research. 
Logistic and Polynomial Regression 
A regression model fits a mathematical function describing some curve (e.g., logistic or 
polynomial) that passes as close as possible to all data points. This enables us to predict a target 
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variable y given some variable values x, even though x may not have been one of the instances 
used during the training of the data [50]. In logistic regression the outcome variable is binary, in 
contrast to linear regression where the outcome variable is continuous. In addition, the error 
distribution is not assumed to follow a normal distribution but instead is assumed to follow a 
binomial distribution.  
CART (Classification and Regression Tree) 
 CART is a nonparametric method that uses either classification methods if the target 
variable is categorical or regression trees if the target variable is continuous..  It was first 
introduced by a group of researchers from Stanford in 1984 that included Leo Breiman, Jerome 
Friedman, Richard Olshen and Charles Stone. They defined three key components for generating 
a decision tree. First rules are defined for splitting the data based on the value for a particular 
variable (or feature). Second a rule must be defined for determining when the tree is complete, a 
stopping rule. Finally, each terminal or leaf node should be assigned a prediction or outcome 
value. During the decision tree process the data are recursively thinned down into more 
homogenous groups. The paths from each node to each leaf node are the resulting rules for 
assigning the outcome values [53]. One benefit of utilizing CART is that although large sample 
sizes are always preferred, when using CART accurate findings can be learned with smaller 
sample sizes. Secondly, assumptions such as the data fitting a normal distribution, linear 
relationships between independent and dependent variables and the data having the same 
variance are also not necessary for obtaining accurate results [54].   
Naïve Bayes 
The origin of the Naïve Bayes classifier is debated. However; it is named after Reverend 
Thomas Bayes who studied how to compute the distribution for the probability parameter of a 
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binomial distribution during the 18
th
 century. He defines the fundamentals underlying a general 
Bayes classifier in the famous article “An Essay Towards Solving a Problem in the Doctrine of 
Chances” published in 1763. Bayes’ theorem shown below, defines the relationship between a 
hypothesis H and evidence E [55, 56].  
       
          
    
  
          
∑               
 
The sum in the denominator in the third installment is over all hypotheses    that are 
considered to have non-zero probability     . A Naïve Bayes classifier is a specialization of 
the above general equation. In particular, a Naïve Bayes assumes that each piece of evidence ei 
in E is independent of each other piece of evidence ej in E  given a hypothesis   or  . Thus, we 
have:  
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3.0  METHODS 
This chapter details the steps taken and methods used for completing the hypotheses 
described in section 1.2.   
3.1 SPECIFIC AIM 1: CREATION OF THE DATA REPOSITORY 
We collected 27 de-identified CTPA cases with PH state confirmed via right heart 
catheterization (22 positive and 5 control cases). The pressure data corresponding to these cases 
are summarized in Appendix A.  
In addition to these 27 cases, we have an additional 94 CTPA cases that have been 
determined by a radiologist to be negative for PH as well as for any gross abnormality. These 94 
cases resulted from a dataset that began with over 500 CTPA cases (de-identified dictated reports 
and DICOM images) that were ordered to rule out pulmonary embolism (PE). I reviewed the 
associated radiology reports for those 500 plus cases to ensure that there were no other gross 
vascular abnormalities, including PH. If cases were rejected based on the contents of the reports, 
then additional control cases were randomly selected from the database until 100 cases were 
collected that contained no gross vascular abnormalities. After the initial 100 was identified, one 
case was eliminated due to an incomplete CT exam, leaving 99 cases that we used for negative 
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PH cases or control cases. In the end we had a total of 22 positive cases and 99 control cases (5 
controls from the initial 27 and 94 identified from the PE dataset). 
3.1.1 Power Calculations 
Power is defined as the probability of correctly rejecting the null hypothesis when it is 
false. We have 99 controls and 22 cases for all of the methods that do not involve the use of the 
pressure data. For methods involving the predictions using the pulmonary pressures we only 
have 22 cases and 5 controls to make up the dataset. For this power analysis the null hypothesis 
is that the mean pulmonary pressures of the disease versus control groups are equal. Our desired 
power is a minimum of 80%. To determine the power of the pressure dataset we chose the mean 
arterial pressure as the variable for calculation.  
In a second power analysis, the null hypothesis is that the mean diameters of the right 
main pulmonary artery for the disease versus control groups are equal. This analysis is being 
performed because one of the prediction models focuses on whether or not we can classify 
patients by disease state. I chose the RMPA values over the pulmonary trunk and the LMPA 
because of the positioning in the pulmonary tree, the RMPA is deeper than the trunk and the 
automated measurements are better matched to the manual measurements when compared to the 
LMPA values. 
I used an online power calculator (http://www.statisticalsolutions.net/pss_calc.php.) for 
determining the sample size needed for the experiments and, the results are provided in Section 
4.1.   
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3.2  SPECIFIC AIM 2: CREATE AND VALIDATE PUMA  
Now I will detail the methods and steps taken in the creation of PUMA (PUlmonary 
Mapping and Analysis tool), the tool we built for semi-automatically generating pulmonary 
vascular models that will be quantified in specific aim 3 for the diagnosis of disease.  
We built PUMA primarily using Python and leveraging a variety of existing tools 
including: 
 Insight Toolkit (ITK), an open source image analysis toolkit developed by the NLM 
[57] using WrapITK, or more recently SimpleITK, to create Python wrappers. 
 Visualization Toolkit (VTK), an open source visualization toolkit developed by GE, the 
NLM and others [58]. 
 NetworkX, an open source graph analysis toolkit developed at Los Alamos National 
Laboratory [59].  
 Mayavi, a 3D visualization toolkit written in Python that incorporates VTK 
http://mayavi.sourceforge.net/index.html 
3.2.1 Pulmonary Vascular and Aorta Segmentations 
Originally it was proposed that I would incorporate an existing automated algorithm to 
extract the pulmonary vasculature segmentation. However, due to the dissolution of a joint 
project I no longer had access to the existing algorithm. Instead I performed segmentations down 
to the segmental branches using a semi-automated approach on all the exams. Due to incomplete 
image files an additional three control cases were eliminated from the segmentation dataset. For 
each of the remaining 118 exams there were two segmentations one for the aorta and one for the 
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pulmonary vasculature, totaling 236 segmentations. I used ITK-SNAP [60] to generate the 
segmentations. ITK-SNAP is a software application based on the Insight Tool Kit [57], that is 
used for either manual or semi-automated segmenting structures in 3D medical images. Semi-
automatic segmentation of the images is based on active contour methods[60]. Because the 
active contour segmentation requires the user to  provide seed points and either intensity or 
gradient mappings, PUMA is now a semi-automated modeling method, although I believe that 
these semi-automated segmentations can form the basis for shape-based automated segmentation 
techniques. I segmented the aorta for each case because the measurement of the ascending aorta 
is used for normalization of the pulmonary vasculature measurements across patients using the 
same method as described in some of the studies in Section 2.2.1. [22-26]  
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     (a)                                                                    (b) 
   
(c)                                                                         (d) 
Figures 5a-d. Screenshots taken during the use of ITK-SNAP for the segmentation process. a) 
The initial screen once the image has been loaded. b) Setting the sampling region for the 
segmentation. c) Choosing the intensity values to differentiate between the vasculature to be 
segmented and the surrounding tissues. d) Seed placement to begin the segmentation. 
After the initial segmentations were generated, they were then “cleaned”. Cleaning 
consisted of manually parsing each of the segmentations slice by slice eliminating all areas 
where bleeding occurred.  I define image bleeding as the areas where the image intensities are 
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very similar to that of the vasculature we are trying to segment so that the segmentation crosses 
over and begin to include the surrounding tissue; an example is shown in Figure 6a. In the figure 
the segmentation bleeds from the pulmonary trunk into the aorta. Figure 6b is the same example 
after it has been cleaned and is considered a completed segmentation. The segmentation 
parameters used to generate each of the segmentations such as the intensity values shown in 5c, 
are included in Appendix B.   
  
Figure 6a-b. a) Example of segmentation with bleeding b) Example of a cleaned segmentation. 
 Overall, this entire segmentation process from the development of the initial 
segmentations to the final clean version took the better part of six months to generate for all the 
images. 
3.2.2 Overview of Modeling Steps 
Segmentations are first generated as described in Section 3.2.1. Next, the skeletons are 
extracted from the segmentation. The skeleton is the backbone of the segmentation comprised of 
a single-voxel wide collection of the medial most voxels that stretch the length of each vessel 
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within the segmentation and is described in detail in Section 3.2.4. From the skeleton the graphs 
are then extracted. The graphs represent the structure of the vasculature and consist of 
bifurcation and termination nodes connected by vascular segment centerlines. The graphs are 
described in detail in Section 3.2.5.  Even with the tedious cleaning of the segmentations, 
imperfections still remain and lead to faults in these graphs. To address these faults we explore 
methods of preprocessing the segmentations described in Section 3.2.3. 
3.2.3 Preprocessing of the Segmentations 
The remaining segmentation errors primarily consist of small holes in the segmentation 
(areas within the vascular lumen that the active contour did not “flow” into) and surface 
irregularities due to partial volume artifacts. These segmentation errors create numerous spurious 
segments in the skeleton. Before we continue with the modeling of the vasculature we first need 
to reduce these segmentation errors by preprocessing. We applied four different preprocessing 
methods and then evaluated the refined segmentation based on the number of edges within the 
graph. A graph edge corresponds to a single segment of the skeleton.  We first calculated the 
number of edges within the graph generated from the “raw” (not processed) segmentation. We 
did this on a training set of 27 control cases and ten PH cases.  
The preprocessing was performed with a script called PreprocessSegmentation.py 
developed in house with the goal to reduce the number of edges by smoothing out the 
segmentation. The script can be found in Appendix C. Smoothing was obtained with 
combinations of median filtering and morphological closing, where the kernel sizes of these 
steps were varied. We evaluated the segmentation smoothing and its impact on the generated 
vascular models. Our outcome measure was the number of edges in the graph of the model.  We 
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used median filtering and morphological closing both alone and in combination and then 
compared them to the original segmentation with no preprocessing. These findings are 
summarized in the results Section 4.2.  
3.2.4 Vascular Skeleton Generation 
At this point we have the finished preprocessed segmentation. The next step is to 
generate the skeletons (or medial lines). The skeleton is composed of one-voxel thick lines that 
are at the center of the vessels. To generate the skeleton we used an existing ITK-based parallel 
thinning algorithm. A segmentation example and the corresponding skeleton are shown in Figure 
7. 
 
Figure 7). Visualization of the pulmonary vasculature model in ITK-SNAP. (Left) Surface 
rendering of the segmentation obtained with ITK-Snap. (Right) Illustration of the skeleton 
achieved from the segmentation using parallel thinning 
The parallel thinning algorithm is a mathematical morphological tool we have examined 
as an approach for extracting a skeleton from the data in a discrete space. The purpose of the 
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thinning algorithm is to iteratively remove the object's surface until only the centerlines remain. 
The goal is to preferentially remove large amounts of data such that only the skeleton remains 
[49, 61, 62]. Erosion, as discussed in Section 2.5.2, must be performed symmetrically from each 
side to ensure the centerline is preserved. There are two possible approaches to thinning an 
image: 1) use a kernel-based filter and 2) use decision trees.  In kernel-based filters the kernel is 
the defined structural element that is applied to the image. The method presented here is a 
decision tree based method for the thinning of a 3D image and was used to generate the skeletons 
in this research[61] .  
A key component of thinning is to be sure that the centerline is at the medial-most 
position of the vessel within a 3D image. To be sure this is the case, the algorithm performs a 
series of tests for each pixel to determine if it can be eroded from the image, this process repeats 
until no more pixels are removed. There is also a topological requirement of the thinning 
algorithm: the algorithm must preserve the number of connected objects, cavities and holes in the 
original shape. To ensure this is done the Euler characteristic and the connectivity are preserved 
to guarantee the invariance of the topology [62]. The Euler characteristic is a value used to 
describe the shape and structure in a particular space [63].  S is a subset of the data consisting of 
all ones. The complement of S is s and it contains all zeros. When s is completely surrounded by 
S, there is a cavity [62]. In a 3D image the only difference between a hole and a cavity is that the 
hole is not completely surrounded by S. In the algorithm pixels are deleted based on four 
characteristics: 1) The pixel is a surface or border pixel; the algorithm checks one of the six 
directions at a time to make sure the centerline is not shifted to one side of the vessel. 2) The 
pixel is not at the end of a line. 3) No holes are created when the pixel is removed. 4) The final 
test, and the most computationally expensive one, looks to see if the current pixel is a simple 
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pixel whose deletion will have no effect on the number of connected segments, not interrupting 
the path [62]. The tests are performed in parallel on all the voxels in the 3D image. The final step 
is to double check that the connectivity of the skeleton has been preserved[62].  
We generate the skeleton from the smoothed segmentation using the BinaryThinning3D 
executable, a compiled C++ program unmodified from the code acquired from the Insight 
Journal website that defines the algorithm [61].  
Figures 8a and b are examples of the resulting skeletons for the aorta and pulmonary 
vasculature for one case. 
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               (a)                                                                    (b) 
 
                                       (c)                                                                    (d) 
Figures 8a-d) Skeleton comparison before and after preprocessing, a) An example skeleton of an 
aorta b) An example skeleton of the pulmonary vasculature, c) An example of the skeleton of an 
unprocessed segmentation and d) a skeleton after the preprocessing occurs. 
3.2.5 Vascular Graph (Model) Generation (based on NetworkX [59] )  
The skeleton is simply an image of unordered voxels. In order to make our 
measurements, we must first transform these unordered voxels into a structure that represents the 
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underlying anatomy. We did this by creating vascular graphs comprised of three classes of 
nodes: degree one nodes are either endpoint or terminal voxels. Degree two nodes are centerline 
voxels and degree three nodes are the bifurcation voxels. This is a multi-step process that we 
now describe.   
First, we created an undirected graph with every voxel in the skeleton being a node in the 
graph. Edges were added between any nodes coexisting within a 3x3x3 (3-dimensional) 
neighborhood of voxels. From this, undirected graph bifurcations and endpoints were recognized 
by the node degree. This is illustrated in Figure 9. 
 
Second, a directed graph was generated from the undirected graph. A root node was 
required for the directed graph and we selected the undirected graph node with the highest 
distance from edge (DFE) value as the root. The DFE was calculated using the city distance 
transform. Expanding out from the root, all bifurcation and endpoint nodes in the undirected 
graph were added as nodes in the directed graph with the collection of degree-two nodes 
(centerlines) forming the directed edge between the nodes. Each node is labeled with the (i, j, k) 
coordinate of the skeletal image voxel from which the node was obtained.  The algorithm 
Figure 9) Example of an undirected 
graph generated from a skeleton 
image. Here blue nodes are 
bifurcations, green nodes are 
centerlines, and red nodes are 
endpoints. 
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identifies all termination voxels and bifurcations in the undirected graph. The paths between the 
termination points and the seed node are then traced out using a bidirectional Dijkstra algorithm.  
The algorithm is used to identify the minimum cost path between the seed node and each 
endpoint in the undirected graph. The path is split into segments defined by the endpoints and 
bifurcations along the path. The endpoint and bifurcation nodes are then added as nodes in the 
directed graph with a directed edge, while the connecting centerline node paths are added as 
attributes of the corresponding edges  
Third, because of imperfections that remain in the segmentation, the resulting directed 
graph still has edges leading to false endpoint nodes. To further clean the graph we deleted any 
edge that was shorter than five voxels, because the edges of interest are the three largest edges in 
the vasculature representing the pulmonary trunk, the right and the left main pulmonary arteries, 
all of which are larger in length than 5 voxels. This naïve rule was proven inadequate, so we 
manually deleted extraneous edges as well. We experimented with machine learning techniques 
to create more comprehensive pruning rules; this is described in the next section. Finally, the 
edges of the pruned graph were fit with a least-squares cubic spline. The spline fit provides a 
smooth function that will later be used to capture vascular features from the segmented image. 
An example of a fitted graph is shown in Figure 10.    
 
Figure 10) An example of a 
directed graph that has had the 
centerlines fit with a least-
squared cubic spline. The root 
of the graph is highlighted in 
red. Note that in this case the 
selected root corresponds to the 
bifurcation of the pulmonary 
trunk into the left and right 
pulmonary arteries. 
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An in-house script was written using NetworkX [59] called GenerateGraph.py for the 
graph generation and is in Appendix C.  
One problem encountered with the graph involved the placement of the root node as seen 
in Figure 10. Figures 11a-c visually steps through the graph development and refinement process 
(the root node is highlighted in red). In the original segmentation shown in Figure 11a, the root 
node is not correctly identified. Figure 11b shows the graph after preprocessing. A script was 
developed to correct the placement of the root node called rerootGraph.py and is in Appendix C. 
Figure 11c shows the graph after this script is applied and the root node is now properly placed. 
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                  (a)                                                                     (b)             
 
(c) 
Figures 11a-c) Stepwise visual representation of graph development 
3.2.6 Vascular Graph Pruning and Rule Development 
The basis for all of our analysis is an accurate graph representation of the vasculature. 
Unfortunately, the graph generation described above results in a graph with a number of errors, 
most notably a large number of false centerline segments due to imperfections in the surfaces of 
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the segmentations. Figure 12 below shows an example cartoon demonstrating what happens 
when there are small divots and bumps in the segmentation causing extra lines to be drawn 
distorting the skeleton and subsequently the graph.  
 
 
Thus it is of fundamental importance to be able to delete false segments while preserving 
true vascular segments. An important element of these algorithms is to be able to delete false 
nodes/edges. Initially the graph is automatically cleaned by deleting edges with lengths shorter 
than a specified threshold currently set at five voxels. The appropriate threshold is dependent on 
the nature of the segmented vasculature. The pulmonary vasculature segmentations are 
particularly challenging because of the wide range of vascular diameters present and the short 
segments (with respect to diameter) in the tree.   
A script called editGraph.py (Appendix C) was developed that allows manual editing of 
the graphs by giving the user the ability to visualize the graph and remove additional false 
centerlines. We did this for 15 PH cases and 69 control cases. The program stores the 
Figure 12. Example of extraneous 
lines in the skeleton. 
 
The arrows in the figure highlight 
the addition of unwanted center 
lines because of inconsistencies in 
the segmentation.  
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information of the original graph as well as the edited graph and we are able to identify features 
by looking at the positive edges that were kept and the negative edges that were removed. During 
the editing process there were a few cases that had unusual discrepancies in the centerline that 
needed to be addressed on an individual basis and will be described in detail later. Figures 13a 
and b are such examples. Figure 13a shows how the pulmonary trunk is separated into two edges 
when it should all be one. This seems to be an issue with a few of the cases where a segment is 
separated when it clearly should not be. Figure 13b shows an odd edge in the aorta (highlighted 
in yellow). 
                   
                                  (a)                                                                       (b) 
Figure 13a and b) Edge discrepancies a) Pulmonary vasculature example, b) Aorta example. 
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(a)                                                                             (b)  
Figures 14a and b. Examples of what the graphs should resemble if no editing is required or after 
editing has occurred. a) the aorta and b) the pulmonary vasculature.                 
The complete tables of the edge data from the unedited and edited graphs for this process 
can be found in Appendix E and the summary results are listed in Section 4.3.  
3.2.7 Summary of Steps 
This section summarizes in Table 2, the overall steps taken during the creation of PUMA. 
It also clarifies the steps that were performed manually from those that were done in an 
automated capacity. 
 
 
 
 
 
 55 
Table 2. Overall Summary of Steps. 
Segmentation 
Initial Segmentation 
Generation 
A combination of manual input in choosing the 
threshold values for ITK-SNAP to implement in the 
automatic generation of the initial segmentation.  
Cleaning 
Manually edited the segmentations slice by slice 
eliminating bleeds. 
Preprocessing 
Automatic step using the PreprocessSegmentation.py 
script 
Skeleton Generate Skeleton Automatic step using BinaryThinning3D executable 
Graph 
Generate Initial Graph Automatic step using GenerateGraph.py script 
Clean Graph 
Manually deleted additional unwanted edges using 
editGraph.py 
 
3.2.8 Prediction Model Development for Pruning Edges 
This section describes how the prediction models were generated for classifying correct 
and incorrect edges for fine tuning and pruning the vascular graphs. The purpose of the model is 
to be able to eliminate the manual pruning step using editGraph.py described in the previous 
section.   
Gathering Feature Data 
We decided to use the open source machine learning software package Weka [64] for 
generating the Simple Cart decision tree classifier and to generate the logistic regression model 
for classifying the edges that should remain or be deleted from the graph to eliminate the manual 
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editing step previously discussed. We first had to generate the distance from edge (DFE) values 
for each voxel within a given edge. The distance from edge is the value assigned to the distance 
between a voxel in the segmentation and the nearest voxel not in the segmentation. By 
calculating the DFE value for each voxel along each of the edges within the skeleton we can 
calculate different features of the vessels that can be used in the classifier. We calculated seven 
features for each of the edges within the segmentations. The features are as follows: 1) the 
pathlength, defined as the total number of voxels along a given edge; 2) The value associated 
with the shape of the edge; 3) The volume of the edge; 4) the ratio of length relative to depth 
calculated as the minimum DFE value over the maximum DFE value; 5) the difference between 
the minimum and maximum DFE value or average mean distance to the surface of the edge; 6) 
the minimum DFE value for each edge; and 7) the maximum DFE value for each edge. There are 
three scripts used for gathering this data. The first is getDFE.py the initial script for calculating 
the DFE’s across the images. The scripts Extract_DFE_Values.py and ExtractShapeVolume.py 
were used for calculating the specific features. All of these scripts are located in Appendix C. 
These seven features were gathered for the dataset comprised of 122 images (99 control and 22 
disease cases), a total of 1,546 edges each with seven attributes. It is important to note that the 
edges that were not manually deleted when using editGraph.py (found in Appendix C) were 
labeled as positive edges to represent the edges that should remain. The edges that were deleted 
were labeled as negative edges. Due to the size of this dataset it is not included in the appendices. 
However, it is available upon request. 
Prediction Model Development 
As stated earlier, we decided to use Weka [64] to generate a Simple CART decision tree 
for classifying edges. We also used logistic regression to build a classifier for comparison. The 
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entire dataset containing 1,546 edges was used and 10 fold cross validation was applied for 
evaluating the model. This model was generated twice: the first with the original data and the 
second time with normalized data. We normalized each of the attributes using min-max 
normalization with the exception of the shape and volume. These values were already on a 
normalized scale from 0 to 1. The normalized values are simply the values divided by the 
difference of the minimum and the maximum values. The results from this process can be found 
in results Section 4.4 and the actual output from the model is located in Appendix F.  
Weka [64] was also used to generate the logistic regression model again for both the 
normalized and non-normalized data. The results are summarized in Section 4.4. Due to the 
length of the output only summary data has been included in this document; however, the entire 
output for each model is available upon request. 
3.3 SPECIFIC AIM 3 
Use PUMA to diagnose PH. This will be done by performing a semi-automated 
measurement of vascular diameters and making comparisons to manual measurements of the 
same cases. 
3.3.1 Generating Measurements 
We randomly selected 100 normal CT pulmonary angiography (CTPA) exams from our 
data bank. The exams were determined to be negative with respective to both pulmonary 
embolism (the indication for the exams) and PH by examining the accompanying dictated 
radiology reports. From a separate databank of images, we selected 24 CTPA exams where the 
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patient was diagnosed with PH via right heart catheterization. For each case, human observers 
manually quantified the vascular geometry. Independent of these measurements, the models of 
the pulmonary arterial vasculature and the aorta generated in Specific Aim 2 were used to 
automatically quantify the vascular geometry in the same cases.  
3.3.2 Step 1: Make manual measurements of the vasculature and aorta. 
In order to determine how well the automated measurements were performing, we first 
needed to generate a baseline for comparison. We did this by first going though each of the 124 
exams (normal cases plus the PH cases) and identifying the slices on which to measure the 
diameters of the ascending aorta, the pulmonary trunk and the right and left main pulmonary 
arteries (reviewer 0). Upon review of the images four of the control cases and one disease case 
were eliminated due to incomplete image files. The remaining 96 control cases and 23 disease 
cases were used for manual measurement. The slice data is reported in in Appendix G. A Python 
(www.python.org) script was written in house that was used to isolate these slices for manual 
quantification. Manual quantification was done by me and three independent reviewers (all 
graduate students) using OsiriX (http://www.osirix-viewer.com/). For the identified slice, each 
reviewer used a line ROI (region of interest) tool to measure the diameter of each vessel. Each 
observer was blind to both the other reviewers’ results and the quantification from the vascular 
models. The actual written instructions provided to the viewer can be found in Appendix H. 
Figures 15a-c show one of the normal cases where the measurements were made using OsiriX. 
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Figures 15a-c) Example of manual the measurements made in OsiriX. a) Aorta and pulmonary 
trunk, b) right main pulmonary artery and c) left main pulmonary artery. 
Statistics defined in the following sections were calculated for each reviewer’s 
measurements for comparisons between reviewers to determine agreement as well as for 
comparisons between disease and control cases. Then the average of the reviewer’s 
measurements for each case was taken for comparison to the automated measurements.   For 
instance, each case has four measurements associated with each vessel. The average of those four 
measurements was taken for each vessel to give one value to use for comparison. These average 
values can be found in Appendix I. The original reviewer measurements can be found in 
Appendix J. 
3.3.3 Step 2: Making automated measurements for comparison. 
A Python script called AutomatedMeasurements4.py is in Appendix C. It was generated in 
house for identifying the segments of interest and calculating the necessary measurements. We 
first identified the median or mean location of the aorta centerlines. The ascending aorta is 
defined as the centerline points with x values less than the median (mean). Then from those 
centerlines satisfying the criteria we selected the midpoint measurement as simply the point 
closest to the median z value for these points. 
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The pulmonary trunk segment is defined as the edge between the root and the bifurcation 
node in the direction of the greatest number of descendants. The left and right main pulmonary 
artery segments were identified as the edges that followed directly from the root-identified 
bifurcation. A local coordinate system was defined at each point along the spline-fitted 
centerline. This local coordinate system was then used to define orthogonal planes at each point; 
the surface points (points with a distance-from-edge value of zero) for that vascular segment 
were mapped to orthogonal planes corresponding to each point on the fitted centerline. We 
estimated the vessel radius at each point along the fitted centerline as the average distance 
between the centerline point and the surface points mapped to the corresponding orthogonal 
plane. We computed the radius at the midpoint of each vessel centerline. A full table of these 
resulting automated measurements along with the average of the manual measurements can be 
found in Appendix I.  
In order to make automated measurements from an ordered graph, we must first match the 
graph to the anatomy of interest. Although originally motivated by the need to recognize the 
pulmonary trunk, our heuristic of setting the root node to be the node with the maximum distance 
from edge was not sufficiently accurate, since, as illustrated with Figure 9, the root node was 
placed at the bifurcation rather than in the trunk (other incorrect locations were also observed).  
 The identification of the root node in the pulmonary trunk in the segmentation is difficult 
particularly in creating a method that is robust in the presence of segmentation imperfections. 
We explored a median (mean) x measure as well as the root mean square (RMS) algorithm. We 
found the best performance using a heuristic that assumes the terminus of the pulmonary trunk 
lies near the center in the left-right direction, near the back in the posterior-anterior direction, and 
near the top in the inferior-superior direction. Finding the degree-one node with the minimum 
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root mean square distance from the coordinate (DIM_X/2, 0, max (Z)) correctly identifies the 
root node location in the 118 cases examined. This heuristic works because our segmentation is 
not extending deeply into the vascular tree. The re-rooted graph from Figure 10 is shown in 
Figure 16. The pulmonary trunk is defined as the edge between the root node and its child 
bifurcation. The left and right pulmonary arteries are the edges exiting this child bifurcation. The 
rerootGraph.py script discussed above can be seen in Appendix C. 
With the graph matched to anatomy, we went back to the original segmentation and 
matched each surface voxel to the nearest edge. Finally, the spline-fit to each edge was used to 
define a plane at each point along the centerline that was orthogonal to the local direction of the 
centerline. The mapped surface points for each edge were then mapped to one of these 
orthogonal planes. These steps are illustrated in Figure 16. The average distance between 
centerline and surface points in the orthogonal plane then define a local radius measure. 
          . 
Figure 16) (Left) Graph from Figure 9 with surface points matched to each edge. (Right) Surface 
points mapped to the plane orthogonal to the midpoint of the centerline.  
When generating the automated measurements, out of the 118 cases nine were eliminated 
due to the inability to generate the automated measurement. The remaining 109 (21 disease cases 
and 88 control cases) were used for comparisons. The nine cases that were eliminated returned 
the same error relating to the plane points and the measurements were unable to be obtained. The 
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exact cause of the error is unclear. At each point along the edge there is a plane of points that 
expands in the x, y and z directions. I believe there may be a gap in these points due to an 
imperfection in the segmentation making a measurement impossible because the points cannot be 
traversed to the surface of the vessel. An error in these points could be caused by an error in the 
graph generation from a faulty segmentation. Further scrutiny will be required to address this 
flaw in the program. 
3.3.4 Statistics for Comparison between Measurements 
This section describes the methods for the analysis of the measurement data. The 
following sections include comparisons within the manual measurements only, the automated 
measurements only, and then a comparison between the two classes of measurements as well. t-
tests were used for determining statistical significance between the classes of measurements and 
the FDA’s method of equivalence analysis was applied to test the agreement between reviewers. 
3.3.5 Determining Agreement between Reviewers of Manual Measurements 
A series of comparisons were performed to determine if the measurements generated by 
the different reviewers met the assumption of no significant difference between the reviewer’s 
measurement values. If there is a large variation in the measurements across reviewers then the 
comparison to the automated measurements will not be informative. We chose to use the FDA’s 
method of equivalence analysis that is used when comparing an original drug to the generic 
version. In this situation the null hypothesis (H0) is the means between the two groups are 
significantly different, the alternative hypothesis (HA) is the means are not significantly different.  
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Six comparisons were generated reviewer 0 vs. 1, 0 vs. 2, 0 vs. 3, 1 vs. 2, 1 vs. 3, and 2 vs. 3.  
The means ( ̅), were calculated for each group. 
The following are the specific steps taken for the generation of this data as reported and 
used by the FDA [65].  
H0: μT / μR ≤ θ1 or μT / μR ≥ θ2 versus HA : θ1 < μT / μR < θ2, where θ1 = 0.80 and θ2 = 1.25. 
Where μT = mean of the first comparison group, and μR = mean of the second comparison 
group. Typically, the H0 is rejected with a type I error α = 0.05 (two 1-sided tests), if the 90% 
confidence interval for the ratio of means between the two groups (μT / μR) is contained within 
the interval [θ1, θ2]. Rejection of the null hypothesis H0 supports the conclusion of equivalence of 
the two products.   In summary, the ratio of the means, 90%, 95% and 99% confidence interval 
was calculated for each comparison and then compared to the specified interval.              
These findings are found in the results Section 4.5.1. 
3.3.6 Manual Measurements of the Negative Cases Compared to the Disease Cases 
We wanted to be sure that the measurements of the control cases were significantly 
different from the disease cases. First, using the manual measurements only, a comparison was 
performed between the control cases and the disease cases. This comparison was done for the 
aorta, pulmonary trunk, right main pulmonary artery and the left main pulmonary artery.  The 
error mean difference and the unpaired t-test were used as measures of significance. The online 
software package GraphPad was used to perform these calculations    
(http://www.graphpad.com/quickcalcs/ttest1/?Format=C). The specific calculations are detailed 
in Appendix D and the findings are outlined in the results Section 4.5.2. 
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The same calculations were used for the comparison within the automated measurements 
as well, for the aorta, pulmonary trunk, right main pulmonary artery and the left main pulmonary 
artery.  The findings for the automated comparisons for the three major pulmonary vessels and 
the aorta can be found in Section 4.5.3. 
3.3.7 Comparison between the Manual Measurements and the Automated Measurements 
We wanted to determine if there was a statistically significant difference between the 
manual and the automated measurements. We calculated the mean ( ̅), variance (S2) and 
standard deviation (S) for each group for each vessel. We then applied the paired t-test using the 
same online software package as in the comparison between disease and controls (GraphPad, 
(http://www.graphpad.com/quickcalcs/ttest1/?Format=C). . 
When determining statistical significance, if the calculated t value was less than the 
critical t-value, there was no difference found between the means of the automated and manual 
measurements. If the calculated t value was greater than the critical -value, then the two means 
were significantly different, and the null was rejected [66]. In addition to the t-test further 
evaluation was performed using Equivalence Analysis as described in Section 3.3.5. In our null 
hypothesis we are making the assumption that there is a difference between the manual and the 
automated measurements. These results as well as the paired t-test values can be found in Section 
4.5.4. 
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3.3.8  Predicting the Presence of Pulmonary Hypertension 
The next step was to determine if we can accurately classify patients based on the 
vasculature measurements as having pulmonary hypertension or not. To answer this question we 
built a logistic regression model using Weka.  The model was given all four of the automated 
measurement variables (the Aorta, PT, RMPA and LMPA) as predictors and the label of disease 
versus control as the target to be predicted for each of the 109 images. 10-fold cross validation 
was used for evaluating the model. We then repeated the experiment using normalized data. We 
normalized each of the four measurements using min-max normalization. The normalized values 
are the values divided by the difference of the minimum and the maximum values. For 
comparison and to rule out any uncertainty surrounding the automated measurements, the same 
models were generated using the manual measurements.  
Table 3). Ranges of Measurements 
 Automated Manual 
Vessel/Class Minimum Maximum Minimum Maximum 
PT Disease 1.29 3.98 2.81 4.23 
RMPA Disease 1.83 3.04 1.70 3.63 
LMPA Disease 1.82 3.09 1.97 3.53 
PT Control 1.08 4.46 1.93 3.90 
RMPA Control 1.1 `3.67 1.48 3.36 
LMPA Control 1.28 3.68 1.32 3.18 
 
An ROC (Receiver Operating Characteristic) analysis was performed. This includes 
calculations of the sensitivity or true positive rate and specificity or true negative rate of the 
model. Sensitivity is calculated as the number of true positives (TP) over the sum of the TP and 
the false negatives (FN). Specificity is calculated as the true negatives (TN) over the sum of the 
false positives (FP) and the TN.  The TP’s are the patients that have PH and were predicted as 
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such. The TN’s are the patients that do not have PH and are predicted as such. The FP’s are those 
predicted to have PH but in reality do not and finally, the FN’s are those that have the disease 
and are classified as negative for the presence of disease. The classification accuracy of the 
model was assessed with the area under the ROC curve (AUC).  
In addition to the logistic regression model a Naïve Bayes model was also generated for 
comparison. The data and methods are the same only the classifying algorithm was changed. The 
findings for both sets of models (one set for the automated measurement data and one set for the 
manually measured data) are detailed in the results Section 4.5.5 and the output is shown in 
Appendix K. 
3.3.9 Generating a Polynomial Regression Model for Predicting Pressure 
This section is focused on the relationship between the measurements and the pressure 
values. Can we predict the arterial pressure based on the diameter measurements gathered? We 
model this relationship by generating a polynomial regression model in SPSS [67]. Polynomial 
regression determines the polynomial equation to predict a response of dependent variables (Y) 
based on a predictor (X) the independent variable. The order of the polynomial determines the 
number of possible inflections on the curvi-linear fitted line. The results from this model are 
summarized in Section 4.5.6 and can be seen in their entirety in Appendix L. 
There are four measurements that were included 1) aorta, used for normalizing across 
patients, 2) pulmonary trunk, 3) right main pulmonary artery and 4) the left main pulmonary 
artery. Additional variables gathered are the mean pulmonary arterial pressure (MPAP), vascular 
pulmonary resistance (VPR), trans-pulmonary gradient (TPG), PA (pulmonary artery) systolic 
and PA diastolic pressures. The MPAP was chosen as the dependent variable because it is 
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measured directly through right heart catheterization where the majority of the other pressures 
are calculated based on other values. The measurement data that are included is dependent on the 
pressure. As the pressure increases the vessel dilates to accommodate; the longer the pressure 
persists the weaker the vessel becomes until it atrophies and begins to deteriorate. For these 
reasons, MPAP was named the dependent variable. The model was generated for both the 
pressure values in combination with the manual measurements and then the automated 
measurements. 
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4.0  RESULTS 
This section summarizes the data gathered and reports the findings in response to the 
methods previously detailed. 
4.1 POWER CALCULATIONS 
I used an online power calculator (http://www.statistical solutions.net/pss calc.php) to 
determine the power of the pressure dataset for either accepting or rejecting the null hypothesis 
with 95% confidence in reference to the pressure data (27 cases). We are testing the null 
hypothesis that the mean pulmonary arterial pressure (MPAP) in the presence of pulmonary 
hypertension (PH) is equal to the MPAP in the absence of PH. We chose a one sided test because 
the only acceptable alternative hypothesis is that the mean pulmonary arterial pressure (MPAP) 
in the presence of pulmonary hypertension (PH) is greater than the MPAP in the absence of PH. 
The mean of the MPAP for the disease cases is 46.5; the mean for the normal cases is 18 and the 
standard deviation of the group is 17.63. According to the online calculator the power for the 
pressure dataset of 27 cases is 1.0.  
I repeated these steps a second time calculating the power based on the automated right 
main pulmonary artery measurements. In this case we are testing the null hypothesis that the 
mean diameter of the right main pulmonary artery (RMPA) in the presence of PH is equal to the 
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mean diameter of the RMPA in the absence of PH. Again I used a one sided test because the only 
viable alternative hypothesis is that the mean diameter of the RMPA in the presence of PH is 
greater than the mean diameter of the RMPA in the absence of PH. The mean of the diameter of 
the RMPA for the disease cases is 2.46; the mean for the normal cases is 2.21 and the standard 
deviation of the group is 0.4. According to the online calculator the power is also 1.0. 
4.2 PREPROCESSING OF THE SEGMENTATIONS 
We found that each of the preprocessing methods reduced the number of edges in the 
original segmentation by about 50%.  Increasing the kernel size had no effect on edge reduction. 
However, using both median filtering and morphological closing resulted in a reduction in the 
number of edges by half compared to using either method alone. I chose to use the method that 
utilized both smoothing methods in combination with an increase in the kernel size giving the 
lowest average number of edges for either segmentation (Column 6).  
Tables 4 and 5 below are the summarized preprocessing results. The full tables of edge 
values for each case in the training set can be found in Appendix E. 
Table 4). Preprocessing of the Aorta Segmentation Data 
 
No 
Preprocessing 
median 
only 
close 
only 
median 
& close 
median & close with a 
kernel size of (2,2,2) 
Total Number of 
Edges 
1510 373 303 228 214 
Average Number 
of Edges per case 
40.81 10.08 8.19 6.16 5.78 
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Table 5). Preprocessing of the Pulmonary Vascular Segmentation Data 
  
No 
Preprocessing 
median 
only 
close 
only 
median 
& close 
median & close with a 
kernel size of (2,2,2) 
Total Number of 
Edges 
1927 678 671 757 626 
Average Number 
of Edges per case 
52.08 18.32 18.14 20.46 16.92 
4.3 EDGE DATA 
In summary, out of the 15 disease cases, 12 (80%) of the aorta segmentations and eight or 
53.3% of the pulmonary vasculature segmentations required editing. For the 70 control cases 34 
aortas (48.57%) required editing and 20 (28.57%) of the pulmonary vasculature segmentations 
required editing. Complete tables of the edge data can be found in Appendix E. 
4.4 PRUNING PREDICTION MODEL FINDINGS 
Appendix F shows the summary statistics from the output of the two models that were 
built for classifying the edges into positives (the edges that should remain) and the negatives (the 
edges that should be removed). When looking at the results there is not much difference between 
the two types of models built whether it is the Simple CART decision tree or the logistic 
regression model. Normalization did not affect the model results. 
Looking at the summary statistics in Table 6 the Simple CART model has a sensitivity or 
true positive rate of 82.4%. The specificity is 96.3%.  The logistic regression model gave a 
sensitivity of 78.7% and a specificity of 87%.  In comparing the two classifiers the Cart model 
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appears to perform slightly better with an ROC area of 89.3% versus the logistic regression at 
84.8%.The actual output generated by Weka for the logistic regression model is also located in 
Appendix F. Due to the size of the output generated by Weka the entire output is available upon 
request but only the summary of the models can be found in Appendix F.  
Table 6 lists the summary statistics for these models. For reference, a perfect model 
would give an ROC area of 1.0.  
Table 6. Summary of model statistics.  
Models Sensitivity Specificity AUC Mean Absolute Error 
CART  82.4% 96.3% 89.3 % 0.0899 
Logistic Regression  78.7% 87 84.8 0.1551 
4.5 MANUAL MEASUREMENTS VS AUTOMATED MEASUREMENTS 
4.5.1 Determining Agreement between Reviewers 
We first analyze the variability between the manual measurements among the different 
reviewers.  
Tables 7a-b) Summary Statistics of the manual measurements for user agreement comparisons 
(n=119 for each reviewer)  
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Table 7a. 
Vessel Aorta Pulmonary Trunk 
Reviewer 0 1 2 3 0 1 2 3 
Mean 3.194 3.284 3.114 3.021 2.826 2.864 2.832 2.733 
Variance 0.343 0.401 0.342 0.383 0.374 0.420 0.402 0.394 
Standard Deviation 0.586 0.633 0.585 0.619 0.612 0.648 0.634 0.628 
SEM 0.054 0.058 0.054 0.057 0.056 0.059 0.058 0.058 
 
Table 7b. 
 
        Vessel RMPA LMPA 
Reviewer 0 1 2 3 0 1 2 3 
Mean 2.284 2.279 2.223 2.197 2.249 2.213 2.209 2.175 
Variance 0.331 0.351 0.346 0.333 0.326 0.297 0.319 0.340 
Standard Deviation 0.575 0.592 0.588 0.577 0.571 0.545 0.565 0.583 
SEM 0.053 0.054 0.054 0.053 0.052 0.05 0.052 0.053 
 
Table 8a) Aorta 
 
Comparison 0 and 1 0 and 2 0 and 3 
Ratio of Means 0.9726 1.0257 1.0573 
Confidence Intervals Lower Upper Lower Upper Lower Upper 
90% CI 0.9342 1.0126 0.9857 1.0673 1.0142 1.1023 
95% CI 0.927 1.0206 0.9782 1.0756 1.0061 1.1113 
99% CI 0.9129 1.0364 0.9635 1.092 0.9904 1.1291 
 
Table 8b). Aorta 
 
Comparison 1 and 2 1 and 3 2 and 3 
Ratio of Means 1.0546 1.08717 1.0308 
Confidence Intervals Lower Upper Lower Upper Lower Upper 
90% CI 1.0125 1.0984 1.0418 1.1344 0.9884 1.0752 
95% CI 1.0045 1.1071 1.0333 1.1438 0.9804 1.084 
99% CI 0.989 1.1244 1.0167 1.1626 0.9649 1.1016 
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Table 9a). Pulmonary Trunk 
 
Comparison 0 and 1 0 and 2 0 and 3 
Ratio of Means 0.9867 0.9979 1.034 
Confidence Intervals Lower Upper Lower Upper Lower Upper 
90% CI 0.9411 1.0347 0.9519 1.0461 0.9858 1.0848 
95% CI 0.9325 1.0443 0.9433 1.0557 0.9768 1.0949 
99% CI 0.9159 1.0633 0.9266 1.0749 0.9592 1.115 
 
Table 9b). Pulmonary Trunk 
 
Comparison 1 and 2 1 and 3 2 and 3 
Ratio of Means 1.0113 1.0479 1.0362 
Confidence Intervals Lower Upper Lower Upper Lower Upper 
90% CI 0.9637 1.0612 0.998 1.1004 0.9871 1.0878 
95% CI 0.9548 1.0712 0.9886 1.1108 0.9779 1.0981 
99% CI 0.9374 1.091 0.9704 1.1317 0.96 1.1186 
 
Table 10a). RMPA 
 
Comparison 0 and 1 0 and 2 0 and 3 
Ratio of Means 1.0022 1.0274 1.0396 
Confidence Intervals Lower Upper Lower Upper Lower Upper 
90% CI 0.9488 1.0587 0.9722 1.086 0.9839 1.0986 
95% CI 0.9388 1.07 0.9619 1.0877 0.9375 1.1104 
99% CI 0.9195 1.0923 0.9419 1.1211 0.9534 1.134 
 
Table 10b). RMPA 
 
Comparison 1 and 2 1 and 3 2 and 3 
Ratio of Means 1.0118 1.0373 0.9754 
Confidence Intervals Lower Upper Lower Upper Lower Upper 
90% CI 0.9221 1.0317 0.9809 1.097 0.9563 1.0706 
95% CI 0.9122 1.043 0.9703 1.109 0.9459 1.0823 
99% CI 0.8928 1.0655 0.9499 1.1329 0.9258 1.1059 
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Table 11a). LMPA 
 
Comparison 0 and 1 0 and 2 0 and 3 
Ratio of Means 1.0163 1.0181 1.034 
Confidence Intervals Lower Upper Lower Upper Lower Upper 
90% CI 0.9632 1.0722 0.964 1.0752 0.9779 1.0936 
95% CI 0.9533 1.0833 0.9539 1.0867 0.9674 1.1055 
99% CI 0.934 1.1056 0.9343 1.1095 0.9471 1.1294 
 
Table 11b). LMPA 
Comparison 1 and 2 1 and 3 2 and 3 
Ratio of Means 0.9982 1.0175 1.0156 
Confidence Intervals Lower Upper Lower Upper Lower Upper 
90% CI 0.9459 1.0533 0.963 1.0753 0.9603 1.0743 
95% CI 0.9361 1.0643 0.9529 1.0869 0.9499 1.0861 
99% CI 0.917 1.0862 0.9332 1.1101 0.9299 1.1096 
 
For each comparison all of the ratio values along with the calculated confidence interval 
values fall within the designated threshold of 0.80 (θ1) and 1.25 (θ2) therefore we reject the null 
and find that the measurements are effectively equivalent. We will now take the average across 
reviewers for each vessel for each case for comparison to the automated values. 
4.5.2 Summary Statistics from Manual Measurements Only: a Comparison between Case 
and Control 
For comparison purposes we need to test whether the manual measurements between the 
disease cases and the control cases are overall significantly different. Since agreement has been 
determined in the previous section, the average across reviewers for each vessel for each case 
was taken.  
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A comparison of the average manual measurements was performed between the control 
cases (n=96) and the disease cases (n=23) for each the Aorta, Pulmonary Trunk (PT), Right Main 
Pulmonary Artery (RMPA) and the Left Main Pulmonary Artery (LMPA). These findings are 
detailed in Tables 12 and 13. When looking at the comparisons of the aortas, the difference in 
means (control versus disease) is less than the error mean difference (EMD) and therefore, the 
controls are not significantly different from the cases. In addition, the p-value is greater than 0.05 
also implying no significant difference. The results are as expected, the aorta was used for 
normalization and is not affected by pulmonary hypertension, and there should not be a 
difference between cases versus controls. On the other hand we expected to find a difference 
between the cases and controls when looking at the comparisons between the different 
pulmonary vessels.  In each of these comparisons (the pulmonary trunk, RMPA and LPMA) the 
difference in means is greater than the EMD and therefore, the controls are significantly different 
from the cases.  We found when comparing the t values to the t critical value (t .05,22 = 1.717) for 
these vessels the t critical is much less than the calculated t therefore, the null of equal means is 
rejected and the control cases are significantly different from the disease cases. For the aorta we 
accept the null of equal means.  
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Table 12. Average manual measurements for comparison between control and disease cases for 
the Pulmonary Trunk and the RMPA. 
Vessel Pulmonary Trunk RMPA 
Label Control Disease Control Disease 
Mean 2.83 3.31 2.18 2.52 
Standard Deviation 0.4313 0.451 0.378 0.438 
N 96 23 96 23 
95% Confidence Interval -0.687 to -0.287 -0.524 to -0.165 
Difference in Means 0.484 0.34 
Standard Error of the 
Mean 
0.044 0.094 0.039 0.091 
Error Mean Difference 0.101 0.09 
t-value 4.8169 3.8079 
p-value < 0.0001 < 0.0002 
 
Table 13. Average manual measurements for comparison between control and disease cases  for 
the LMPA and the Aorta. 
Vessel LMPA Aorta 
Label Control Disease Control Disease 
Mean 2.13 2.57 3.15 3.16 
Standard Deviation 0.3478 0.327 0.455 0.427 
N 96 23 96 23 
95% Confidence Interval -.6056 to -0.2893 -0.2149 to 0.1986 
Difference in Means 0.44 0.01 
Standard Error of the 
Mean 
0.036 0.068 0.0464 0.0891 
Error Mean Difference 0.08 0.104 
t-value 5.604 0.781 
p-value < 0.0001 0.9379 
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4.5.3 Summary Statistics from Automated Measurements Only: a Comparison between 
Case and Control 
Tables 14 and 15 contain the summary statistics for the automated measurement 
comparisons.  
For each comparison, with the exception of the aorta, all the calculated t-values are 
greater than the critical t.05,20 =1.725. Therefore the null hypotheses that the means in each of the 
three main pulmonary vessel comparisons (Pulmonary Trunk, RMPA and LPMA) are equal are 
rejected. The means are significantly different, which was expected as with the findings in the 
comparisons within the manual measurements. Similarly, according to the p value of 0.1844 
there was no difference found for the values of the Aorta and again as in the manual 
measurements the null of equal means is accepted.  
Table 14). Comparisons between the Disease Cases (n=21) and the Control Cases (n=88) within 
the Automated Measurements for the Pulmonary Trunk and RMPA. 
Vessel Pulmonary Trunk RMPA 
Label Control Disease Control Disease 
Mean 2.74 3.12 2.21 2.46 
Standard Deviation 0.513 0.568 0.436 0.38 
N 88 21 88 21 
95% Confidence Interval -.06330 to -0.1288 -0.4561 to -0.0457 
Difference in Means 0.3809 0.2509 
Standard Error of the 
Mean 
0.055 0.124 0.047 0.083 
Error Mean Difference 0.127 0.104 
t-value 2.9951 2.4241 
p-value 0.0034 0.017 
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Table 15). Comparisons between the Disease Cases (n=21) and the Control Cases (n=88) within 
the Automated Measurements for the LMPA and Aorta. 
 
Vessel LMPA Aorta 
Label Control Disease Control Disease 
Mean 2.2 2.53 3.14 3.32 
Standard Deviation 0.383 0.381 0.576 0.475 
N 88 21 88 21 
95% Confidence Interval -0.5112 to -0.1430 -0.4503 to 0.0877 
Difference in Means 0.3271 0.18 
Standard Error of the 
Mean 
0.041 0.083 0.061 0.104 
Error Mean Difference 0.093 0.136 
t-value 3.5227 1.3359 
p-value 0.0006 0.1844 
 
4.5.4 Automated versus Manual Measurement Comparison 
Now that we have discussed the results for the comparisons for each class of 
measurements individually, we will now discuss the comparison of the automated to the manual 
measurements. According to the following Tables 16 and 17, the manual measurements were 
found to be significantly different in reference to the pulmonary trunk and the RMPA. However, 
when looking at the values in Table 17 for the LMPA and the aorta there was no significant 
difference found between the measurements. There are a number of reasons to cause these 
findings and are described at length in the discussion.  
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Table 16). Paired t-test results for the comparison between the automated and manual 
measurements (n=109) for the pulmonary trunk and the RMPA. 
Vessel Pulmonary Trunk RMPA 
Label Manual Automated Manual Automated 
Mean 2.93 2.81 2.179 2.025 
Standard Deviation 0.464 0.543 0.378 0.742 
N 109 109 
95% Confidence Interval 0.037 to 0.198 0.0085 to 0.2988 
Difference in Means 0.12 0.1536 
Standard Error of the 
Mean 0.0444 0.052 0.0385 0.0757 
Error Mean Difference 0.041 0.073 
t-value 2.892 2.102 
p-value 0.0046 0.0382 
 
Table 17). Paired t-test results for the comparison between the automated and manual 
measurements (n=109) for the LMPA and the Aorta. 
Vessel LMPA Aorta 
Label Manual Automated Manual Automated 
Mean 2.215 2.263 3.151 3.175 
Standard Deviation 0.373 0.402 0.445 0.561 
N 109 109 
95% Confidence Interval -0.1021 to 0.0066 -0.0973 to 0.050 
Difference in Means 0.0477 0.024 
Standard Error of the 
Mean 0.0357 0.0385 0.0426 0.561 
Error Mean Difference 0.027 0.037 
t-value 1.74 0.6354 
p-value 0.0847 0.5265 
 
The following Table 18 summarizes the results from the equivalence analysis. Each of 
the ratio values fall within the specified threshold of 0.80 and 1.25. Therefore, we reject the null 
hypothesis of the two groups having significantly different means and instead accept the 
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alternative that the two groups are not significantly different. These findings further support that 
our automated measurements are comparable to the manual measurements.  
Table 18). Equivalence analysis results for the comparison between the automated and manual 
measurements (n=109) for each of the vessels. 
 
Pulmonary 
Trunk RMPA LMPA Aorta 
Ratio of Means 1.0427 1.0765 0.9823 0.9906 
Confidence 
Intervals Lower Upper Lower Upper Lower Upper Lower Upper 
90% CI 1.002 1.085 1.011 1.149 0.945 1.021 0.956 1.027 
95% CI 0.9949 1.0933 0.999 1.165 0.938 1.029 0.949 1.034 
99% CI 0.9802 1.1101 0.976 1.195 0.924 1.044 0.937 1.048 
 
The following four plots Figures 17-20 are scatterplots of the comparison between the 
automated and manual measurements for each vessel. The automated values are along the x-axis 
and the manual measurements are plotted along the y-axis. 
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Figure 17) Measurement Comparisons for the Pulmonary Trunk 
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Figure 18) Measurement Comparisons for the RMPA 
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Figure 19) Measurement Comparisons for the LMPA 
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4.5.5 Models for Predicting Disease State with Automated versus Manual Measurements 
The first set of models generated used the automated measurement data and they include 
a logistic regression model followed by a naïve Bayes that according to Weka literature follows a 
Gaussian distribution and the default classification cutoff threshold value of 0.5 was used. The 
complete output for both of these models using both the original and the normalized data for both 
measurement types can be found in  Appendix K. According to the output generated by Weka, 
there was no difference between the use of the normalized data or the original data for either the 
automated or manual measurement datasets. The models developed using the automated 
measurements are discussed first. The logistic regression model performed slightly better than 
the Naïve Bayes model For the logistic regression model, out of the 88 control cases it classified 
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Figure 20) Meaurement Comparisons for the Aorta 
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85 of them correctly; unfortunately, it only classified 4 out of 21 of the disease cases correctly; 
giving a specificity of 96.6% but a sensitivity of 19%. The naïve Bayes model performed better: 
it classified 80 of the controls correctly and 9 of the disease cases correctly, giving a specificity 
of 90.9% and a sensitivity of 42.9%. The sensitivity and specificity values are shown in the 
output, but were also calculated based on the information shown in the confusion matrix.  
The findings for the models built using the manually measured data appear to be quite 
similar. This was expected because as we have previously shown in Section 4.5.4, the automated 
measurements are not significantly different from the manual measurements. 
Table 19). Summary of ROC Characteristics 
 Logistic Regression Naïve Bayes 
 Manual Automated Manual Automated 
 Original Normal Original Normal Original Normal Original Normal 
Accuracy 83.4% 83.7% 79.82% 79.82% 81.2% 84% 77.98% 77.98% 
SN 28.6% 28.6% 19% 19% 47.6% 52.4% 42.9% 42.9% 
SP 94.3% 93.2% 96.6% 96.6% 92% 85.2% 90.9% 90.9% 
Mean 
Absolute 
Error 
0.2281 0.2286 0.2811 0.2812 0.2096 0.2047 0.2687 0.2696 
ROC Area 83.7% 83.7% 69.4% 69.5% 81.2% 84% 68.1% 68.2% 
4.5.6 Polynomial Regression Model for Predicting Pressure 
Table 20 gives the R (column 2) and adjusted R
2 
(column 3) statistics. These values 
summarize the goodness of the polynomial fit to the observations. The closer the values are to 1 
the better the fit, with a value of 1 indicating a perfect fit. The adjusted R
2
 is similar to R
2
 except 
it accounts for the number of predictors in the model allowing adjusted R
2
 (column 4) statistics 
from models with a different number of predictors to be compared, where R
2 
values cannot.  In 
reference to the table, each of the pressure variables (PA-systolic, PA-diastolic, TPG, and VPR) 
showed adjusted R
2 
and R
2 
values close to 1. The aorta measurement variable gave the poorest 
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values which were expected since the aorta should not be affected by PAH, it is used for 
normalization across patients. The standard error of the estimate is a measure of accuracy of the 
predictions; the smaller the value, the more accurate. In this case the measurements appear to 
have the lower error rate and seem to be better predictors when it comes to the pressure. 
In addition to the R statistics, analysis of variance was also used to test the hypothesis 
that the polynomial fit is a better fit than the mean. The total variance, the variance of the 
predictor fitted to just the mean, is partitioned into variance explained by the polynomial 
regression model and residual variance (the difference from the fitted line to the observations).  
An F- test then compares the variances to determine if they are significantly different. The F 
statistic shows the ratio of the variances (column 6 in Table 20), and the p- value (column 7) the 
probability that the polynomial fit is no better than fitting to the mean. If the p- value is 
significant then polynomial fit is better than the mean [68].   
The complete output from SPSS for the model is found in Appendix L. 
Table 20). Output from the polynomial regression model for both sets of measurements 
Variable R R
2
 Adjusted R
2
 Std. Error of the 
Estimate 
F-value p-value 
Automated Measures 
Aorta .412 .170 .062 .385 1.572 0.223 
PT .619 .383 .302 .497 4.756 0.10 
RMPA .712 .507 .443 .312 7.895 0.001 
LMPA .758 .575 .519 .309 10.362 0.000 
Manual Measures 
Aorta .485 .236 .136 .352 2.364 .097 
PT .753 .568 .511 .380 10.066 .000 
RMPA .656 .431 .356 .392 5.801 .004 
LMPA .778 .605 .553 .276 11.734 .000 
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Table 21. Output from the polynomial regression model for the pressure measurements. 
Variable R R
2
 Adjusted R
2
 Std. Error of the 
Estimate 
F-value p-value 
TPG .973 .946 .939 4.702 135.303 0.000 
VPR .933 .871 .854 2.679 51.631 0.000 
PA_Systolic .981 .962 .958 6.107 196.412 0.000 
PA_Diastolic .920 .846 .826 5.317 42.057 0.000 
 
 The results in Table 20 are comparable across the different sources of measurements. The 
results for the PT, RMPA and LMPA are all larger or closer to 1 than the aorta values.Since the 
aorta is not affected by disease we would expect these values to be close to zero. The manual 
aorta measurements did not give  R
2
 values as close to zero as the automated aorta giving values 
of 0.236 and 0.170 respectively. The corresponding p-values were 0.223 amd 0.97 both greater 
than 0.05 and therefore the aorta measurement is not a predictor of pulmonary artery mean 
pressure.  This will be disussed at length in the discussion in section 5.2.1. It has been stated that 
disgnosis of pulmonary hypertension is done via these specific pressure values. The results 
shown in Table 21 were as expected, the pressure values seem to give the best fit for the model 
with the R
2 
values closest to 1 and p-values less than 0.05. 
Figure 21 shows the model plots for each variable as generated in SPSS.  
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Figure 21. Model plots by measurement variable.  
 
                                (a)       (b) 
 
 
                               (c)       (d) 
* For each plot the x axis is the pulmonary artery mean pressure (PAMP) measured by 
catheterization in mmHg units. For plots a-d, the y-axes are the different automated vessel 
diameter measurements in cm. 
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Figure 22. Model plots by pressure variables. 
 
                              (a)              (b) 
 
                                (c)                                                                         (d) 
* For each plot the x axis is the pulmonary artery mean pressure (PAMP) measured by 
catheterization in mmHg units. Plot a plots the trans-pulmonary gradient (TPG) also in mmHg 
units along the y axis and plot b shows the vascular pulmonary resistance (VPR) in Woods units. 
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Plots c and d have along the y axis the systolic and diastolic pressures by catheterization in 
mmHg units. 
 Referring to the plots specific to the measurements plots a-d in Figure 21, there appears 
to be a functional relationship between the pulmonary artery mean pressure and the RMPA and 
LMPA measurements in the 2.5 cm region. A functional relationship means that when the 
vessels are at a particular size there is a particular range of pressures associated with them.  
The plots are generated using the automated data; the manual measurements would have 
shown a stronger relationship according to the values in Table 19. The aorta measurements as 
expected are scattered and no direct relationship can be seen. For the PT measurements in plot b, 
there are a few outliers that may be skewing the data and will be discussed in Section 5.2.1. The 
question we are asking is can we predict the pulmonary artery mean pressure from the vessel 
diameters?  Since we can as previously reported diagnose disease state and now we have 
identified a functional relationship between the vessel diameters and the pressure, the future step 
would be to use the combination of the vessel diameters to classify pressure based on the 
polynomial regression model.  
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5.0  DISCUSSION 
5.1 HYPOTHESIS 1 
The primary goal of this research was to be able to accurately model and obtain 
vasculature measurements of the three primary arteries of the pulmonary vasculature anatomy 
that in turn could be used for the disease classification and pressure prediction of PAH. If such 
classification and prediction could be done well, it has the potential to aid in the early diagnosis 
and characterization of PAH without the need for invasive catheterization. The gold standard for 
diagnosis of PAH is through right heart catheterization (RHC), an invasive and costly procedure, 
where pressure measurements are made directly within the affected vessels. During RHC a 
catheter is passed in to the right side of the heart through the ventricle to the pulmonary trunk to 
monitor the blood flow as it is being pumped to the lungs as well as cardiac output, the hearts 
function. The fact that PAH is associated with the remodeling of the pulmonary arteries, raises 
the possibility of quantifying the vessel geometry depicted in CT images as an alternative, non-
invasive technique for diagnosing PAH.  
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5.1.1 Specific Aim 1: Create a repository of CTPA exams. The exams will consist of cases 
that are both positive for PAH and are negative for PAH 
Specific aim 1 is self-explanatory, however, the problem encountered during data 
gathering is not. As shown there was plenty of data to perform all of the tasks outlined in this 
research with exception of the pressure data. Although the pressure data does not come into play 
until the end of the second hypothesis, I would like to discuss it now while on the subject of the 
data.  Due to the low prevalence of PAH, it takes years to gather cases. We ended up with 22 
PAH cases that were positive for disease with accompanying CT images. The problem lies with 
the acquisition of the control cases because the majority of people that undergo the right heart 
catheterization procedure do so because elevated pressures are expected, resulting in a low 
number of normal cases partnered with CT exams. Due to the risk of the procedure, it is rarely 
done unless warranted based on an underlying disease involving the heart or the lungs and in 
most cases a normal pressure is a rare event.  Although the normal cases with corresponding 
pressure are limited, it did not affect the outcomes presented in this work. According to the 
power calculation results shown in Section 4.1 both the pressure dataset and the measurement 
dataset gave a power of 1.0. 
5.1.2 Specific Aim 2: Create and validate PUMA, a PUlmonary Mapping and Analysis 
tool that semi-automatically generates pulmonary vascular models.  
To achieve the end result of a semi-automated model, numerous steps had to be taken. 
One of the more difficult steps was in the development of the segmentations. The vasculature 
was segmented as described in the methods in Section 3.2.1. The main problem with this process 
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was choosing an intensity value that would reduce the amount of “bleeding” into the surrounding 
anatomy. The intensity values of the pulmonary vasculature are almost the same as the 
surrounding tissues, making it extremely difficult to segment out the entire vessel of interest and 
not include portions of the heart or the venous system, a problem encountered with the studies 
discussed in Section 2.2.1. Due to this complexity, we were not able to fully automate this 
process as we had originally proposed. Instead we took on the painstakingly tedious job of 
manually segmenting the pulmonary vasculature as described in Section 3.2.1. Having a 
successful automated segmentation method for separating the pulmonary vasculature is a popular 
problem and unfortunately like other researchers we had limited success in finding a solution due 
to the complexity of the vasculature and the low variability in the image intensities of the various 
tissues in the thoracic cavity.  
The next step was to extract the skeletons from the segmentations. Here we encountered 
our next set of problems. The resulting segmentation had holes and errors within the 
segmentation that developed during the skeleton generation process. Three rounds of cleaning 
and inspection reduced these imperfections but did not eliminate them entirely. To try and 
eliminate these imperfections we applied a variety of preprocessing methods to help smooth out 
the segmentation and get a more accurate depiction of the vasculature’s backbone as detailed in 
Section 3.2.3.   
We found that a combined method of median filtering and morphological closing reduced 
the number of the unwanted edges the most. Although the preprocessing greatly reduced these 
unwanted edges, additional methods were needed. After the graphs were generated, we manually 
deleted the extra unwanted edges that remained after preprocessing, as described in Section 
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3.2.6. We then used this data to develop a classifier that separates the edges into those that 
should remain (positive) and those that should be deleted (negative).   
According to the results shown in Table 6 in Section 4.4, the ROC area for the CART 
model is 89.3% and the logistic regression model gave 84.8%.  An online calculator developed at 
Vassar College (http://www.vassarstats.net/roc_comp.html) was used to test whether these ROC 
areas are statistically significantly different. According to the calculator these areas are 
statistically different giving p-values less than 0.05 at 0.04. 
Seven features proved to be strong enough for classifying edges. The features used in the 
development of the pruning model were reasonably discriminatory. However, future automated 
pruning algorithms could consider the anatomic locations (depth in the vascular tree) of the 
edges. Had we incorporated this feature, it would have been much easier to identify the vessels 
we wanted to keep simply by counting down the branches and referring to the three dimensional 
coordinate locations.  
 A possible problem with the pruning data may be the editing of the graph edges. Due to 
human error it is possible that edges remained in the dataset that should have been eliminated 
that were missed, resulting in edges predicted to be negative edges that were labeled as positive , 
and vice versa. An additional problem that led to the retention of unwanted edges occurred 
during the manual editing process; some edges that should have been eliminated were not 
visualized and led to retaining some unwanted edges. Specifically, there were a number of times 
that an edge with the path length of zero was listed and kept in the edited graph because it was 
not visualized to be removed during the manual editing process. Why these zero path length 
edges are listed is not clear. This is an area for further exploration. A more detailed analysis of 
the individual edges, perhaps with the addition of more descriptive features, such as proximity to 
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the larger vessels, as well as branching depths, would help construct a more accurate predictive 
model. This is an area of the research that needs further exploration to find a less tedious method 
of pruning the unwanted edges.  
Future exploration would be to take these classifiers and apply them to the original un-
cleaned graphs to see how well they can classify the wanted from unwanted edges, and how 
successful they are in pruning the graphs. 
At the completion of hypothesis 1, although the model of the vasculature is imperfect, it 
is a semi-automated model that depicts the three major vessels of interest allowing us to proceed 
with the second hypothesis and final aim. 
5.2 HYPOTHESIS 2 
5.2.1 Specific Aim 3: Use PUMA to diagnose PAH. This will be done by performing a 
semi-automated measurement of vascular diameters and making comparisons to 
measurements from known normal cases. 
The main goal of this research is to answer the question can we predict the presence of 
pulmonary hypertension based on CT images of the pulmonary vasculature.  
When looking at the measurements, specifically Table 3 in Section 3.3.8, we would 
expect the overall minimum and the overall maximum measurement values to be greater for the 
disease cases than the normal cases. This is in fact what is shown. The effect of pulmonary 
hypertension on the vessels is similar to the effects of stretching a steel spring. As the spring 
stretches past its plastic deformation limit, it does not return to its original size.  This is what is 
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happening in the vessels. The increase in the pressure distends the vessels and prolonged 
exposure reduces the chances that the vessel will begin to lose its elasticity and start to atrophy. 
An area of future research related to this was touched upon in the background. It would be 
interesting to look at the difference in the diameter of the vessels across the cardiac cycle. One 
measurement would be taken during systole and one during diastole. The difference between 
these two measurements would be taken and used for study. Just like the balloon example the 
difference is expected to be greater for control patients or patients with mild hypertension 
compared to those with more advanced disease. One possible avenue for future work would be to 
add more vessel measurements to the model. If we were to proceed deeper into the vasculature 
and obtain measurements at deeper branching depths and include those values in the 
development of the prediction model, it may improve the accuracy of the model.  In particular, 
due to the nature of the disease the deeper vessels will show the effects of disease if pulmonary 
hypertension is present making it easier to classify disease from controls. Signs of pulmonary 
hypertension are first seen in the most distal vessels or deepest branches and travels up the tree 
until it begins to affect the elasticity of the pulmonary trunk [1]. Obtaining information from 
deeper branching depths would be expected to also improve the model when predicting pressure 
based on the measurements because it would give a more complete picture of the effects of the 
remodeling and the severity of the disease. Incorporating this additional information into the 
regression model would allow the comparison of more severe changes in the vasculature sizes to 
be compared to the pressure changes, it seems plausible that there would be a larger difference 
between the normal cases and the disease cases. This would not only improve the classification 
of the model but it would open up the possibility of classifying the degree of severity of the 
disease by tracking the progression as we travel along the branches of the pulmonary tree.  Of 
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course, the problem with doing this task would be the segmenting out of those additional levels. I 
have shown that it can be done manually, but not easily or quickly.  
When comparing disease and control cases for each of the vessels, we expected to see 
that they are significantly different with the exception of the aorta comparisons. This was the 
case when analyzing the manual measurement data: there is a difference between the control and 
the disease cases shown in Tables 12 and 13 in Section 4.5.2. The same conclusions are made 
when looking at the automated measurements in Tables 14 and 15 in Section 4.5.3.  Each of the 
vessels, excluding the aorta, showed a significant difference between the disease and control 
cases. The p-values are all less than 0.05. For both the manual and automated measurements the 
aorta showed no significant difference between disease cases and control cases.   When 
comparing the manual measurements to the automated measurements there are variations in the 
measurements.  In Table 16 in Section 4.5.4, we report that there is no significant difference 
between the two types of measurements in regards to the pulmonary trunk and the right main 
pulmonary artery. In Table 17 we show the findings for the comparison for left main pulmonary 
artery and the aorta; here there is a significant difference found with respect to the p-values, both 
are greater than 0.05. The equivalence analysis performed for these comparisons reported in 
Table 18 in the same section show that the measurements are comparable and fall within the 
designated threshold across all confidence intervals. The causes for possible differences between 
the measurements may have to do with the location of where the measurement is being made 
within the vessel. Future work to address this problem may be to have the automated 
measurement made at the same location in the vessel that corresponds to the slice where the 
manual measurement is made. This would eliminate the possible variable of measurement 
location affecting the results. Figures 17-20 are scatterplots of the manual measurements on the 
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y-axis and the automated measurements along the x-axis. These plots show the variation in 
values. Specifically Figures 19 and 20, the outliers are easily identified where the automated 
measurements are much greater than the manual measurements. Consistent anatomic location for 
measurement may be able to reduce this variation and help reduce the measurement error. 
We investigated disease classification using machine learning. Two different methods of 
classification, logistic regression and naïve Bayes were applied. Due to the variation between the 
two types of measurement as previously discussed we developed models for both the manual and 
automated measurements. We found that for both classifiers (using normalized data) the manual 
measurements classified more cases correctly with an ROC area of 83.7% for the logistic 
regression model and 84% for the naïve Bayes. . The automated measurements resulted in a 
ROC area for the logistic regression model of 69.5% and 68.2% for the naïve Bayes model. 
These results are encouraging. If improvements are made to this process such as the segmenting 
of additional branches, this may further improve classification. It is very possible that some of 
the disease cases are in the beginning stages and segmenting out the higher order vessels alone 
may not show enough difference from the normal cases to diagnose disease. The model may only 
be classifying the more severe cases, since we do not have a severity of disease attribute and 
there is no way of knowing for sure if this is the case; only future research will resolve this issue.  
Trying to predict a relationship between pressure and size proved difficult. It is plausible 
that the inclusion of gender, weight and height data would have improved the relationship by 
helping to define the baseline size of the pulmonary vessels; however, this data was not available 
to us. The polynomial regression model indicated that pressure was a good classifier of disease. 
However, the measurements were not nearly as strong and this was the case for both types of 
measurements (manual and automated). An important limitation is that we only had five normal 
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cases with pressures and measurements and 27 disease cases with pressures. Depending on the 
severity of disease, it is possible that the three vessels we measured were not yet affected enough 
by disease to reveal the disease reliably. When looking at the output from Table 23 in Section 
4.5.6 for the measurements, as the vessels decrease in size with depth in the pulmonary branches 
the R
2 
values increase. 
 Section 2.2.1 described a study by Devaraj et. al.. They manually measured the segmental 
and subsegmental arteries, which are branches deeper than those presented here. Then using 
linear regression they assessed the relationship of the measurements with the mean pulmonary 
artery pressure. Their main focus was determining the ratio of the main pulmonary artery and the 
ascending aorta because it is a strong indicator of the presence of pulmonary hypertension in 
patients with pulmonary fibrosis. We did not specifically look at this ratio but it would be an area 
for future exploration with this dataset. Our primary focus was to measure the change in vessel 
diameter based on branching depth and the difference between normal and disease cases based 
on vessel diameters at the different branching levels. The majority of their findings are not 
comparable directly because of the stated differences, however, they did report that the 
correlation between the segmental artery and the mean pulmonary artery pressure was found to 
have an R
2
 = 0.19, p-value = 0.001 in 56% of their patients. They found no correlation for the 
subsegmental arteries [26]. According to our results shown in Table 23, we found a relationship 
between the mean pulmonary artery pressure and the PT, RMPA, and LMPA with the exception 
of the automated PT measurement.  These arteries are higher in the pulmonary tree and would be 
less affected by disease than the deeper branches. The exception of the PT value may have to do 
with the potential for extreme outliers because of the method of measurement. Looking at the 
following Figure 23, the same plot found in Section 4.5.6, we can see that at around 60 mmHG 
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there are two extreme PT measurements: one very small around 1.5 cm and one very large 
around 4.0 cm. Since these measurements are automated it is possible that there are errors in the 
anatomic location of the measurements in some of the cases resulting in erratic measurements. 
This is an area for additional research in the future as discussed earlier. 
Figure 23 Plot of PT versus mean pulmonary artery pressure. 
 
 Another study mentioned in Section 2.2.1 was Grubstein et al..  This group measured the 
same vessels as we did and reported a correlation between the pulmonary arteries and pressure 
but not as significant a correlation as were the pressures measured by echocardiography.  
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6.0 CONCLUSION 
In conclusion, PAH is a progressive and potentially fatal disease. PAH causes the 
remodeling of the pulmonary vasculature and because of this we were able to quantify the vessel 
geometry depicted in CT images as a non-invasive technique for diagnosing PAH. The research 
presented in this work provides the foundation for future work of the fully automated 
measurements of the major vessels for diagnosis of disease. We have shown that using 
measurements of the blood vessels are strong indicators for presence of disease, and we are one 
step closer to eliminating the need for the invasive and costly right heart catheterization 
procedure. Even with the limitations of this research we were able to classify just under 75% of 
the patients correctly when using the automated measured data as to whether or not the disease is 
present. If we build upon this work we should include travelling deeper into the vasculature and 
gathering data on deeper branches. For the disease cases, the deeper branches may better reveal 
the effects of the disease and therefore, be better indicators for and improve the classification of 
PAH cases. Of course, gathering additional data, specifically pressures from normal cases, would 
be optimal. Although we have shown there is a relationship between the vessel size and the mean 
pulmonary artery pressure, the increase in branching depth along with more data would vastly 
improve this relationship due to the nature of the disease. The deeper vessels will show the 
effects of the disease before the higher level branches that were segmented in this research. It is 
entirely possible that incorporating this information would give us the ability to predict the 
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pressure accurately within a specified range, thus removing the necessity for RHC. This work 
lays a useful foundation for future work, but improvements need to be made to the generation of 
the automated measurements, specifically consistency needs to be maintained in regards to 
anatomic location to make the values comparable to manual measurements to make this a fully 
automated process.  
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APPENDIX A 
Table 22).  Pressure data for the 27 specified cases 
Image 
Catheter 
Date 
PA Systolic 
Pressure 
PA Diastolic 
Pressure 
PAMP TPG 
1 2/25/2005 73 30 42 38 
3 5/16/2005 125 52 79 70 
5 5/26/2005 45 18 31 23 
6 6/1/2005 83 42 58 48 
8 6/27/2005 40 16 26 19 
9 7/7/2005 33 17 21 7 
10 7/11/2005 111 51 70 63 
11 8/11/2005 27 13 20 7 
13 9/22/2005 100 20 57 50 
15 10/11/2005 28 12 19 10 
19 11/17/2005 75 33 50 39 
20 12/15/2005 74 34 50 34 
23 1/10/2006 40 16 26 10 
24 3/2/2006 24 9 17 5 
25 3/22/2006 112 54 75 69 
27 12/27/2006 75 31 51 37 
28 5/2/2007 59 21 35 24 
29 5/17/2007 19 8 13 6 
32 1/15/2008 44 17 28 17 
33 10/1/2009 80 32 51 41 
34 10/16/2009 83 27 46 36 
35 11/17/2009 66 26 43 30 
36 1/26/2010 108 22 59 38 
37 5/4/2010 52 17 30 18 
38 5/7/2010 67 30 39 14 
40 6/23/2010 50 16 31 13 
41 6/25/2010 87 22 46 31 
*PAMP ~ Pulmonary Artery Mean Pressure, TPG ~ Trans-pulmonary Gradient 
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Table 23). Additional Pressure Data collected for the 27 cases. 
Image PVR 
Days between RHC 
and CT 
CT Date Case Label 
1 8.84 -2 2/23/2005 PH 
3 23.26 +3 5/19/2005 PH 
5 4.41 +12 6/8/2005 PH 
6 15.26 -32 4/30/2005 PH 
8 2.6 +2 6/29/2005 PH 
9 0.84 0 7/7/2005 Normal 
10 24.9 +3 7/14/2005 PH 
11 1.35 -8 8/3/2005 Normal 
13 15.43 0 9/22/2005 PH 
15 2 -12 9/29/2005 Normal 
19 10.54 +8 11/25/2005 PH 
20 8.26 +1 12/16/2005 PH 
23 2.13 +30 2/9/2006 PH 
24 0.57 0 3/2/2006 Normal 
25 21.9 -1 3/21/2006 PH 
27 8.53 +1 12/28/2006 PH 
28 4.94 +1 5/3/2007 PH 
29 0.91 +1 5/18/2007 Normal 
32 3.51 0 1/15/2008 PH 
33 7.41 +1 10/2/2009 PH 
34 11.84 -1 10/15/2009 PH 
35 7.32 0 11/17/2009 PH 
36 5.51 0 1/26/2010 PH 
37 4.44 0 5/4/2010 PH 
38 1.51 0 5/7/2010 PH 
40 2.31 0 6/23/2010 PH 
41 7.36 0 6/25/2010 PH 
*PVR~ Pulmonary Vascular Resistance, RHC ~ Right Heart Catheterization 
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APPENDIX B 
This Section lists the parameters used to generate each of the segmentations for both the 
pulmonary vasculature and the aorta described in Section 3.2.1.  The ROI value or region of 
interest is the value associated with the placement of the red box as demonstrated in Figure 4b. 
The lower and upper are the bounds for the intensity value used for differentiating between the 
vasculature to be segmented out and the surrounding tissues. The curvature value refers to the 
smoothness of the expansion of the bubbles that are placed as seed points to begin the 
segmentation. We found the closer to 1 the value the more smooth, which proved to result in 
cleaner segmentations. 
Table 24. Segmentation Parameters 
Image ROI 
Pulmonary Vasculature Aorta 
Lower Upper Curvature Lower Upper Curvature 
3 0.814453 -161.37 1364.73 1 70.87 468.98 1 
9 0.582031 69.34 577.08 1 69.34 577.08 1 
34 0.53125 101.11 859.26 1 58.99 859.26 1 
39 0.564453 -43.99 937.87 1 -83.27 1252.07 1 
46 0.523438 46.1 715.14 1 46.10 715.14 1 
57 0.650391 120.38 966.61 0.92 819.20 505.03 0.98 
105 0.714844 186.12 577.47 1 55.67 512.25 1 
109 0.796875 20.01 668.23 0.97 60.83 587.79 0.97 
111 0.568359 148 601 0.96 146.15 435.82 0.98 
119 0.976562 128.97 444.61 1 160.54 318.35 1 
127 0.857422 60.69 718.66 1 60.69 796.07 1 
136 0.78125 54.55 558.53 1 121.75 457.73 1 
142 0.537109 252.94 1115.42 0.95 6.52 417.23 0.98 
146 0.486328 321.31 903 1 94.18 903 1 
148 0.859375 48.17 664.09 0.96 23.70 556.01 0.97 
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Image ROI 
Pulmonary Vasculature Aorta 
Lower Upper Curvature Lower Upper Curvature 
156 0.585938 175.75 793.18 0.92 11.10 875.5 0.96 
169 0.734375 17.55 551.32 1 89.20 658.07 1 
184 0.708984 111.51 967.21 1 111.51 967.21 1 
196 0.511719 269.2 816.66 1 184.97 732.44 1 
201 0.703125 89.9 533.28 1 9.16 775.18 1 
202 0.613281 56.13 765.42 1 91.59 800.89 1 
207 0.625 95.89 547.49 1 50.62 660.32 1 
209 0.703125 -12.39 546.13 1 -12.39 865.29 1 
218 0.576172 133.84 833.35 1 92.69 874.5 1 
225 0.662109 224.62 561.59 1 71.45 500.32 1 
228 0.78125 78.93 1380.18 0.99 43.76 817.48 0.98 
231 0.511719 100.73 431 1 11.00 1153 1 
239 0.626953 30.08 730.41 1 30.08 730.41 1 
253 0.703125 -13.42 918.63 1 -225.25 1172.83 1 
259 0.802734 101.93 327.11 1 69.76 455.79 1 
278 0.523438 164.46 717.33 0.99 206.99 674.8 0.98 
282 0.585938 -25.23 635.74 0.95 52.54 557.98 0.97 
288 0.78125 290.26 427.25 0.98 85.28 358.86 0.99 
294 0.613281 94.64 850.51 1 -31.34 1228.45 1 
322 0.724609 27.68 973.38 1 64.05 718.77 1 
328 0.714844 155.11 535.31 0.99 171.67 297.95 0.98 
353 0.703125 87.43 491.46 0.98 53.78 188.44 0.99 
367 0.78125 -128.85 341.26 1 51.96 811.37 1 
369 0.630859 173.68 523.61 1 138.68 978.51 1 
378 0.558594 167.39 1615.27 1 -2.94 1189.42 1 
381 0.601562 101.74 1074.75 1 61.20 628.79 1 
392 0.625 64.75 622.68 1 64.51 478.83 1 
393 0.619141 64.51 622.68 1 64.51 478.83 1 
410 0.564453 301.77 1009.72 1 78.20 1046.98 1 
441 0.617188 112.6 663.08 1 112.6 663.08 1 
453 0.503906 19.63 989.68 0.96 146.15 567 0.98 
455 0.533203 216.82 845.65 1 216.82 845.65 1 
460 0.533203 166.24 576.1 1 43.28 699.06 1 
462 0.535156 193.39 753.49 0.92 153.39 553.46 0.98 
471 0.912109 187.14 737.92 1 125.94 309.54 1 
473 0.78125 17.85 725.53 1 55.09 837.27 1 
482 0.12891 91.8 1093.73 1 -68.51 652.88 1 
499 0.585938 -21.73 35.39 0.96 176.83 653.37 0.96 
502 0.533203 79.36 1151.05 1 117.63 768.3 1 
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Image ROI 
Pulmonary Vasculature Aorta 
Lower Upper Curvature Lower Upper Curvature 
518 0.703125 235.17 513.2 1 26.65 443.69 1 
522 0.6875 210.35 1019.59 1 -87.79 295.54 1 
527 0.708984 86.69 536.61 1 -25.79 911.54 1 
542 0.654297 81.96 644.32 0.91 38.55 363.14 0.98 
547 0.712891 300.91 1209.54 1 82.84 700.7 1 
550 0.847656 126.87 400.45 1 -9.92 1084.39 1 
555 0.556641 155.34 889.45 0.95 155.34 673.54 0.96 
564 0.642578 191.08 585.31 0.92 -6.03 322.49 0.96 
569 0.578125 293.96 962.8 1 43.14 461.17 1 
572 0.599609 284.89 951.14 0.96 76.68 618.01 0.98 
588 0.701172 33.72 677.58 1 67.61 642.03 1 
593 0.654297 17.9 734.3 1 -24.24 355.03 1 
611 0.650391 178.58 896.17 1 -20.75 497.51 1 
612 0.566406 67.58 737.25 1 -44.04 774.46 1 
624 0.603516 189.06 708.14 0.91 -90.45 268.92 0.96 
626 0.652344 97.45 922.24 0.96 14.97 757.28 0.99 
628 0.607422 175.27 1139.65 1 7.55 552.63 1 
629 0.748047 68.35 925.02 1 31.11 403.57 1 
637 0.625 58.51 656.44 1 25.3 1121.5 1 
650 0.642578 96.42 353.75 1 59.66 464.03 1 
671 0.529297 67.77 546.59 1 27.87 626.39 1 
672 0.632812 169.17 371.39 1 -100.48 843.25 1 
679 0.517578 418.54 1087.15 1 84.23 794.63 1 
680 0.642578 114.27 821.59 1 -3.62 978.77 1 
686 0.966797 99.62 333.53 0.98 118.49 660.69 0.99 
690 0.78125 64.17 805.58 1 -9.97 768.51 1 
816 0.78125 109 659 0.91 67.00 532 0.98 
818 0.507812 284.85 928.11 0.92 124.03 606.48 0.98 
820 0.78125 41.7 1152.69 1 80.01 846.21 1 
821 0.564453 396.94 926.48 0.92 152.00 926 0.96 
825 0.632812 201 609 0.9 37.54 323.65 0.98 
829 0.976562 -3.06 184.31 1 104.01 425.22 1 
838 0.78125 50.99 527.23 0.92 50.00 527 0.99 
878 0.828125 -31.14 263.32 0.96 99.73 328.76 0.98 
896 0.660156 179.9 736.73 0.96 60.68 657.2 0.98 
916 0.548828 167.08 710.13 0.92 125.28 668.35 0.96 
919 0.683594 181.94 524.32 0.91 105.86 600.41 0.98 
RV01 0.632812 220.35 566.21 0.98 143.49 912.08 0.97 
RV03 0.587891 151.92 764.52 0.92 229.07 730.58 0.96 
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Image ROI 
Pulmonary Vasculature Aorta 
Lower Upper Curvature Lower Upper Curvature 
RV05 0.578125 200.42 438.17 0.97 200.42 540.08 0.96 
RV06 0.625 90.83 873.23 0.92 59.54 560.27 0.96 
RV08 0.621094 162.68 484.09 1 122.51 684.97 0.99 
RV09 0.658203 121.03 337.83 1 229.43 410.1 1 
RV10 0.695312 192.94 810.86 0.95 192.94 772 0.9 
RV11 0.777344 80.89 552.94 1 80.89 485.51 1 
RV13 0.541016 242.3 890.93 1 204.14 738.31 1 
RV15 0.591797 151.79 1226.31 1 82.46 394.42 1 
RV19 0.488281 276.9 756.44 0.9 92.46 387.56 0.9 
RV20 0.703125 184.41 481.93 0.9 110.03 333.17 0.92 
RV23 0.525391 164.23 566.27 1 3.42 1410.56 1 
RV24 0.488281 210.18 511.14 1 172.56 661.62 1 
RV25 0.619141 208.71 856.66 0.92 208.00 856 0.92 
RV27 0.617188 156.7 437 0.92 611.90 53.42 0.92 
RV28 0.541016 150.54 368.21 1 107.00 803.56 1 
RV29 0.501953 428.45 1183.49 1 145.31 711.59 1 
RV32 0.578125 190.17 867.7 1 99.28 641.86 1 
RV33 0.333984 136.38 459.27 1 182.51 874.41 1 
RV34 0.384766 217.37 821.2 0.92 217.00 670.24 0.96 
RV35 0.609375 258.84 636.5 1 371.93 560.91 1 
RV36 0.330078 247.44 617.51 1 136.42 1838.74 1 
RV37 0.488281 475.95 1108.81 1 249.93 701.97 1 
RV38 0.753906 161.68 578.72 0.96 161.00 578 0.96 
RV40 0.726562 235.96 844.75 0.92 45.71 502.3 0.92 
RV41 0.662109 316.7 1139.52 1 171.49 849.11 1 
 
 107 
APPENDIX C 
This Section contains all of the PUMA scripts referenced throughout this work. 
PreprocessSegmentation.py (referenced in Section 3.2.3) 
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 109 
 
GenerateGraph.py (referenced in Section 3.2.5) 
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rerootGraph.py (referenced in Section 3.2.5) 
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editGraph.py (referenced in Section 3.2.6)  
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getDFEModified.py (referenced in Section 3.2.8.1) 
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grabVolumes.py (referenced in Section 3.2.8.1) 
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Extract_DFE_Values.py (referenced in Section 3.2.8.1) 
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ExtractShapeVolume.py (referenced in Section 3.2.8.1) 
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AutomatedMeasurements4.py (referenced in Section 3.4.2) 
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APPENDIX D 
The specific steps for the calculation of the statistical measures for comparison. 
• Calculate the mean  ̅, variance (S2) and standard deviation(S) for the   
  two groups (with and without PH). 
   ̅     ∑         
       
∑      ̅ 
 
   
 
   
          
• Calculate the difference in means. 
• Calculate the Pooled Standard Deviation: This will provide insight into how much 
variance exists between the groups. 
        √[
[          
 ] [           
 ]
        
]   
                                                                
                                                                   
• Calculate the Error in the Standard Deviation of the Mean Difference: 
                                               
                      (
 
  
 
 
   
)                                
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     is the t value associated with 95% confidence with degrees of    
   freedom of          . 
•  Calculate the t-statistic and compare it to the critical value and determine         
  whether to accept or reject the null of equal means. 
                       
Determining statistical significance: if the difference in means is greater than the Error 
mean difference then the two means are statistically different at the 95% confidence level. This 
means that we are 95% confident that the difference in means is not due to random error.  
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APPENDIX E 
This section contains the complete tables of the resulting edge counts for the different 
preprocessing methods, one for the pulmonary vasculature and one for the aorta as discussed in 
Section 3.2.3 and 4.2. The Tables 25 and 26 contain the edge counts that resulted from the use of 
the editgraph.py script as discussed in Section 3.2.6. on both the pulmonary vasculature and the 
aorta for each case. Table 27 reports the values for the 69 control cases in the training set, and 
Table 28 contains the edge totals for the 15 disease cases. 
Table 25. Pulmonary Vasculature Preprocessing Edge Data 
Image 
Without 
Preprocessing 
median 
only 
close 
only 
median 
& close 
median & close with a 
kernel size of (2,2,2) 
57 13 9 9 11 10 
109 97 13 13 15 9 
111 21 16 16 16 16 
142 81 29 30 33 30 
148 7 5 5 7 7 
156 23 23 24 17 15 
228 92 13 15 24 11 
278 25 17 15 15 21 
282 17 11 9 9 9 
288 28 20 14 27 17 
353 9 7 5 10 7 
453 25 23 23 39 21 
462 29 25 27 25 21 
499 86 13 19 19 9 
542 75 51 48 50 47 
555 272 31 31 34 29 
564 19 16 18 19 16 
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572 9 7 7 7 7 
624 114 18 13 13 15 
626 38 7 7 9 7 
818 14 13 13 15 11 
821 18 19 17 18 18 
825 13 11 13 11 11 
838 56 12 13 11 11 
896 12 7 7 12 9 
916 193 30 30 36 27 
919 126 20 19 19 19 
RV03 27 15 13 23 14 
RV06 126 12 12 20 10 
RV10 13 13 13 13 13 
RV19 69 71 67 67 67 
RV20 9 9 11 11 7 
RV25 13 13 13 11 11 
RV27 25 23 26 29 16 
RV34 86 9 11 19 13 
RV38 31 31 29 29 29 
RV40 16 16 16 14 16 
 
Table 26. Aorta Preprocessing Edge Data 
Image 
Without 
Preprocessing 
median 
only 
close 
only 
median 
& close 
median & close with a 
kernel size of (2,2,2) 
57 3 3 4 3 3 
109 1 2 1 2 2 
111 67 20 14 9 9 
142 16 11 14 6 6 
148 2 ERROR 1 1 1 
156 13 8 13 8 9 
228 7 7 7 7 7 
278 7 7 7 7 7 
282 150 4 3 4 2 
288 40 6 10 5 5 
353 12 7 9 7 7 
453 19 7 9 7 7 
462 4 5 4 5 6 
499 6 6 5 5 1 
542 100 11 11 10 10 
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555 78 12 10 7 11 
564 4 2 6 2 2 
572 5 2 5 2 1 
624 387 13 18 9 10 
626 3 1 3 1 1 
818 62 15 19 13 9 
821 16 10 12 12 10 
825 111 9 14 13 9 
838 7 7 8 7 5 
896 2 2 2 2 2 
916 16 122 14 7 5 
919 8 7 8 7 7 
RV03 3 2 3 2 2 
RV06 77 9 14 4 4 
RV10 5 5 5 3 1 
RV19 9 7 8 7 7 
RV20 7 7 5 7 5 
RV25 7 7 7 7 7 
RV27 234 8 9 8 12 
RV34 8 8 9 8 8 
RV38 5 5 5 5 5 
RV40 9 9 7 9 9 
 
Table 27. The Edge counts for the control cases in the training dataset 
 
Aorta Pulmonary Vasculature 
Image Unedited Edited Unedited Edited 
3 3 NA 7 NA 
9 3 2 3 NA 
39 2 NA 23 NA 
46 9 1 35 20 
57 4 2 10 NA 
105 1 NA 10 8 
109 2 NA 5 NA 
111 2 NA 12 NA 
119 2 NA 5 NA 
142 9 3 5 4 
148 1 NA 5 NA 
156 9 2 3 NA 
201 2 NA 7 NA 
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202 2 NA 3 NA 
207 3 2 11 9 
209 1 NA 8 NA 
223 7 2 8 NA 
228 7 2 11 NA 
231 4 2 5 4 
239 3 NA 5 NA 
253 4 2 13 NA 
278 5 1 11 9 
282 1 NA 3 NA 
322 2 1 9 NA 
328 3 NA 5 NA 
353 7 2 4 3 
369 8 3 14 12 
378 4 2 19 17 
392 2 NA 15 NA 
410 3 2 22 NA 
453 5 2 11 NA 
455 2 NA 40 37 
462 1 NA 14 NA 
471 4 2 17 15 
473 4 2 9 NA 
482 2 NA 15 NA 
499 2 NA 11 NA 
518 5 2 11 NA 
522 2 NA 11 NA 
542 2 NA 8 NA 
547 3 NA 7 NA 
564 3 NA 15 13 
569 6 3 10 NA 
572 2 1 7 NA 
588 1 NA 11 NA 
593 8 2 22 NA 
612 4 2 12 NA 
626 1 NA 9 NA 
628 3 NA 14 13 
629 7 2 11 NA 
650 9 1 19 11 
679 4 2 19 15 
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680 1 NA 23 NA 
686 3 NA 9 NA 
690 2 NA 5 NA 
818 8 1 13 NA 
820 5 2 6 5 
829 2 NA 9 NA 
838 5 2 10 9 
849 9 2 19 NA 
878 7 2 11 NA 
896 2 NA 9 NA 
900 2 NA 9 NA 
916 5 2 7 NA 
919 2 NA 7 NA 
RV09 3 NA 9 NA 
RV11 2 NA 5 4 
RV15 2 NA 12 9 
RV24 3 2 13 NA 
RV29 2 NA 10 9 
 
Table 28. The Edge counts for the disease cases in the training dataset 
 
Aorta Pulmonary Vasculature 
Image Unedited Edited Unedited Edited 
1 5 3 8 7 
3 5 2 9 7 
6 3 NA 12 9 
10 3 NA 11 9 
19 6 2 67 NA 
20 9 2 7 NA 
23 4 3 20 19 
25 9 2 11 NA 
27 5 2 7 NA 
32 5 2 15 NA 
34 8 2 13 9 
35 3 NA 11 NA 
38 7 3 19 17 
40 7 2 9 8 
41 9 3 21 NA 
*Unedited refers to the edge counts after preprocessing with additional edges that needed to be 
manually removed. Edited contains the edge counts after the use of editGraph.py. 
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APPENDIX F 
This section contains the limited output for the classification models for pruning edges 
referred to in 3.8.2 and Section 4.4. Due to length the entire output is available upon request. 
The output from Weka for the Simple CART model  
=== Run information === 
 
Scheme:weka.classifiers.trees.SimpleCart -S 1 -M 2.0 -N 5 -C 1.0 
Relation:     FeatureDataSetNormalizedCompleteRev 
Instances:    1750 
Attributes:   8 
              PathLength 
              MinMaxDiff 
              Min 
              Max 
              Ratio to depth 
              Shape 
              Volume 
              Label 
Test mode:10-fold cross-validation 
 
=== Classifier model (full training set) === 
 
CART Decision Tree 
 
Volume=(0.263247598)|(0.338448776)|(0.155548493)|(0.228946966)|(0.20561028
1)|(0.211827489)|(0.401991288)|(0.262370062)|(0.374797407)|(0.307465205)|(
0.287486218)|(0.432587859)|(0.21388567)|(0.191460935)|(0.160623093)|(0…… 
Number of Leaf Nodes: 8 
 
Size of the Tree: 15 
 
Time taken to build model: 1851.4 seconds 
 
=== Stratified cross-validation === 
=== Summary === 
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Correctly Classified Instances        1628               93.0286 % 
Incorrectly Classified Instances       122                6.9714 % 
Kappa statistic                          0.8013 
Mean absolute error                      0.0899 
Root mean squared error                  0.2676 
Relative absolute error                 25.1294 % 
Root relative squared error             63.2978 % 
Total Number of Instances             1750      
 
=== Detailed Accuracy By Class === 
 
               TP Rate   FP Rate   Precision   Recall  F-Measure   ROC 
Area  Class 
                 0.824     0.037      0.87      0.824     0.846      0.893    
positve 
                 0.963     0.176      0.947     0.963     0.955      0.893    
negative 
Weighted Avg.    0.93      0.144      0.929     0.93      0.93       0.893 
 
=== Confusion Matrix === 
 
    a    b   <-- classified as 
  336   72 |    a = positve 
   50 1292 |    b = negative 
 
The output from Weka for the Logistic Regression model  
Time taken to build model: 1013.41 seconds 
 
=== Stratified cross-validation === 
=== Summary === 
 
Correctly Classified Instances        1489               85.0857 % 
Incorrectly Classified Instances       261               14.9143 % 
Kappa statistic                          0.6117 
Mean absolute error                      0.1551 
Root mean squared error                  0.3734 
Relative absolute error                 43.3628 % 
Root relative squared error             88.2984 % 
Total Number of Instances             1750      
 
=== Detailed Accuracy By Class === 
 
               TP Rate   FP Rate   Precision   Recall  F-Measure   ROC Area  Class 
                 0.787     0.13       0.648     0.787     0.711      0.848    positve 
                 0.87      0.213      0.931     0.87      0.899      0.848    negative 
Weighted Avg.    0.851     0.194      0.865     0.851     0.856      0.848 
 
=== Confusion Matrix === 
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    a    b   <-- classified as 
  321   87 |    a = positve 
  174 1168 |    b = negative 
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The output 
from Weka for the Simple Cart model using the normalized dataset 
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APPENDIX G 
The following table contains the slice data, the levels at which the manual measurements 
were made for each image along with the series from which the measurements were made. 
Table 29. Slice Data 
Cases Aorta PT RMPA LMPA Image Series 
3 131 131 127 138 4 
9 129 129 130 137 6 
34 104 104 105 109 6 
39 142 142 140 147 5 
46 101 101 95 110 5 
57 141 141 139 143 5 
105 178 178 180 198 4 
109 138 138 134 150 5 
111 98 98 96 107 5 
119 29 29 28 37 6 
127 105 105 106 97 4 
136 92 92 94 81 3 
142 111 111 112 123 5 
146 109 109 118 135 5 
148 77 77 86 77 3 
156 105 105 110 121 5 
169 121 121 120 129 5 
184 99 99 98 105 6 
196 104 104 102 118 5 
201 128 128 131 144 5 
202 129 129 131 138 5 
207 149 149 153 161 5 
209 65 65 62 64 5 
218 115 115 112 124 5 
223 37 37 38 52 4 
225 37 37 43 52 5 
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228 94 94 89 85 3 
231 122 122 123 132 5 
239 74 74 82 89 5 
253 111 111 112 107 6 
259 57 57 58 61 104 
278 102 102 112 120 5 
282 109 109 106 115 5 
288 96 96 90 85 3 
294 93 93 94 98 5 
322 122 122 125 134 5 
328 119 119 118 123 5 
353 98 98 95 114 4 
367 94 94 93 84 3 
369 106 106 111 119 5 
378 104 104 103 116 5 
392 133 133 139 149 4 
393 93 93 92 102 5 
410 120 120 118 137 5 
441 117 117 120 133 5 
453 124 124 127 131 5 
455 111 111 117 132 5 
460 125 125 120 148 5 
462 130 130 129 134 5 
471 254 254 238 241 4 
473 92 92 95 87 3 
482 158 158 154 169 5 
499 102 102 105 93 4 
502 96 96 99 106 1 
518 76 76 80 93 5 
522 132 132 133 144 5 
527 29 29 27 31 6 
542 133 133 129 136 7 
547 136 136 139 146 5 
550 83 83 84 79 3 
555 125 125 123 131 5 
564 64 64 63 68 4 
569 125 125 127 146 5 
572 281 281 260 290 5 
588 122 122 117 125 6 
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593 103 103 108 120 5 
611 119 119 117 127 5 
612 110 110 109 118 5 
624 127 127 125 140 5 
626 109 109 116 113 5 
628 116 116 117 130 5 
629 118 118 129 130 5 
637 126 126 125 134 5 
650 122 122 125 121 5 
671 105 105 112 125 5 
672 90 90 84 81 3 
679 174 174 168 193 5 
680 114 114 116 129 5 
686 66 66 73 68 2 
690 70 70 75 60 3 
816 105 105 107 99 2 
818 140 140 139 145 5 
820 79 79 85 74 3 
821 83 83 87 101 5 
825 125 125 126 135 5 
829 119 119 120 98 3 
838 84 84 93 87 3 
878 121 121 124 130 5 
896 127 127 122 135 5 
916 117 117 113 124 5 
919 153 153 155 164 5 
RV09 116 116 115 124 N/A 
RV11 128 128 126 139 N/A 
RV15 79 79 78 70 N/A 
RV24 208 208 212 227 N/A 
RV29 118 118 127 135 N/A 
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APPENDIX H 
Familiarizing Yourself with Osirix 
- These are your mouse controls:   
- The only two buttons you will be using will be the magnifying glass if you choose to 
zoom in and out (when going from left to right it is the fourth button over) and the 
measuring tool the last button (green line). 
- To zoom in and out you select the magnifying glass and then click on the image and hold 
the button down as you zoom in and out 
- To make a measurement you select the measurement tool and then click the spot where 
you want the line to begin and draw over and click where it will end. If you want to erase 
a measurement just click on the measurement and hit delete, to move just again select the 
measurement and drag to where you would like to have it. 
- If the images have not already been imported, you must select the import tab at the top of 
the frame and go to the folder where the data is stored and it will import the folder. When 
starting in Osirix it will look like this after the data is imported:  
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Then just double click on the first series and a new window will open where you can begin 
making your measurements as described below. 
Making the Requested Measurements 
Step1) Select an image. Each image will contain 4 series, shown in the left-hand column.
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Step 2) The first series is the aorta. It is marked as such. In this slice you make a diameter 
measurement of the aorta and a diameter measurement of the pulmonary trunk at the midpoint as 
in the example below. 
 
Step 3) The second series is labeled as the trunk. On this slice you are to make a measurement at 
the bifurcation point between the pulmonary trunk and where the split occurs between the right 
and left pulmonary arteries. As shown below.  
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Step 4) Make a measurements of the right main pulmonary artery.  
 
Step 5) Make a measurement of the left main pulmonary artery. 
 
 
Once finished with a case just close out the window that popped up, not out of Osirix 
completely, click on this red x button above the left hand column that shows the 4 slices and 
below the database button. This will put you back to the initial screen and you can select the next 
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case.  Once finished do not close Osirix I will take over from there. Thank you!
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APPENDIX I 
This is a table containing the averages of the manual measurements partnered with the 
corresponding automated measurements. The third column under each major vessel is the 
difference between the two measurements. 
Table 30. Comparison table of manual and automated measurements 
Aorta PT RMPA LMPA 
Cases Man. Auto. Diff. Man. Auto. Diff. Man. Auto. Diff. Man. Auto. Diff. 
3 2.90 2.22 0.68 3.01 3.25 0.24 2.33 2.67 0.33 2.43 2.44 0.02 
9 2.85 2.46 0.39 2.79 2.84 0.04 2.08 2.08 0.00 1.89 2.01 0.12 
34 2.96 2.53 0.43 2.28 2.58 0.30 1.74 1.78 0.04 1.84 2.06 0.22 
39 3.65 3.72 0.07 3.16 2.47 0.69 3.03 2.20 0.83 2.59 2.31 0.28 
46 3.30 3.49 0.19 3.26 3.61 0.35 2.87 2.90 0.03 2.85 3.04 0.19 
57 3.31 4.77 1.46 2.39 2.74 0.35 1.99 2.59 0.60 2.01 2.59 0.58 
105 2.50 2.52 0.02 2.67 2.56 0.11 1.80 1.65 0.15 1.65 1.77 0.12 
111 2.34 1.78 0.56 2.18 2.44 0.25 2.20 2.06 0.14 1.91 2.51 0.61 
119 2.60 22.44 0.15 3.07 3.05 0.02 2.16 2.18 0.02 1.88 1.81 0.06 
127 2.68 2.78 0.10 2.64 2.54 0.10 1.99 2.31 0.32 1.90 1.96 0.06 
136 2.49 2.41 0.08 2.33 2.90 0.57 2.10 2.26 0.16 2.12 2.44 0.32 
142 2.95 2.69 0.26 2.23 2.16 0.07 2.45 2.23 0.22 2.22 2.23 0.01 
146 3.05 3.34 0.29 2.08 2.17 0.09 2.38 1.88 0.50 2.28 2.37 0.09 
148 3.15 2.86 0.30 3.13 3.04 0.08 2.16 2.36 0.20 2.61 2.38 0.23 
156 2.09 2.16 0.07 1.78 2.06 0.28 1.53 1.22 0.30 1.32 1.41 0.08 
169 2.87 3.04 0.17 2.86 3.01 0.15 2.24 2.18 0.06 2.33 2.15 0.19 
184 3.49 3.32 0.17 2.61 2.76 0.15 2.11 2.37 0.27 2.33 2.31 0.02 
196 3.33 3.21 0.12 2.67 2.47 0.20 2.21 2.72 0.52 2.32 2.46 0.15 
201 3.84 3.36 0.48 3.45 3.62 0.17 2.35 2.41 0.06 2.01 2.19 0.18 
202 2.72 2.52 0.20 2.24 2.59 0.34 1.70 1.58 0.12 1.77 1.89 0.12 
207 2.93 2.78 0.15 2.67 3.68 1.01 2.25 2.63 0.39 2.31 2.72 0.41 
218 3.37 3.87 0.50 2.40 1.08 1.33 2.09 1.10 1.00 2.13 1.28 0.85 
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225 2.78 2.43 0.35 3.24 3.30 0.06 2.13 2.79 0.66 2.52 2.37 0.15 
228 3.28 3.23 0.05 3.12 2.90 0.22 2.02 2.33 0.31 1.95 2.89 0.94 
231 3.17 3.31 0.14 2.51 2.12 0.39 1.70 2.29 0.60 1.93 2.29 0.37 
239 3.04 2.75 0.29 3.12 2.88 0.23 1.55 2.18 0.63 2.21 2.30 0.09 
253 3.56 4.43 0.87 3.42 3.05 0.37 2.11 2.38 0.27 2.15 2.17 0.02 
259 2.73 2.55 0.18 2.84 3.03 0.19 2.39 1.61 0.78 2.05 1.84 0.21 
278 2.93 3.01 0.08 3.07 2.62 0.45 2.46 2.71 0.24 2.53 2.69 0.16 
282 3.30 2.98 0.32 2.96 2.96 0.01 2.80 2.70 0.10 2.34 2.73 0.39 
294 4.91 5.21 0.30 2.52 3.18 0.66 2.36 2.39 0.03 2.15 2.25 0.10 
322 2.73 2.62 0.11 2.53 2.77 0.24 2.78 2.86 0.07 2.18 2.21 0.03 
328 3.16 3.09 0.07 3.27 3.11 0.16 2.21 2.45 0.24 2.31 2.12 0.19 
353 3.14 2.97 0.17 2.58 2.63 0.06 1.90 2.17 0.27 1.71 1.72 0.01 
367 2.97 2.58 0.39 2.74 2.92 0.18 2.35 2.64 0.29 2.21 2.24 0.03 
369 3.57 3.20 0.37 2.16 2.50 0.34 1.78 1.85 0.06 1.74 2.09 0.35 
378 3.63 3.78 0.15 2.97 2.83 0.14 2.35 2.21 0.14 2.32 2.50 0.18 
392 3.16 3.26 0.10 2.92 2.74 0.18 1.48 1.82 0.34 2.00 1.89 0.11 
393 2.50 2.60 0.10 2.25 2.68 0.43 1.76 1.95 0.19 1.84 1.89 0.05 
410 3.07 3.01 0.06 2.49 2.70 0.21 2.31 2.56 0.26 2.16 2.07 0.09 
441 3.56 3.85 0.29 2.48 2.44 0.04 2.33 2.43 0.10 2.94 2.39 0.54 
453 2.72 2.79 0.07 2.45 2.70 0.25 2.20 2.54 0.33 1.98 2.09 0.11 
455 2.99 2.34 0.65 2.52 2.52 0.00 2.38 2.10 0.28 2.06 2.22 0.16 
460 3.29 3.46 0.17 2.96 3.14 0.18 2.57 2.95 0.38 2.41 2.52 0.11 
462 3.19 3.02 0.17 2.60 2.59 0.01 2.55 2.29 0.26 2.11 2.31 0.20 
471 3.40 3.24 0.16 3.25 1.38 1.87 2.65 2.02 0.64 2.34 2.73 0.38 
473 2.92 2.81 0.11 3.12 4.46 1.35 2.26 3.01 0.74 2.34 3.21 0.87 
482 3.72 3.60 0.12 2.88 3.04 0.16 2.35 2.26 0.08 2.18 2.55 0.37 
499 3.01 3.12 0.11 2.35 1.57 0.78 2.72 1.77 0.95 1.47 2.76 1.29 
502 2.68 2.78 0.10 2.49 2.67 0.18 1.87 1.78 0.09 1.68 1.60 0.08 
518 3.16 3.26 0.10 2.97 1.99 0.98 2.09 2.51 0.42 2.16 2.15 0.01 
522 3.75 4.02 0.27 2.17 2.21 0.04 1.83 1.80 0.03 2.04 1.91 0.13 
527 3.13 2.82 0.31 2.48 2.49 0.00 2.36 2.11 0.24 2.13 1.91 0.22 
542 
3.41 3.27 0.14 2.87 3.40 0.53 2.38 2.36 0.01 2.06 2.43 0.37 
547 3.21 3.49 0.28 2.96 2.69 0.27 1.94 1.77 0.18 2.11 2.13 0.03 
550 2.92 3.15 0.23 3.10 2.84 0.26 2.32 1.88 0.44 2.39 2.04 0.35 
555 
3.07 3.01 0.06 2.10 2.33 0.22 1.98 2.13 0.15 1.63 2.30 0.67 
564 2.61 2.85 0.24 2.40 2.16 0.23 1.52 1.49 0.02 1.51 1.65 0.14 
569 
2.90 2.84 0.06 2.21 2.19 0.02 1.90 1.60 0.31 1.78 1.79 0.01 
572 2.36 2.47 0.11 2.08 2.39 0.31 1.92 1.80 0.11 1.95 1.80 0.15 
588 4.03 4.42 0.39 3.20 2.99 0.21 2.62 2.69 0.07 2.44 2.23 0.21 
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593 
3.40 3.26 0.14 3.67 4.00 0.33 3.36 3.67 0.31 3.18 3.68 0.51 
611 3.43 3.57 0.14 2.76 2.88 0.12 2.04 1.97 0.07 2.20 2.03 0.17 
612 2.86 2.95 0.09 2.66 2.72 0.06 1.67 2.22 0.55 1.69 2.10 0.41 
624 
3.47 3.56 0.09 2.99 3.00 0.01 2.22 1.95 0.27 2.53 2.45 0.08 
626 3.51 3.52 0.01 2.53 2.54 0.01 1.87 2.24 0.37 2.22 2.23 0.01 
628 
3.63 3.21 0.42 2.82 2.60 0.22 2.16 2.12 0.04 2.24 2.27 0.03 
629 4.24 3.98 0.26 3.15 3.03 0.12 2.45 2.85 0.40 2.30 2.27 0.03 
637 
3.27 3.46 0.19 3.14 2.70 0.44 1.56 1.96 0.40 1.95 1.87 0.08 
650 3.14 2.97 0.17 3.40 3.06 0.34 2.46 2.11 0.36 2.46 2.17 0.29 
671 3.10 3.16 0.06 2.29 2.32 0.03 1.94 1.89 0.06 1.92 1.77 0.15 
672 
3.08 3.21 0.13 3.05 2.88 0.16 2.24 2.24 0.00 2.44 2.57 0.12 
679 3.16 3.06 0.10 3.36 3.24 0.12 2.48 2.89 0.41 2.50 2.48 0.02 
680 
3.84 3.72 0.12 2.65 2.61 0.05 2.87 2.98 0.11 2.47 2.35 0.12 
690 3.27 3.36 0.09 3.04 3.21 0.18 2.43 2.37 0.06 1.93 1.95 0.02 
816 3.02 2.84 0.18 3.07 3.08 0.01 2.20 1.67 0.53 1.79 2.06 0.27 
820 
2.96 2.81 0.15 2.80 2.80 0.01 2.07 1.77 0.30 2.05 1.84 0.21 
821 3.33 3.52 0.19 2.47 2.50 0.03 2.21 2.00 0.21 1.91 2.02 0.11 
825 
3.68 3.79 0.11 2.48 2.47 0.01 2.35 2.01 0.34 1.89 1.96 0.06 
829 3.67 3.51 0.16 3.29 3.51 0.22 2.25 2.90 0.65 2.61 2.73 0.12 
838 
2.73 2.77 0.04 3.05 2.87 0.18 1.99 2.23 0.24 1.98 2.12 0.14 
878 3.04 3.82 0.78 2.86 3.07 0.20 2.11 2.05 0.06 2.20 2.31 0.11 
896 4.18 4.03 0.15 3.32 3.33 0.00 2.59 2.47 0.12 2.34 2.11 0.23 
916 
2.45 2.49 0.04 1.99 2.06 0.06 1.53 1.61 0.08 1.74 1.72 0.02 
919 2.65 2.98 0.33 2.53 2.34 0.20 1.94 1.80 0.14 1.82 1.80 0.02 
RV09 
3.14 3.11 .03 3.07 2.39 0.68 2.19 2.13 0.06 2.27 1.88 0.39 
RV11 2.99 3.05 .06 2.82 2.93 0.11 2.04 1.96 0.07 2.06 1.94 0.12 
RV29 2.65 2.69 0.04 1.99 1.96 0.03 1.64 1.80 0.17 1.62 1.61 0.01 
RV03 2.99 3.06 0.07 2.89 3.32 0.43 2.75 2.78 0.03 2.68 2.59 0.09 
RV05 3.18 3.11 0.07 3.18 2.84 0.34 2.37 2.10 0.27 2.30 2.14 0.17 
RV06 3.82 4.11 0.30 3.59 3.63 0.05 2.74 2.86 0.12 2.96 2.83 0.13 
RV08 2.90 3.05 0.15 2.66 2.65 0.01 2.35 2.19 0.16 2.53 2.57 0.05 
RV10 3.96 4.08 0.12 3.67 3.42 0.25 2.51 2.61 0.10 2.52 2.72 0.20 
RV13 3.90 3.87 0.03 3.62 3.98 0.36 3.07 2.84 0.23 2.92 2.82 0.11 
RV19 3.38 3.26 0.12 3.33 3.53 0.20 3.03 3.04 0.01 3.08 3.09 0.01 
RV20 4.15 4.19 0.04 3.77 3.62 0.15 2.96 3.01 0.05 2.61 2.62 0.01 
RV23 2.92 2.85 0.07 2.86 2.90 0.03 2.30 2.30 0.00 2.46 2.26 0.21 
RV25 3.22 3.01 0.21 3.16 3.03 0.13 2.54 2.39 0.15 2.53 2.40 0.12 
RV27 3.86 3.76 0.10 3.61 3.83 0.22 2.62 3.03 0.41 2.65 3.06 0.40 
RV28 2.99 3.01 0.02 2.80 3.06 0.26 1.71 2.22 0.52 2.33 2.09 0.24 
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RV32 2.83 2.96 0.13 2.49 2.66 0.17 1.70 1.83 0.13 1.97 1.82 0.15 
RV33 3.41 3.21 0.20 3.33 3.31 0.02 2.35 2.30 0.06 2.50 2.36 0.14 
RV34 2.85 2.80 0.05 2.62 3.06 0.44 2.05 2.11 0.06 2.68 2.37 0.30 
RV35 3.48 3.68 0.20 3.38 3.41 0.03 2.64 2.48 0.16 2.52 2.50 0.01 
RV36 2.93 3.15 0.22 2.69 1.29 1.40 2.31 1.84 0.47 2.34 2.17 0.17 
RV37 3.02 3.09 0.07 2.92 2.89 0.03 2.02 1.99 0.03 2.24 2.14 0.10 
RV38 4.23 4.29 0.06 3.91 3.05 0.85 3.63 2.60 1.04 3.53 3.41 0.12 
RV40 2.81 2.7 0.11 2.52 2.63 0.11 2.73 2.48 0.25 2.41 2.44 0.03 
RV41 3.14 2.98 0.16 3.06 3.36 0.30 2.62 2.66 0.03 2.69 2.67 0.02 
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APPENDIX J 
This section contains the tables of the four reviewer’s original measurements and 
summary data. 
Table 31. Reviewer 0’s measurements for the Control Cases 
 
  Aorta PT RMPA LMPA 
3 3.007 3.027 2.352 2.453 
9 2.907 2.794 2.046 1.941 
34 2.95 2.250 1.742 1.835 
39 3.656 3.329 2.826 2.541 
46 3.332 3.795 3.097 2.818 
57 3.389 2.522 2.207 1.840 
105 2.563 2.663 1.793 1.731 
109 3.401 2.899 2.614 2.662 
111 2.478 2.178 2.226 2.038 
119 2.865 3.183 2.253 1.880 
127 2.674 2.338 2.034 1.977 
136 2.791 2.204 2.160 2.204 
142 3.066 2.266 2.390 2.179 
146 3.118 2.104 2.327 2.237 
148 3.263 3.037 2.174 3.263 
156 2.072 2.143 1.533 1.412 
169 2.976 2.858 2.259 2.440 
184 3.548 2.598 2.127 2.372 
196 3.453 2.898 2.260 2.253 
201 3.927 3.418 2.622 2.038 
202 2.735 2.181 1.964 1.910 
207 2.928 2.621 2.529 2.428 
209 3.264 4.040 2.907 3.023 
218 3.402 2.456 2.122 2.246 
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223 4.106 2.997 2.483 2.687 
225 2.878 3.241 2.573 2.502 
228 3.321 3.161 2.098 2.086 
231 3.183 2.636 1.731 1.977 
239 3.073 3.098 1.740 2.240 
253 3.678 3.413 2.159 2.127 
259 2.812 2.910 2.165 1.977 
278 3.047 3.073 2.574 2.646 
282 3.392 3.152 3.066 2.111 
288 2.565 2.170 2.092 1.817 
294 4.971 2.559 2.327 2.271 
322 2.761 2.577 2.763 2.103 
328 3.176 3.369 2.320 2.338 
353 3.112 2.444 1.732 1.444 
367 3.012 2.830 2.272 2.305 
369 3.778 2.234 1.819 1.867 
378 3.619 3.036 2.246 2.362 
392 3.303 2.855 1.505 1.926 
393 2.622 2.233 1.763 1.954 
410 3.071 2.526 2.399 2.307 
441 3.604 2.555 2.491 2.622 
453 2.778 2.476 2.214 1.909 
455 3.078 2.677 2.278 2.294 
460 3.336 3.320 2.878 2.591 
462 3.049 2.499 2.585 1.957 
471 3.398 3.034 2.532 2.481 
473 2.84 3.009 2.258 2.317 
482 3.77 2.741 2.415 2.079 
499 3.172 2.390 2.728 1.613 
502 2.791 2.452 1.953 1.694 
518 3.264 3.104 2.047 2.126 
522 3.758 2.169 1.881 2.112 
527 3.078 2.383 2.232 2.095 
542 3.477 2.622 2.321 1.912 
547 3.105 2.989 2.098 2.167 
550 2.972 2.876 2.183 2.561 
555 3.04 2.125 1.986 1.381 
564 2.705 2.467 1.538 1.565 
569 2.843 2.153 1.893 1.861 
 156 
572 2.335 2.185 1.922 1.974 
588 3.864 3.023 2.686 2.664 
593 3.308 3.662 3.430 3.139 
611 3.58 2.783 2.120 2.148 
612 2.864 2.960 1.585 1.753 
624 3.485 2.804 2.240 2.563 
626 3.407 2.517 1.718 2.231 
628 3.678 2.912 2.253 2.381 
629 4.136 3.139 2.644 2.366 
637 3.297 3.318 1.666 2.077 
650 2.889 3.393 2.249 2.396 
671 3.201 2.492 2.088 1.981 
672 3.08 2.815 2.208 2.555 
679 3.214 3.397 2.598 2.676 
680 3.94 2.723 3.083 2.431 
686 3.424 2.952 2.702 2.714 
690 3.309 3.321 2.537 1.918 
816 3.162 2.936 2.130 1.730 
818 2.501 2.031 1.346 1.405 
820 3.173 2.840 1.859 2.091 
821 3.325 2.551 2.094 1.910 
825 3.613 2.221 2.272 1.983 
829 3.694 3.340 2.411 2.667 
838 2.814 2.771 1.946 2.153 
878 3.17 2.894 2.089 2.086 
896 4.3 3.354 2.638 2.394 
916 2.471 1.952 1.518 1.655 
919 2.849 2.415 1.902 1.845 
RV09 3.012 2.840 2.156 2.180 
RV11 2.969 2.724 1.978 1.839 
RV15 3.472 2.126 2.112 1.978 
RV24 2.989 2.221 1.530 1.659 
RV29 2.61 2.124 1.690 1.678 
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Table 32). Reviewer 0’s measurements for the Disease Cases 
Cases Aorta PT RMPA LMPA 
RV01DW 2.589 2.951 2.768 2.735 
RV03CH 3.001 2.978 2.778 2.774 
RV05TH 3.048 3.143 2.387 2.193 
RV06AP 3.646 3.609 2.822 3.051 
RV08JR 3.312 2.633 2.32 2.652 
RV10JB 2.5 3.749 2.67 2.537 
RV12DC 2.579 3.147 2.549 2.294 
RV13CB 3.706 3.669 3.041 2.959 
RV19RD 3.368 3.308 3.09 3.107 
RV20CT 3.305 3.709 2.895 2.557 
RV23RB 3.415 2.997 2.086 2.479 
RV25KN 2.929 3.035 2.609 2.488 
RV27TH 4.087 3.819 2.768 2.928 
RV28TB 3.892 2.747 2.086 2.479 
RV32ST 2.837 2.477 1.742 2.036 
RV33TM 3.128 3.302 2.396 2.452 
RV34VS 3.077 2.727 2.065 2.751 
RV35RH 3.614 3.301 2.539 2.57 
RV36LH 2.686 2.676 2.31 2.232 
RV37MW 3.101 3.037 2.172 2.32 
RV38JM 3.207 3.739 3.813 3.532 
RV40RS 2.939 2.514 2.743 2.329 
RV41CB 3.658 2.906 2.807 2.844 
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Table 33) Reviewer 1’s measurements for the Control Cases 
 
Aorta  PT RMPA LMPA 
3 2.8540 3.0830 2.4240 2.5000 
9 2.9410 2.9180 2.1900 1.8620 
34 3.0300 2.2850 1.7530 1.9920 
39 3.6750 3.2150 3.0110 2.6060 
46 3.1590 3.6370 2.7780 2.8430 
57 3.5540 2.2510 1.8300 1.9760 
105 2.4380 2.4820 1.7400 1.7460 
109 3.3530 2.8430 2.7470 2.5910 
111 2.5460 2.1340 2.1120 1.8150 
119 2.7390 2.9050 2.0980 1.8750 
127 2.7170 3.0430 1.9570 2.1000 
136 2.7550 2.3260 2.0600 2.1570 
142 2.7880 2.2910 2.5050 2.1160 
146 3.1930 2.1510 2.5650 2.4490 
148 3.5170 3.1770 2.2720 2.4600 
156 2.2600 1.7060 1.4650 1.4110 
169 2.8880 3.2310 2.2760 2.1970 
184 3.5950 2.7390 2.2420 2.2700 
196 3.5020 2.4950 2.4110 2.4480 
201 4.0110 3.5560 2.3930 2.0350 
202 2.7490 2.2750 1.7050 1.7850 
207 2.8950 2.7170 2.2210 2.1320 
209 3.9590 3.4310 2.7640 2.7640 
218 3.5360 2.4570 2.1220 2.0830 
223 3.9840 2.7510 2.2180 2.6870 
225 2.9160 3.2620 2.0280 2.5190 
228 3.3390 3.0010 1.9210 1.9280 
231 3.2600 2.5610 1.7880 1.9670 
239 3.2400 3.0530 1.4790 2.2320 
253 3.7350 3.6370 2.1680 2.3250 
259 2.6250 3.0420 2.1010 2.0570 
278 2.9440 3.2890 2.7900 2.1390 
282 3.4100 2.9310 2.9000 2.5140 
288 2.7710 2.5090 2.3100 1.5640 
294 5.2250 2.5610 2.4800 2.1390 
322 2.8490 2.3960 2.9560 2.3780 
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328 3.4000 3.2730 2.3710 2.4100 
353 3.5960 2.5990 2.0300 1.9170 
367 3.2000 3.0110 2.4730 2.2150 
369 3.6500 2.2150 1.6860 1.8360 
378 4.0380 2.9450 2.4620 2.4080 
392 3.2090 3.2730 1.5560 1.9610 
393 2.6370 2.2890 1.7420 1.8100 
410 3.0210 2.3980 2.5110 1.9190 
441 3.6920 2.5730 2.3430 2.8780 
453 2.8330 2.3290 2.1970 1.9680 
455 2.9650 2.5230 2.4400 1.8960 
460 3.5120 3.2280 2.8510 2.5420 
462 3.2830 2.5480 2.5870 1.9790 
471 3.5870 3.0850 2.7990 2.3850 
473 2.9600 3.0130 2.4380 2.3300 
482 3.8210 2.4730 2.3480 2.1110 
499 3.1610 2.2510 2.7840 1.4700 
502 2.8670 2.5000 1.9330 1.7670 
518 3.2190 3.2460 1.9160 2.2730 
522 4.1720 2.0390 1.7710 2.1150 
527 3.4680 2.5620 2.3950 2.1990 
542 3.3780 3.0900 2.4750 2.1470 
547 3.2560 3.0460 1.9690 2.1420 
550 3.0700 3.1020 2.3850 2.3670 
555 3.0230 2.0770 2.0090 1.6290 
564 2.5770 2.3380 1.7870 1.6440 
569 2.9640 2.2810 1.8760 1.9330 
572 2.5110 2.0010 1.9610 1.8720 
588 4.3970 3.2520 2.6860 2.5210 
593 3.8110 3.5730 3.5070 3.1570 
611 3.6680 2.7940 2.1810 2.3190 
612 2.9860 2.6800 1.6930 1.5760 
624 3.7020 3.3750 2.2310 2.4430 
626 3.6720 2.5400 1.9740 2.2930 
628 3.7790 2.8820 2.3300 2.3880 
629 4.5820 3.2310 2.4360 2.4970 
637 3.4430 3.4200 1.4660 2.0960 
650 3.3140 3.5970 2.5850 2.7290 
671 3.4340 2.3170 2.0140 1.8400 
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672 3.1610 3.2320 2.2640 2.3940 
679 3.5730 3.4970 2.5540 2.2860 
680 3.9720 2.5290 2.8320 2.4160 
686 4.2510 3.1180 3.0130 2.2680 
690 3.6300 3.4410 2.4580 2.2160 
816 3.2650 3.5720 2.2270 2.0060 
818 2.4770 1.9110 1.1790 1.4990 
820 3.4590 2.9600 1.5110 2.1140 
821 3.3810 2.5310 2.2080 1.9210 
825 3.7190 2.4370 2.5200 1.9060 
829 3.7370 3.4150 2.2420 2.4770 
838 2.5200 3.3840 2.1000 2.0870 
878 3.0170 2.7630 2.1680 2.2870 
896 4.3790 3.1690 2.5650 2.3540 
916 2.5020 1.9440 1.5500 1.7710 
919 2.8420 2.6150 1.9480 1.6870 
RV09 3.2870 3.5750 2.2070 2.3710 
RV11 3.1790 2.8220 2.1920 1.9430 
RV15 3.4940 2.1880 2.1360 1.7130 
RV24 3.0720 2.2450 1.4620 1.5820 
RV29 2.5960 2.0140 1.6730 1.5230 
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Table 34) Reviewer 1’s measurements for the Disease Cases 
 
Aorta  PT RMPA LMPA 
RV01DW 2.462 3.1 2.753 2.364 
RV03CH 2.985 2.92 2.816 2.633 
RV05TH 2.961 3.183 2.379 2.213 
RV06AP 3.692 3.625 2.757 2.994 
RV08JR 3.469 2.736 2.419 2.413 
RV10JB 2.516 3.738 2.727 2.568 
RV12DC 3.179 2.822 2.192 1.943 
RV13CB 3.623 3.753 3.296 3.001 
RV19RD 3.48 3.159 2.976 3.073 
RV20CT 3.601 4.096 3.017 2.504 
RV23RB 3.501 3.1 2.397 2.614 
RV25KN 2.996 3.313 2.625 2.585 
RV27TH 3.962 3.501 2.439 2.151 
RV28TB 3.75 2.828 1.489 2.247 
RV32ST 2.832 2.466 1.728 1.942 
RV33TM 3.155 3.364 2.449 2.586 
RV34VS 3.121 2.672 1.914 2.609 
RV35RH 3.693 3.414 2.599 2.474 
RV36LH 2.648 2.694 2.372 2.312 
RV37MW 3.095 2.898 2.005 2.228 
RV38JM 3.287 3.872 3.691 3.409 
RV40RS 2.897 2.634 2.43 2.46 
RV41CB 3.599 3.282 2.694 2.519 
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Table 35). Reviewer 2’s measurements for the Control Cases 
 
Aorta  PT RMPA LMPA 
3 3.079 2.932 2.37 2.319 
9 2.95 2.639 2.139 1.863 
34 2.889 2.405 1.885 1.969 
39 3.756 3.139 3.099 2.695 
46 3.8 3.053 2.902 2.998 
57 3.391 2.322 2.077 1.871 
105 2.566 3.029 1.824 1.532 
109 3.407 3.031 2.532 2.641 
111 2.2 2.09 2.125 1.866 
119 2.837 3.181 2.242 1.954 
127 2.693 3.122 2.041 1.699 
136 2.222 2.421 2.08 2.009 
142 3.029 2.264 2.485 2.315 
146 2.93 2.098 2.346 2.277 
148 2.965 3.053 2.063 2.477 
156 2.109 1.677 1.545 1.32 
169 3.058 3.086 2.27 2.219 
184 3.521 2.609 2.021 2.323 
196 3.253 2.844 1.808 2.294 
201 3.74 3.343 2.099 2.087 
202 2.811 2.281 1.533 1.815 
207 3.145 2.58 2.262 2.32 
209 3.269 3.904 3.193 3.144 
218 3.291 2.234 2.153 2.21 
223 3.666 2.637 2.25 2.592 
225 2.819 3.225 2.034 2.5 
228 3.308 3.112 2.048 1.801 
231 3.146 2.492 1.708 1.793 
239 3.029 3.222 1.51 2.177 
253 3.362 3.069 2.127 2.152 
259 2.867 3.005 3.427 2.245 
278 3.038 3.261 2.114 2.519 
282 3.197 2.96 2.984 2.457 
288 2.618 2.235 1.958 1.421 
294 4.657 2.472 2.547 2.075 
322 2.712 2.36 2.795 2.156 
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328 3.078 3.215 2.077 2.306 
353 2.744 2.47 1.868 1.636 
367 3.041 2.942 2.349 2.219 
369 3.552 2.159 1.849 1.661 
378 3.503 3.201 2.483 2.352 
392 3.234 3.055 1.572 2.053 
393 2.175 2.084 1.711 1.894 
410 3.158 2.495 2.271 2.309 
441 3.518 2.529 2.253 3.188 
453 2.749 2.463 2.21 2.144 
455 3.012 2.504 2.475 2.244 
460 3.051 2.615 2.114 1.875 
462 3.393 2.972 2.506 2.545 
471 3.198 3.639 2.624 2.382 
473 2.91 3.512 2.017 2.356 
482 3.745 3.606 2.274 2.381 
499 2.859 2.335 2.703 1.428 
502 2.463 2.751 1.809 1.702 
518 3.039 3.007 2.044 2.152 
522 3.631 2.116 1.796 2.073 
527 3.033 2.243 2.432 2.259 
542 3.358 3.032 2.438 2.064 
547 3.153 2.865 1.851 2.083 
550 2.891 3.558 2.281 2.236 
555 3.084 2.096 1.932 1.77 
564 2.871 2.374 1.284 1.487 
569 2.906 2.354 1.882 1.758 
572 2.348 2.178 1.938 1.997 
588 3.97 3.413 2.487 2.531 
593 3.335 3.573 3.373 3.206 
611 3.067 2.706 1.819 2.15 
612 2.652 2.876 1.618 1.662 
624 3.101 3.24 2.294 2.739 
626 3.395 2.466 1.914 2.181 
628 3.648 2.84 2.182 2.184 
629 3.992 3.037 2.58 2.191 
637 3.239 3.169 1.419 1.923 
650 3.674 3.311 2.736 2.614 
671 2.542 2.305 1.87 2.014 
 164 
672 2.841 3.355 2.24 2.477 
679 2.864 3.364 2.331 2.655 
680 3.69 2.577 2.752 2.653 
686 3.267 2.994 2.677 2.315 
690 3.221 2.803 2.224 1.98 
816 3.084 2.946 2.488 1.685 
818 2.39 1.883 1.109 1.401 
820 2.749 2.888 1.493 1.98 
821 3.343 2.542 2.204 1.841 
825 3.555 2.439 2.284 1.848 
829 3.644 3.292 2.076 2.494 
838 2.71 3.24 1.815 1.8 
878 3.087 2.735 2.132 2.173 
896 3.95 3.477 2.456 2.352 
916 2.466 1.973 1.528 1.682 
919 2.494 2.288 1.988 1.859 
RV09 3.147 3.364 2.084 2.335 
RV11 2.989 2.706 2.165 1.819 
RV15 3.454 2.117 2.103 1.817 
RV24 2.995 2.149 1.494 1.626 
RV29 2.603 1.99 1.597 1.639 
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Table 36). Reviewer 2’s measurements for the Disease Cases 
 
Aorta  PT RMPA LMPA 
RV01DW 2.585 2.948 2.733 2.412 
RV03CH 2.829 2.786 2.577 2.666 
RV05TH 2.819 3.066 2.343 2.334 
RV06AP 3.598 3.52 2.54 2.916 
RV08JR 3.228 2.643 2.289 2.69 
RV10JB 2.576 3.653 2.508 2.488 
RV12DC 2.534 3.007 2.323 2.192 
RV13CB 3.492 3.559 2.946 2.71 
RV19RD 3.435 3.48 2.988 3.004 
RV20CT 3.546 3.676 2.766 2.617 
RV23RB 3.42 2.879 2.301 2.575 
RV25KN 2.84 3.17 2.519 2.427 
RV27TH 3.885 3.615 2.892 2.607 
RV28TB 3.724 2.839 1.635 2.378 
RV32ST 2.825 2.501 1.685 1.993 
RV33TM 3.111 3.315 2.411 2.47 
RV34VS 3.029 2.674 1.947 2.614 
RV35RH 3.549 3.312 2.632 2.48 
RV36LH 2.597 2.765 2.355 2.325 
RV37MW 3.072 2.903 2.054 2.196 
RV38JM 3.25 3.702 3.567 3.409 
RV40RS 2.954 2.4 2.7 2.329 
RV41CB 3.531 2.839 2.61 2.563 
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Table 37). Reviewer 3’s measurements for the Control Cases 
  Aorta PT RMPA LMPA 
3 2.67 3.009 2.189 2.435 
9 2.616 2.826 1.947 1.912 
34 2.985 2.183 1.591 1.561 
39 3.507 2.942 3.166 2.524 
46 2.924 2.542 2.715 2.742 
57 2.91 2.46 1.849 2.365 
105 2.418 2.49 1.856 1.592 
109 3.156 3.336 2.573 2.573 
111 2.131 2.335 2.335 1.906 
119 1.945 3.004 2.045 1.793 
127 2.651 2.041 1.929 1.812 
136 2.206 2.352 2.116 2.09 
142 2.925 2.105 2.4 2.274 
146 2.969 1.954 2.288 2.138 
148 2.868 3.234 2.137 2.25 
156 1.91 1.589 1.559 1.145 
169 2.552 2.255 2.171 2.48 
184 3.282 2.506 2.035 2.353 
196 3.105 2.451 2.342 2.278 
201 3.67 3.502 2.291 1.888 
202 2.574 2.242 1.617 1.553 
207 2.751 2.774 1.969 2.36 
209 2.71 4.016 2.845 2.934 
218 3.254 2.465 1.969 1.996 
223 3.643 2.738 2.329 2.542 
225 2.514 3.212 1.878 2.564 
228 3.133 3.207 2.021 1.983 
231 3.078 2.336 1.566 1.98 
239 2.835 3.095 1.46 2.208 
253 3.463 3.567 1.995 1.995 
259 2.598 2.393 1.855 1.926 
278 2.687 2.67 2.37 2.832 
282 3.199 2.785 2.262 2.289 
288 2.313 2.446 2.016 1.54 
294 4.806 2.49 2.092 2.103 
322 2.615 2.778 2.622 2.102 
328 2.968 3.217 2.089 2.182 
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353 3.102 2.803 1.982 1.838 
367 2.639 2.193 2.301 2.114 
369 3.302 2.036 1.783 1.595 
378 3.346 2.71 2.206 2.146 
392 2.901 2.492 1.293 2.051 
393 2.57 2.41 1.808 1.701 
410 3.027 2.534 2.044 2.109 
441 3.432 2.263 2.238 3.055 
453 2.511 2.517 2.198 1.894 
455 2.913 2.364 2.334 1.815 
460 3.271 2.666 2.443 2.636 
462 3.039 2.372 2.519 1.946 
471 3.399 3.241 2.662 2.129 
473 2.96 2.94 2.336 2.371 
482 3.543 2.683 2.343 2.142 
499 2.842 2.422 2.682 1.37 
502 2.58 2.245 1.792 1.572 
518 3.137 2.533 2.349 2.079 
522 3.441 2.35 1.886 1.874 
527 2.96 2.746 2.369 1.971 
542 3.41 2.718 2.279 2.122 
547 3.338 2.943 1.857 2.032 
550 2.762 2.872 2.445 2.387 
555 3.113 2.116 1.994 1.751 
564 2.274 2.403 1.459 1.346 
569 2.9 2.056 1.967 1.576 
572 2.257 1.969 1.839 1.97 
588 3.892 3.108 2.617 2.046 
593 3.141 3.88 3.125 3.199 
611 3.39 2.774 2.036 2.181 
612 2.957 2.118 1.779 1.774 
624 3.58 2.552 2.108 2.385 
626 3.564 2.598 1.865 2.155 
628 3.408 2.65 1.866 1.996 
629 4.238 3.197 2.125 2.132 
637 3.1 2.671 1.67 1.704 
650 2.681 3.281 2.282 2.096 
671 3.221 2.05 1.804 1.834 
672 3.224 2.7782 2.257 2.34 
 168 
679 2.994 3.172 2.436 2.365 
680 3.774 2.785 2.829 2.368 
686 3.607 2.89 2.047 1.839 
690 2.904 2.581 2.502 1.608 
816 2.587 2.832 1.963 1.738 
818 2.677 1.87 1.125 1.152 
820 2.467 2.52 3.413 2.006 
821 3.285 2.255 2.344 1.971 
825 3.829 2.819 2.333 1.83 
829 3.59 3.109 2.266 2.814 
838 2.864 2.798 2.1 1.876 
878 2.872 3.062 2.07 2.258 
896 4.077 3.289 2.7 2.254 
916 2.345 2.105 1.533 1.857 
919 2.426 2.821 1.921 1.902 
RV09 3.101 2.504 2.293 2.211 
RV11 2.818 3.04 1.805 2.645 
RV15 3.314 2.062 1.982 1.964 
RV24 3.15 2.058 1.567 1.803 
RV29 2.772 1.835 1.58 1.623 
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Table 38). Reviewer 3’s measurements for the Disease Cases 
 
Aorta  PT RMPA LMPA 
RV01DW 2.363 3.087 2.565 2.586 
RV03CH 2.683 2.874 2.812 2.633 
RV05TH 2.873 3.324 2.387 2.475 
RV06AP 3.638 3.591 2.836 2.863 
RV08JR 3.327 2.631 2.382 2.35 
RV10JB 2.299 3.542 2.15 2.496 
RV12DC 2.262 3.289 2.21 2.328 
RV13CB 3.538 3.498 3.007 3.029 
RV19RD 3.422 3.38 3.048 3.137 
RV20CT 3.267 3.615 3.169 2.742 
RV23RB 3.199 2.481 2.421 2.19 
RV25KN 2.651 3.114 2.419 2.616 
RV27TH 4.121 3.5 2.384 2.93 
RV28TB 3.756 2.798 1.62 2.206 
RV32ST 2.631 2.502 1.648 1.919 
RV33TM 2.92 3.325 2.15 2.504 
RV34VS 2.816 2.421 2.26 2.745 
RV35RH 3.372 3.488 2.805 2.544 
RV36LH 2.576 2.632 2.219 2.497 
RV37MW 2.775 2.85 1.855 2.233 
RV38JM 3.038 4.312 3.454 3.777 
RV40RS 3.093 2.536 3.042 2.505 
RV41CB 3.541 3.219 2.372 2.823 
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APPENDIX K 
This section contains the output from the disease classification model in its entirety.  
LOGISTIC REGRESSION MODEL OUTPUT WITH ORIGINAL DATA 
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NAÏVE BAYES MODEL OUTPUT WITH ORIGINAL DATA 
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NAÏVE BAYES MODEL OUTPUT WITH NORMALIZED DATA 
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LOGISTIC REGRESSION MODEL OUTPUT WITH NORMALIZED DATA 
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LOGISTIC REGRESSION MODEL NORMALIZED MANUAL DATA 
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LOGISTIC REGRESSION MODEL NORMALIZED DATA MANUAL DATASE
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NAÏVE BAYES MODEL WITH ORIGINAL DATA ON MANUAL DATASET 
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NAÏVE BAYES MODEL WITH NORMALIZED DATA AND MANUAL DATASET 
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APPENDIX L 
The output from the polynomial regression model for predicting pressure. 
 
Curve Fit 
Notes 
Output Created 24-OCT-2012 20:17:55 
Comments  
Input 
Data 
C:\Users\dave\Documents\My 
Dropbox\Data\Prediction_Models\Pressure
Data.sav 
Active Dataset DataSet2 
Filter <none> 
Weight <none> 
Split File <none> 
N of Rows in Working Data File 27 
Missin
g Value 
Handling 
Definition of Missing 
User-defined missing values are treated as 
missing. 
Cases Used 
Cases with a missing value in any variable 
are not used in the analysis. 
Syntax 
CURVEFIT /VARIABLES= Aorta PT RMPA 
LMPA TPG VPR PA_Systolic PA_Diastolic 
WITH PAMP 
 /CONSTANT 
  /MODEL=CUBIC 
 /PRINT ANOVA 
  /PLOT NONE 
  /ID=Disease_State. 
Resou
rces 
Processor Time 00:00:00.06 
Elapsed Time 00:00:00.09 
Use 
From First observation 
To Last observation 
Predict 
From First Observation following the use period 
To Last observation 
Time 
Series Settings 
(TSET) 
Amount of Output PRINT = DEFAULT 
Saving New Variables NEWVAR = NONE 
Maximum Number of Lags in 
Autocorrelation or    
Partial Autocorrelation Plots 
MXAUTO = 16 
Maximum Number of Lags Per Cross-Correlation 
Plots 
MXCROSS = 7 
Maximum Number of New Variables Generated Per 
Procedure 
MXNEWVAR = 60 
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Maximum Number of New Cases Per Procedure MXPREDICT = 1000 
Treatment of User-Missing Values MISSING = EXCLUDE 
Confidence Interval Percentage Value CIN = 95 
Tolerance for Entering Variables in 
Regression Equations 
TOLER = .0001 
Maximum Iterative Parameter Change CNVERGE = .001 
Method of Calculating Std. Errors for 
Autocorrelations 
ACFSE = IND 
Length of Seasonal Period Unspecified 
Variable Whose Values Label Observations in Plots Unspecified 
Equations Include CONSTANT 
Model Description 
Model Name MOD_1 
Dependent Variable 
1 Aorta 
2 PT 
3 RMPA 
4 LMPA 
5 TPG 
6 VPR 
7 PA_Systolic 
8 PA_Diastolic 
Equation 1 Cubic 
Independent Variable PAMP 
Constant Included 
Variable Whose Values Label Observations in Plots Disease_State 
Tolerance for Entering Terms in Equations .0001 
Case Processing Summary 
 N 
Total Cases 27 
Excluded Cases
a
 0 
Forecasted Cases 0 
Newly Created Cases 0 
a. Cases with a missing value in any variable are excluded from the analysis. 
Variable Processing Summary 
 Variables 
Dependent Independent 
Aorta PT RMPA LMPA TPG VPR PA_Systolic PA_Diastolic PAMP 
Number of Positive Values 27 27 27 27 27 27 27 27 27 
Number of Zeros 0 0 0 0 0 0 0 0 0 
Number of Negative Values 0 0 0 0 0 0 0 0 0 
Number of 
Missing Values 
User 0 0 0 0 0 0 0 0 0 
System 0 0 0 0 0 0 0 0 0 
Aorta/Cubic 
Model Summary 
R R Square Adjusted R Square Std. Error of the Estimate 
.412 .170 .062 .385 
The independent variable is PAMP. 
ANOVA 
 Sum of Squares df Mean Square F Sig. 
Regression .700 3 .233 1.572 .223 
Residual 3.416 23 .149   
Total 4.117 26    
The independent variable is PAMP. 
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Coefficients 
 Unstandardized Coefficients Standardized 
Coefficients 
T Sig. 
B Std. Error Beta 
PAMP .067 .077 3.020 .868 .394 
PAMP ** 2 -.001 .002 -4.815 -.642 .527 
PAMP ** 3 5.228E-006 .000 1.689 .400 .693 
(Constant) 2.140 .966  2.214 .037 
PT/Cubic 
Model Summary 
R R Square Adjusted R Square Std. Error of the Estimate 
.619 .383 .302 .497 
The independent variable is PAMP. 
ANOVA 
 Sum of Squares df Mean Square F Sig. 
Regression 3.524 3 1.175 4.756 .010 
Residual 5.681 23 .247   
Total 9.204 26    
The independent variable is PAMP. 
Coefficients 
 Unstandardized Coefficients Standardized Coefficients t Sig. 
B Std. Error Beta 
PAMP .117 .099 3.547 1.182 .249 
PAMP ** 2 -.002 .002 -4.772 -.738 .468 
PAMP ** 3 8.066E-006 .000 1.743 .479 .637 
(Constant) .732 1.246  .587 .563 
RMPA/Cubic 
Model Summary 
R R Square Adjusted R Square Std. Error of the Estimate 
.712 .507 .443 .312 
The independent variable is PAMP. 
ANOVA 
 Sum of Squares df Mean Square F Sig. 
Regression 2.307 3 .769 7.895 .001 
Residual 2.240 23 .097   
Total 4.547 26    
The independent variable is PAMP. 
Coefficients 
 Unstandardized Coefficients Standardized Coefficients t Sig. 
B Std. Error Beta 
PAMP .054 .062 2.304 .859 .399 
PAMP ** 2 .000 .001 -1.801 -.312 .758 
PAMP ** 3 2.720E-007 .000 .084 .026 .980 
(Constant) 1.049 .783  1.340 .193 
LMPA/Cubic 
Model Summary 
R R Square Adjusted R Square Std. Error of the Estimate 
.758 .575 .519 .309 
The independent variable is PAMP. 
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ANOVA 
 Sum of Squares df Mean Square F Sig. 
Regression 2.970 3 .990 10.362 .000 
Residual 2.198 23 .096   
Total 5.168 26    
The independent variable is PAMP. 
Coefficients 
 Unstandardized Coefficients Standardized Coefficients t Sig. 
B Std. Error Beta 
PAMP .086 .062 3.461 1.389 .178 
PAMP ** 2 -.001 .001 -3.803 -.709 .486 
PAMP ** 3 3.219E-006 .000 .928 .307 .761 
(Constant) .578 .775  .745 .464 
TPG/Cubic 
Model Summary 
R R Square Adjusted R Square Std. Error of the Estimate 
.973 .946 .939 4.702 
The independent variable is PAMP. 
ANOVA 
 Sum of Squares df Mean Square F Sig. 
Regression 8974.234 3 2991.411 135.303 .000 
Residual 508.507 23 22.109   
Total 9482.741 26    
The independent variable is PAMP. 
Coefficients 
 Unstandardized Coefficients Standardized Coefficients t Sig. 
B Std. Error Beta 
PAMP .323 .940 .304 .344 .734 
PAMP ** 2 .012 022 1.016 .533 .599 
PAMP ** 3 5.247E-005 .000 -.353 -.329 .745 
(Constant) -1.826 11.790  -.155 .878 
VPR/Cubic 
Model Summary 
R R Square Adjusted R Square Std. Error of the Estimate 
.933 .871 .854 2.679 
The independent variable is PAMP. 
ANOVA 
 Sum of Squares df Mean Square F Sig. 
Regression 1111.886 3 370.629 51.631 .000 
Residual 165.103 23 7.178   
Total 1276.989 26    
The independent variable is PAMP. 
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Coefficients 
 Unstandardized Coefficients Standardized Coefficients t Sig. 
B Std. Error Beta 
PAMP -.083 .536 -.212 .155 .878 
PAMP ** 2 .005 .013 1.233 .417 .681 
PAMP ** 3 5.154E-006 .000 -.095 -.057 .955 
(Constant 1.067 6.718  .159 .875 
PA_Systolic/Cubic 
Model Summary 
R R Square Adjusted R Square Std. Error of the Estimate 
.981 .962 .958 6.107 
The independent variable is PAMP. 
 
ANOVA 
 Sum of Squares df Mean Square F Sig. 
Regression 21979.926 3 7326.642 196.419 .000 
Residual 857.925 23 37.301   
Total 22837.852 26    
The independent variable is PAMP. 
 
Coefficients 
 Unstandardized Coefficients Standardized Coefficients t Sig. 
B Std. Error Beta 
PAMP 2.081 1.222 1.261 1.703 .102 
PAMP ** 2 -.005 .029 -.260 -.163 .872 
PAMP ** 3 7.021E-006 .000 -.030 -.034 .973 
(Constant) -9.607 15.315  -.627 .537 
PA_Diastolic/Cubic 
Model Summary 
R R Square Adjusted R Square Std. Error of the Estimate 
.920 .846 .826 5.317 
The independent variable is PAMP. 
ANOVA 
 Sum of Squares df Mean Square F Sig. 
Regression 3566.390 3 1188.797 42.057 .000 
Residual 650.129 23 28.266   
Total 4216.519 26    
The independent variable is PAMP. 
Coefficients 
 Unstandardized Coefficients Standardized Coefficients t Sig. 
B Std. Error Beta 
PAMP 1.507 1.063 2.126 1.417 .170 
PAMP ** 2 -.026 .025 -3.320 -1.027 .315 
PAMP ** 3 .000 .000 2.186 1.201 .242 
(Constant) -8.713 13.332  -.654 .520 
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Output from the polynomial regression model using the manual measurements with the pressure 
data. 
* Curve Estimation. 
TSET NEWVAR=NONE. 
CURVEFIT 
  /VARIABLES=PA_Systolic PA_Diastolic TPG PVR PT RMPA LMPA Aorta WITH 
PAMP 
  /CONSTANT 
  /MODEL=CUBIC 
  /PRINT ANOVA 
  /PLOT FIT 
  /ID=label. 
Curve Fit 
Notes 
Output Created 01-NOV-2012 16:36:34 
Comments  
Input 
Active Dataset DataSet0 
Filter <none> 
Weight <none> 
Split File <none> 
N of Rows in Working Data 
File 
27 
Missing Value Handling 
Definition of Missing User-defined missing values are treated as missing. 
Cases Used 
Cases with a missing value in any variable are not used in 
the analysis. 
Syntax 
CURVEFIT 
  /VARIABLES=PA_Systolic PA_Diastolic TPG PVR PT 
RMPA LMPA Aorta WITH PAMP 
  /CONSTANT  /MODEL=CUBIC 
 /PRINT ANOVA 
  /PLOT FIT 
  /ID=label. 
Resources 
Processor Time 00:00:03.84 
Elapsed Time 00:00:04.04 
Use 
From First observation 
To Last observation 
Predict 
From First Observation following the use period 
To Last observation 
Time Series Settings 
(TSET) 
Amount of Output PRINT = DEFAULT 
Saving New Variables NEWVAR = NONE 
Maximum Number of Lags in 
Autocorrelation or Partial 
Autocorrelation Plots 
MXAUTO = 16 
Maximum Number of Lags 
Per Cross-Correlation Plots 
MXCROSS = 7 
Maximum Number of New 
Variables Generated Per 
Procedure 
MXNEWVAR = 60 
Maximum Number of New 
Cases Per Procedure 
MXPREDICT = 1000 
Treatment of User-Missing 
Values 
MISSING = EXCLUDE 
Confidence Interval 
Percentage Value 
CIN = 95 
Tolerance for Entering 
Variables in Regression 
Equations 
TOLER = .0001 
Maximum Iterative Parameter 
Change 
CNVERGE = .001 
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Method of Calculating Std. 
Errors for Autocorrelations 
ACFSE = IND 
Length of Seasonal Period Unspecified 
Variable Whose Values Label 
Observations in Plots 
Unspecified 
Equations Include CONSTANT 
[DataSet0]  
Model Description 
Model Name MOD_2 
Dependent Variable 
1 PA_Systolic 
2 PA_Diastolic 
3 TPG 
4 PVR 
5 PT 
6 RMPA 
7 LMPA 
8 Aorta 
Equation 1 Cubic 
Independent Variable PAMP 
Constant Included 
Variable Whose Values Label Observations in Plots label 
Tolerance for Entering Terms in Equations .0001 
Case Processing Summary 
 N 
Total Cases 27 
Excluded Cases
a
 0 
Forecasted Cases 0 
Newly Created Cases 0 
a. Cases with a missing value 
in any variable are excluded from the 
analysis. 
Variable Processing Summary 
 Variables 
Dependent Indepen
dent 
PA_Sy
stolic 
PA_Di
astolic 
TPG PVR PT RMPA LMP
A 
Aorta PAMP 
Number of Positive Values 27 27 27 27 27 27 27 27 27 
Number of Zeros 0 0 0 0 0 0 0 0 0 
Number of Negative Values 0 0 0 0 0 0 0 0 0 
Number of Missing Values 
User-
Missing 
0 0 0 0 0 0 0 0 0 
System-
Missing 
0 0 0 0 0 0 0 0 0 
PA_Systolic/Cubic 
Model Summary 
R R Square Adjusted R Square Std. Error of the Estimate 
.981 .962 .958 6.107 
The independent variable is PAMP. 
ANOVA 
 Sum of Squares Df Mean Square F Sig. 
Regression 21979.926 3 7326.642 196.419 .000 
Residual 857.925 23 37.301   
Total 22837.852 26    
The independent variable is PAMP. 
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Coefficients 
 Unstandardized Coefficients Standardized Coefficients t Sig. 
B Std. Error Beta 
PAM
P 
2.081 1.222 1.261 
1.70
3 
.102 
PAM
P ** 2 
-.005 .029 -.260 
-
.163 
.872 
PAM
P ** 3 
-
7.021E-006 
.000 -.030 
-
.034 
.973 
(Con
stant) 
-9.607 15.315  -
.627 
.537 
 
 
PA_Diastolic/Cubic 
Model Summary 
R R Square Adjusted R Square Std. Error of the Estimate 
.920 .846 .826 5.317 
The independent variable is PAMP. 
ANOVA 
 Sum of Squares Df Mean Square F Sig. 
Regression 3566.390 3 1188.797 42.057 .000 
Residual 650.129 23 28.266   
Total 4216.519 26    
The independent variable is PAMP. 
 
Coefficients 
 Unstandardized Coefficients Standardized Coefficients t Sig. 
B Std. 
Error 
Beta 
PAMP 1.507 1.063 2.126 1.417 .170 
PAMP ** 2 -.026 .025 -3.320 -1.027 .315 
PAMP ** 3 .000 .000 2.186 1.201 .242 
(Constant) -8.713 13.332  -.654 .520 
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TPG/Cubic 
Model Summary 
R R Square Adjusted R Square Std. Error of the Estimate 
.973 .946 .939 4.702 
The independent variable is PAMP. 
ANOVA 
 Sum of Squares Df Mean Square F Sig. 
Regression 8974.234 3 2991.411 135.303 .000 
Residual 508.507 23 22.109   
Total 9482.741 26    
The independent variable is PAMP. 
Coefficients 
 Unstandardized Coefficients Standardized Coefficients t Sig. 
B Std. Error Beta 
PAMP .323 .940 .304 
.
344 
.734 
PAMP ** 2 .012 .022 1.016 
.
533 
.599 
PAMP ** 3 -5.247E-005 .000 -.353 
-
.329 
.745 
(Constant) -1.826 11.790  -
.155 
.878 
 
 
PVR/Cubic 
Model Summary 
R R Square Adjusted R Square Std. Error of the Estimate 
.933 .871 .854 2.679 
The independent variable is PAMP. 
ANOVA 
 Sum of Squares Df Mean Square F Sig. 
Regression 1111.886 3 370.629 51.631 .000 
Residual 165.103 23 7.178   
Total 1276.989 26    
The independent variable is PAMP. 
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Coefficients 
 Unstandardized Coefficients Standardized Coefficients t Sig. 
B Std. Error Beta 
PAMP -.083 .536 -.212 -.155 .878 
PAMP ** 2 .005 .013 1.233 .417 .681 
PAMP ** 3 -5.154E-006 .000 -.095 -.057 .955 
(Constant) 1.067 6.718  .159 .875 
 
PT/Cubic 
Model Summary 
R R Square Adjusted R Square Std. Error of the Estimate 
.753 .568 .511 .380 
The independent variable is PAMP. 
ANOVA 
 Sum of Squares Df Mean Square F Sig. 
Regression 4.363 3 1.454 10.066 .000 
Residual 3.323 23 .144   
Total 7.686 26    
The independent variable is PAMP. 
Coefficients 
 Unstandardized Coefficients Standardized Coefficients t Sig. 
B Std. 
Error 
Beta 
PAMP .054 .076 1.793 .714 .482 
PAMP ** 2 -2.644E-005 .002 -.080 -.015 .988 
PAMP ** 3 -5.148E-006 .000 -1.217 -.400 .693 
(Constant) 1.559 .953  1.636 .116 
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RMPA/Cubic 
Model Summary 
R R Square Adjusted R Square Std. Error of the Estimate 
.656 .431 .356 .392 
The independent variable is PAMP. 
ANOVA 
 Sum of Squares Df Mean Square F Sig. 
Regression 2.669 3 .890 5.801 .004 
Residual 3.527 23 .153   
Total 6.196 26    
The independent variable is PAMP. 
Coefficients 
 Unstandardized Coefficients Standardized Coefficients t Sig. 
B Std. Error Beta 
PAMP .095 .078 3.483 
1
.208 
.239 
PAMP ** 2 -.001 .002 -4.523 
-
.728 
.474 
PAMP ** 3 6.077E-006 .000 1.601 
.
458 
.651 
(Constant) .553 .982  .
563 
.579 
 
LMPA/Cubic 
Model Summary 
R R Square Adjusted R Square Std. Error of the Estimate 
.778 .605 .553 .276 
The independent variable is PAMP. 
 
 
ANOVA 
 Sum of Squares Df Mean Square F Sig. 
Regression 2.688 3 .896 11.734 .000 
Residual 1.756 23 .076   
Total 4.444 26    
The independent variable is PAMP. 
Coefficients 
 Unstandardized Coefficients Standardized Coefficients t Sig. 
B Std. 
Error 
Beta 
PAMP .119 .055 5.182 2.158 .042 
PAMP ** 2 -.002 .001 -7.465 -1.443 .163 
PAMP ** 3 9.382E-006 .000 2.918 1.002 .327 
(Constant) .300 .693  .433 .669 
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Aorta/Cubic 
Model Summary 
R R Square Adjusted R Square Std. Error of the Estimate 
.485 .236 .136 .352 
The independent variable is PAMP. 
ANOVA 
 Sum of Squares Df Mean Square F Sig. 
Regression .877 3 .292 2.364 .097 
Residual 2.845 23 .124   
Total 3.722 26    
The independent variable is PAMP. 
Coefficients 
 Unstandardized Coefficients Standardized Coefficients t Sig. 
B Std. Error Beta 
PAMP .079 .070 3.774 1.130 .270 
PAMP ** 2 -.001 .002 -6.098 -.847 .405 
PAMP ** 3 6.547E-006 .000 2.225 .549 .588 
(Constant 1.976 .882  2.241 .035 
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